Best of the Healthy Skepticism Library

This page lists the best 8869 references in the Main Healthy Skepticism chosen by Peter Mansfield.

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.


HSL16707
Kuehn BM.
Clinical Trials Registry Expands
JAMA 2009 Jul 1;301(1):22
http://jama.ama-assn.org/cgi/content/extract/302/1/22

HSL16681
Chan J, Kliner M, Currie J.
Preserving objectivity in medical education
Lancet 2009 Jun 27;373(9682):2197
Link to source with long URL

HSL16682
Rogans-Watson R.
Preserving objectivity in medical education
Lancet 2009 Jun 27;373(9682):2196
Link to source with long URL

HSL16683
Jessop V, Maxwell S.
Preserving objectivity in medical education
Lancet 2009 Jun 27;373(9682):2196-7
Link to source with long URL

HSL16677
Smyth RL.
Making information about clinical trials publicly available
BMJ. 2009 Jun 25;228
http://www.bmj.com/cgi/content/extract/338/jun25_1/b2473

HSL16705
Kuehn BM.
FDA tells drug and device makers to give balanced picture of risks in ads, labels.
JAMA 2009 Jun 24;301(24):2541
http://jama.ama-assn.org/cgi/content/full/301/24/2541

HSL16664
Lenzer J.
Patient Safety: Watching over the medical device industry
BMJ. 2009 Jun 23;338
http://www.bmj.com/cgi/content/extract/338/jun23_1/b2321

HSL16719
Van Die MD, Bone KM, Burger HG, Teede HJ.
Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial
BMC Medical Research Methodology 2009 2009 Jun 23;9(41)
http://www.biomedcentral.com/1471-2288/9/41/abstract

HSL16654
Stafford N.
German agency refuses to rule on drug’s benefits until Pfizer discloses all trial results
BMJ. 2009 Jun 22;338
http://www.bmj.com/cgi/content/extract/338/jun22_1/b2521

HSL16713
Vivian JC.
Pharmacists Beware: Data Mining Unlawful
US Pharmacist 2009 Jun 18;34(6):48-49
http://www.uspharmacist.com/content/c/13856/

HSL16588
Evans SJ.
Papers with industry ties: Classic confounding conflicts
BMJ. 2009 Jun 15;338
http://www.bmj.com/cgi/content/extract/338/jun15_1/b2397

HSL16650
Chalmers I, Glasziou P.
Avoidable waste in the production and reporting of research evidence
The Lancet 2009 Jun 15
Link to source with long URL

HSL16556
Silversides A.
Charter challenge of ban on direct-to-consumer advertising to be heard by Ontario court in mid-June
CMAJ 2009 Jun 11;181(1)
http://www.cmaj.ca/earlyreleases/091050.pdf

HSL16560
Lenzer J.
Doctors’ group files legal charges against nine French doctors
BMJ. 2009 Jun 11;338
http://www.bmj.com/cgi/content/extract/338/jun11_1/b2347

HSL16550
Steinbrook R.
A Higher Bar — Vermont's New Law on Marketing Prescribed Products
The New England Journal of Medicine 2009 Jun 10
http://content.nejm.org/cgi/content/full/NEJMp0904719

HSL16622
Martín-Llaguno M, Alvarez-Dardet C.
[Withdrawal of an advertising campaign to promote the quadrivalent human papilloma virus vaccine in Spain].
Gac Sanit. 2009 Jun 10
http://www.elsevier.es/revistas/error404.jsp

HSL16542
Lavery JV, Singer PA, Ridzon R, Singh JA, Slutsky AS, Anisko JJ, Buchanan D.
In Global Health Research, Is It Legitimate To Stop Clinical Trials Early on Account of Their Opportunity Costs?
PLoS Med 2009 Jun 9;6(6)
Link to source with long URL

HSL16543
Sweet M.
Australian research council reviews conflict of interest requirements
BMJ. 2009 Jun 9;338
http://www.bmj.com/cgi/content/extract/338/jun09_1/b2338

HSL16547
Sridharan L, Greenland P.
Editorial Policies and Publication Bias: The Importance of Negative Studies
Arch Intern Med. 2009 Jun 8;169(11):1022-1023
http://archinte.ama-assn.org/cgi/content/short/169/11/1022

HSL16520
Incomplete reporting of research in academic press releases
The Lancet 2009 Jun 6;373(9679):1920
Link to source with long URL

HSL16571
Reis T.
Estudo mostra que jornais e revistas são mais importantes que DIM
Medico Familia 2009 Jun 4
Link to source with long URL

HSL16518
Harris E.
Science in court
BMJ 2009 Jun 3;338:b2254
http://www.bmj.com/cgi/content/extract/338/jun03_1/b2254

HSL16497
Gallagher R.
For Shame, Merck and Elsevier
The Scientist 2009 Jun 2;23(6):13
http://www.the-scientist.com/article/display/55741/

HSL16500
Lenzer J.
US Congress introduces bill to end free access to federally funded research.
BMJ 2009 Jun 1;338:b2199
http://www.bmj.com/cgi/content/extract/338/jun01_2/b2199?papetoc

HSL16526
Lee AL.
Changing Effects of Direct-to-Consumer Broadcast Drug Advertising Information Sources on Prescription Drug Requests.
Health Commun 2009 Jun;24(4):361-376
http://www.ncbi.nlm.nih.gov/pubmed/19499430

HSL16527
Tsai MH, Chi SC, Hu HH.
Salespeople's Renqing Orientation, Self-esteem, and Selling Behaviors: An Empirical Study in Taiwan.
J Bus Psychol 2009 Jun;24(2):193-200
Link to source with long URL

HSL16528
Madlon-Kay DJ.
Drug promotion in a family medicine training center: 21 years later.
Fam Med 2009 Jun;41(6):386-7
http://www.stfm.org/fmhub/fm2009/June/Diane386.pdf

HSL16530
Harris G.
Pharmaceutical representatives do influence physician behaviour.
Fam Pract 2009 Jun;26(3):169-70
http://fampra.oxfordjournals.org/cgi/content/full/26/3/169

HSL16524
Moncrieff J, Cohen D
How do psychiatric drugs work?
BMJ. 2009 May 29;338:b1963
http://www.bmj.com/cgi/content/short/338/may29_1/b1963

HSL16519
Spielmans GI.
The promotion of olanzapine in primary care: An examination of internal industry documents
Social Science & Medicine 2009 May 27
Link to source with long URL

HSL16479
Kuehn BM.
IOM: Increase Policing of Conflicts of Interest
JAMA 2009 May 27;301(20):2083
http://jama.ama-assn.org/cgi/content/extract/301/20/2083?etoc

HSL16489
Mintzes B, Morgan S, Wright JM.
Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale
PLoS One 2009 May 27;4(5)
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0005699

HSL16506
Jutel A, Menkes DB.
'But Doctors do it...': Nurses' Views of Gifts and Information from the Pharmaceutical Industry(June).
Ann Pharmacother 2009 May 26
http://www.ncbi.nlm.nih.gov/pubmed/19470854?

HSL16488
Cohen D.
Scientists fear that libel ruling will inhibit debate.
BMJ 2009 May 26;338:b2127
http://www.bmj.com/cgi/content/extract/338/may26_3/b2127

HSL16452
Sismondo S.
Medical publishing and the drug industry: Is medical science for sale?
Academic Matters 2009 May 24
Link to source with long URL

HSL16424
Annas GJ.
Globalized Clinical Trials and Informed Consent
The New England Journal of Medicine 2009 May 14;360(20):2050-2053
http://content.nejm.org/cgi/content/full/360/20/2050

HSL16413
Kuehn BM.
Associations Say No to Industry Funding
JAMA 2009 May 13;301(18):1865-6
http://jama.ama-assn.org/cgi/content/short/301/18/1865

HSL16414
Mitka M.
Unbiased Drug Information
JAMA 2009 May 13;301(18):1868
http://jama.ama-assn.org/cgi/content/extract/301/18/1868-b

HSL16467
Green DA.
Don't criticise, or we'll sue
New Scientist 2009 May 13(2708)
Link to source with long URL

HSL16406
Chimonas S, Kassirer JP.
No More Free Drug Samples?
PloS Med 2009 May 12;6(5)
Link to source with long URL

HSL16456
Dorn SD, Farley JF, Hansen RA, Shah ND, Sandler RS.
Direct to Consumer and Physician Promotion of Tegaserod Correlated with Physician Visits, Diagnoses, and Prescriptions.
Gastroenterology 2009 May 12
Link to source with long URL

HSL16403
Grande D, Frosch DL, Perkins AW, Kahn BE.
Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences
Annals of Internal Medicine 2009 May 11;69(9):887-893
http://archinte.ama-assn.org/cgi/content/abstract/169/9/887

HSL16404
Greenland P.
Time for the Medical Profession to Act
Annals of Internal Medicine 2009 May 11;169(9):829-831
http://archinte.ama-assn.org/cgi/content/short/169/9/829

HSL16407
Jagsi R, Sheets N, Jankovic A, Motomura AR, Amarnath S, Ubel PA.
Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research
Cancer 2009 May 11
Link to source with long URL

HSL16415
Moynihan R.
Merck defends Vioxx in court, as publisher apologises for fake journal
BMJ. 2009 May 11;338
http://www.bmj.com/cgi/content/extract/338/may11_1/b1914

HSL16380
A really serious conflict
Nature Medicine 2009 May 9;15:463 - 464
http://www.nature.com/nm/journal/v15/n5/full/nm0509-463.html

HSL16384
Moynihan R.
Canadian media company demands right to publish direct to consumer drug advertising
BMJ. 2009 May 8;338
http://www.bmj.com/cgi/content/extract/338/may08_2/b1912

HSL16386
Fischer MA, Keough ME, Baril JL, Saccoccio L, Mazor KM, Ladd E, Worley AV, Gurwitz JH
Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?
J Gen Intern Med 2009 May 8
http://www.springerlink.com/content/404524217248p861/

HSL16374
Kamerow D.
Yankee Doodling: No gifts, please, we’re doctors
BMJ. 2009 May 7;338
http://www.bmj.com/cgi/content/extract/338/may07_1/b1835

HSL16387
Atherly A, Rubin PH.
The Cost-Effectiveness of Direct-to-Consumer Advertising for Prescription Drugs.
Med Care Res Rev. 2009 May 7
http://mcr.sagepub.com/cgi/rapidpdf/1077558709335362v1

HSL16364
Woloshin S, Schwartz LM, Casella SL, Kennedy AT, Larson RJ.
Press Releases by Academic Medical Centers: Not So Academic?
Annals of Internal Medicine 2009 May 5;150(9): 613-618
http://www.annals.org/cgi/content/full/150/9/613

HSL16369
Roehr B
Report calls for end of drug promotion to doctors.
BMJ. 2009 May 5;338:b1852
http://www.bmj.com/cgi/content/extract/338/may05_2/b1852

HSL16684
Hahn J, Hargreaves R, Hinde A, Huggins JP, Cohen J, Gillen D.
An academia—industry partnership in health care
Lancet 2009 May 2;373(9674):1504-5
Link to source with long URL

HSL16446
Grens K.
Pharma on Facebook?
The Scientist 2009 May 1;23(5):19
http://www.the-scientist.com/article/display/55631/

HSL16507
Lafley AG
What only the CEO can do.
Harv Bus Rev 2009 May;87(5):54-62,
http://www.ncbi.nlm.nih.gov/pubmed/19462856

HSL16454
Meffert JJ.
Key opinion leaders: where they come from and how that affects the drugs you prescribe.
Dermatol Ther 2009 May-Jun;22(3):262-8
Link to source with long URL

HSL16455
Lindstrom JA.
Sources of drug information: FDA-approved labeling and other official FDA sources.
Dermatol Ther. 2009 May-Jun;22(3):246-56
Link to source with long URL

HSL16457
Nakayama DK, Bozeman AP.
Industry support of graduate medical education in surgery.
Am Surg 2009 May;75(5):395-400
http://www.ncbi.nlm.nih.gov/pubmed/19445290

HSL16342
Steinbrook R.
Controlling Conflict of Interest — Proposals from the Institute of Medicine
NEJM 2009 Apr 29
http://content.nejm.org/cgi/content/full/NEJMp0810200

HSL16333
Moynihan R.
Merck disguised 'marketing publication' as medical journal to help promote Vioxx, court hears.
BMJ. 2009 Apr 28;338:b1714
http://www.bmj.com/cgi/content/extract/338/apr28_1/b1714

HSL16298
Anderson T.
Novartis under fire for accepting new reward for old drug
The Lancet 2009 Apr 25;373(9673):1414
Link to source with long URL

HSL16726
Hirsh J, Guyatt G.
Clinical experts or methodologists to write clinical guidelines?
Lancet 2009 Apr 24
Link to source with long URL

HSL16389
Levaggi R, Orizio G, Domenighini S, Bressanelli M, Schulz PJ, Zani C, Caimi L, Gelatti U.
Marketing and pricing strategies of online pharmacies.
Health Policy 2009 Apr 23
Link to source with long URL

HSL16279
Roehr B
Drug industry protests over need to register trial results.
BMJ 2009 Apr 22;338:b1652
http://www.bmj.com/cgi/content/extract/338/apr22_1/b1652

HSL16282
Spence D.
From the Frontline: Pride and prejudice
BMJ. 2009 Apr 22;338
http://www.bmj.com/cgi/content/extract/338/apr22_1/b1632

HSL16308
Asberg C, Johnson E.
Viagra Selfhood: Pharmaceutical Advertising and the Visual Formation of Swedish Masculinity.
Health Care Anal 2009 Apr 22
http://www.springerlink.com/default.mpx

HSL16280
Antonuccio D, Healy D.
Stealth advertising and academic stalking.
BMJ 2009 Apr 21;338:b1612
http://www.bmj.com/cgi/content/extract/338/apr21_3/b1612

HSL16281
Dudley N
JAMA's rule needs time limit.
BMJ. 2009 Apr 21;338:b1615
http://www.bmj.com/cgi/content/extract/338/apr21_3/b1615

HSL16245
Siva N.
The drug price is right—or is it?
The Lancet 2009 Apr 18;373(9672):1326 - 1327
Link to source with long URL

HSL16246
Strahlman E, Rockhold F, Freeman A.
Public disclosure of clinical research
The Lancet 2009 Apr 18;373(9672):1319 - 1320
Link to source with long URL

HSL16350
Pocock SJ, Ware JH.
Translating statistical findings into plain English
The Lancet 2009 Apr 16
Link to source with long URL

HSL16217
The trouble with screening
The Lancet 2009 Apr 11;373(9671):1223
Link to source with long URL

HSL16218
Aronson JK, Barnett DB, Breckenridge AM, Ferner RE, Jackson P, Maxwell SR, McInnes GT, Rawlins MD, Ritter JM, Routledge P, Walley TJ, Webb DJ, Williams D, Woods KL.
The UK's NHS and pharma: need for more clinical pharmacologists
The Lancet 2009 Apr 11;373(9671):1251 - 1252
Link to source with long URL

HSL16214
Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
Mello MM, Studdert DM, Brennan TA.
N Engl J Med. 2009 Apr 9;360(15):1557-66
Link to source with long URL

HSL16199
Psaty BM.
Conflict of Interest, Disclosure, and Trial Reports
JAMA 2009 Apr 8;301(14):1477-1479
http://jama.ama-assn.org/cgi/content/extract/301/14/1477

HSL16252
Edwards D, Ballantyne A.
Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors
Internal Medicine Journal 2009 Apr 8;39(3):191 - 196
Link to source with long URL

HSL16192
Moynihan R.
Court hears how drug giant Merck tried to 'neutralise' and 'discredit' doctors critical of Vioxx
BMJ 2009 Apr 6;338
http://www.bmj.com/cgi/content/extract/338/apr06_1/b1432

HSL16216
Timonen J, Karttunen P, Bengtström M, Ahonen R.
The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland.
Health Policy 2009 Apr 3
Link to source with long URL

HSL16160
Rothman DJ, McDonald WJ, Berkowitz CD, Chimonas SC, Deangelis CD, Hale RW, Nissen SE, Osborn JE, Scully JH, Thomson GE, Wofsy D.
Professional Medical Associations and Their Relationships With Industry
JAMA 2009 Apr 1;301(13):1367-1372
http://jama.ama-assn.org/cgi/content/abstract/301/13/1367?etoc

HSL16188
Naik AD, Woofter AL, Skinner JM, Abraham NS.
Pharmaceutical company influence on nonsteroidal anti-inflammatory drug prescribing behaviors.
Am J Manag Care 2009 Apr 1;15(4):e9-e15
http://www.ajmc.com/pubMed.php?pii=11097

HSL16152
Alam K, Shah AK, Ojha P, Palaian S, Shankar PR.
Evaluation of drug promotional materials in a hospital setting in Nepal
Southern Med Review 2009 Apr;2(1):2-6
http://www.fmhs.auckland.ac.nz/sop/smr/_docs/SMR_Vol2_Issue1.pdf

HSL16309
Hirotsu M, Sohma M, Takagi H.
[Involvement of medical representatives in team medical care].
Gan To Kagaku Ryoho 2009 Apr;36(4):693-5
Link to source with long URL

HSL16388
Alkhateeb FM, Khanfar NM, Doucette WR, Loudon D.
Characteristics of Physicians Targeted by the Pharmaceutical Industry to Participate in E-detailing.
Health Mark Q. 2009 Apr;26(2):98-116
http://www.ncbi.nlm.nih.gov/pubmed/19408179

HSL16166
Garattini S, Chalmers I.
Patients and the public deserve big changes in evaluation of drugs.
BMJ 2009 Mar 31;338:b1025
http://www.bmj.com/cgi/content/extract/338/mar31_3/b1025

HSL16167
Tremblay M.
Commentary: Risks of doing as the Romans do.
BMJ 2009 Mar 31;338:b1107
http://www.bmj.com/cgi/content/extract/338/mar31_3/b1107

HSL16175
Tanne JH.
JAMA's new rule on whistleblowers creates controversy.
BMJ 2009 Mar 31;338:b1352
http://www.bmj.com/cgi/content/extract/338/mar31_2/b1352

HSL16116
Mashta O.
Banning drugs from NHS stifles new development, drug company says.
BMJ 2009 Mar 27;338:b1295
http://www.bmj.com/cgi/content/extract/338/mar27_2/b1295?papetoc

HSL16128
Schachter SC, Mandell W, Harshbarger S, Grometstein R.
Managing Relationships with Industry: A Physician's Compliance Manual
The New England Journal of Medicine 2009 Mar 26;360(13):1366-1367
http://content.nejm.org/cgi/content/short/360/13/1366

HSL16126
Tanne JH.
US justice department sues company for off-label promotion of antidepressants for children.
BMJ 2009 Mar 25;338:b1222
http://www.bmj.com/cgi/content/extract/338/mar25_3/b1222?papetoc

HSL16127
Shaughnessy AF.
An insider’s view of the drug industry
BMJ 2009 Mar 25;338
http://www.bmj.com/cgi/content/extract/338/mar25_1/b1138?papetoc

HSL16184
Day R, Komesaroff P, Mant A.
Do ethical Guidelines make a difference to decision making?
Internal Medicine Journal 2009 Mar 23
Link to source with long URL

HSL16290
Sadika Sultana M, Manivannan L.
Knowledge Management in Pharmaceutical Marketing: Theoretical Models
Social Science Research Network 2009 Mar 23;7(2):62-76
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1366930

HSL16109
Meilof JF, Hylkema MN.
The Lancet and advertorials.
Lancet. 2009 Mar 21;373(9668):1004
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(09)60600-0

HSL16092
DeAngelis CD, Fontanarosa PB.
Conflicts Over Conflicts of Interest
JAMA 2009 Mar 20:epub
http://jama.ama-assn.org/misc/jed90012pap_E1_E3.pdf

HSL16061
Bud R.
Take this with a pinch of salt
BMJ 2009 Mar 18;338:b1098
http://www.bmj.com/cgi/content/extract/338/mar18_1/b1098

HSL16112
Masoni M, Guelfi MR, Gensini GF.
Google needs better control of its advertisements and suggested links
BMJ 2009 Mar 18;338
http://www.bmj.com/cgi/content/full/338/mar18_1/b1083

HSL16300
Van Der Weyden MB.
Doctors and the pharmaceutical industry: time for a national policy?
MJA 2009 Mar 15;190(8): 407-408
http://www.mja.com.au/public/issues/190_08_200409/van10295_fm.html

HSL16064
Grant B.
In bed with big pharma
The Scientist news blog 2009 Mar 12
http://www.the-scientist.com/blog/display/55506/

HSL16046
Mitka M.
Physician Payments
JAMA. 2009 Mar 11;301(10):1011
http://jama.ama-assn.org/cgi/content/extract/301/10/1011-b

HSL16529
Zaric GS, Xie B.
The Impact of Two Pharmaceutical Risk-Sharing Agreements on Pricing, Promotion, and Net Health Benefits.
Value Health 2009 Mar 10
http://www3.interscience.wiley.com/journal/122251642/abstract?CRETRY=1

HSL16043
Gornall J.
Research Transparency: Industry attack on academics
BMJ 2009 Mar 9;338:b736
http://www.bmj.com/cgi/content/extract/338/mar09_1/b736

HSL16063
Søndergaard J, Vach K, Kragstrup J, Andersen M.
Impact of pharmaceutical representative visits on GPs' drug preferences.
Fam Pract 2009 Mar 8
http://fampra.oxfordjournals.org/cgi/content/abstract/cmp010v1

HSL15935
Ramsay S.
Advertising on TheLancet.com
The Lancet 2009 Mar 7;373(9666):794
Link to source with long URL

HSL16020
Thomas L.
Medical professionals for sale?
The Lancet 2009 Mar 7;373(9666):810
Link to source with long URL

HSL16090
Leo J, Lacasse JR.
Clinical Trials of Therapy versus Medication: Even in a Tie, Medication wins
BMJ 2009 Mar 5:Rapid response
http://www.bmj.com/cgi/eletters/338/feb05_1/b463#211098

HSL16004
Watson R.
Organisations question EC changes on drug information for patients
BMJ 2009 Mar 4;338(7694):b894
http://www.bmj.com/cgi/content/extract/338/mar04_1/b894

HSL15884
Abernethy AP, Raman G, Balk EM, Hammond EM, Orlando LA, Wheeler JL, Lau J, McCrory DC.
Reliability of Compendia Methods for Off-Label Oncology Indications
Annals of Internal Medicine 2009 Mar 3;150(5)
http://www.annals.org/cgi/content/full/0000605-200903030-00107v1

HSL15885
Sox HC.
Evaluating Off-Label Uses of Anticancer Drugs: Time for a Change
Annals of Internal Medicine 2009 Mar 3;150(5)
http://www.annals.org/cgi/content/full/0000605-200903030-00110v1

HSL15986
Dobson R.
Roche’s vouchers to patients breach regulatory code
BMJ 2009 Mar 3;338(7694):b899
http://www.bmj.com/cgi/content/extract/338/mar03_3/b899

HSL16006
Aagaard L, Hansen EH.
Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs
BMC Clinical Pharmacology 2009 Mar 3;9:4 (epub)
http://www.biomedcentral.com/1472-6904/9/4/abstract

HSL16009
[Drug marketing: methods, effect and regulation].
Søndergaard J, Koefoed MM, Andersen M.
Ugeskr Laeger 2009 Mar 2;171(10):778-780
http://www.ncbi.nlm.nih.gov/pubmed/19265598

HSL15953
Crigger N, Barnes K, Junko A, Rahal S, Sheek C.
Nurse practitioners' perceptions and participation in pharmaceutical marketing.
J Adv Nurs 2009 Mar;65(3):525-33
http://www3.interscience.wiley.com/journal/121676372/abstract

HSL15956
Goodman M.
Market watch: Specialty pharmaceuticals to provide majority of sales by 2012.
Nat Rev Drug Discov. 2009 Mar;8(3):184
http://www.nature.com/doifinder/10.1038/nrd2840

HSL16047
Marcus A.
Fraud Case Rocks Anesthesiology Community
Anesthesiology News 2009 Mar;35(3)
Link to source with long URL

HSL16055
Han J.
Serious Side Effects
Health Affairs 2009 Mar-Apr;28(2):533-539
http://content.healthaffairs.org/cgi/content/extract/28/2/533

HSL16056
Morton M.
Buying Lunch...And What Else?
Health Affairs 2009 Mar-Apr;28(2):540-545
http://content.healthaffairs.org/cgi/content/full/28/2/540

HSL16059
Freedman R, Lewis DA, Michels R, Et AL.
Conflict of interest: an issue for every psychiatrist.
American Journal of Psychiatry 2009 Mar;166(3):274-277
http://ajp.psychiatryonline.org/cgi/content/full/166/3/274

HSL16098
Applbaum K.
'Consumers are Patients!' Shared Decision-making and Treatment Non-compliance as Business Opportunity.
Transcult Psychiatry 2009 Mar;46(1):107-30
http://tps.sagepub.com/cgi/reprint/46/1/107

HSL16099
Ecks S, Basu S.
The unlicensed lives of antidepressants in India: generic drugs, unqualified practitioners, and floating prescriptions.
Transcult Psychiatry 2009 Mar;46(1):86-106
http://tps.sagepub.com/cgi/reprint/46/1/86

HSL16100
Healy D.
Trussed in Evidence? Ambiguities at the Interface between Clinical Evidence and Clinical Practice.
Transcult Psychiatry. 2009 Mar;46(1):16-37
http://tps.sagepub.com/cgi/reprint/46/1/16

HSL16103
The corporate bias and the molding of prescription practices: the case of hypertension.
Fuchs FD.
Braz J Med Biol Res. 2009 Mar;42(3):224-8
Link to source with long URL

HSL16390
New chemical entities and their market penetration in Finland during the years 1996 through 2005.
Martikainen JE, Enlund H.
Clin Ther. 2009 Mar;31(3):668-76
Link to source with long URL

HSL15976
Editorial .
Pharmaceuticals, patents, publicity…and philanthropy?
The Lancet 2009 Feb 28;373(9665):693
Link to source with long URL

HSL15955
Applbaum K.
Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster.
Cult Med Psychiatry 2009 Feb 27
http://www.springerlink.com/content/u62742285u871576/

HSL15961
Lacasse JR, Leo J.
Consumer Advertisements for Psychostimulants in the United States: A Long Record of Misleading Promotion
Psychiatric Times 2009 Feb 26;26(2)
http://www.psychiatrictimes.com/display/article/10168/1382819

HSL15914
Schiff GD, Galanter WL.
Promoting More Conservative Prescribing
JAMA 2009 Feb 25;301(8):865
http://jama.ama-assn.org/cgi/content/extract/301/8/865

HSL15915
Shaneyfelt TM, Centor RM.
Reassessment of Clinical Practice Guidelines: Go Gently Into That Good Night
JAMA 2009 Feb 25;301(8):868-9
http://jama.ama-assn.org/cgi/content/extract/301/8/868

HSL15907
An Unbiased Scientific Record Should Be Everyone's Agenda
PLoS Med 2009 Feb 24;6(2):e38
Link to source with long URL

HSL15987
Horton R.
Reframing relations with Pharma: Chair of RCP working party responds to editorial
BMJ 2009 Feb 24;338(7693):b767
http://www.bmj.com/cgi/content/extract/338/feb24_1/b767

HSL15988
Collier J.
Reframing relations with Pharma: Author’s reply
BMJ 2009 Feb 24;338(7693):b768
http://www.bmj.com/cgi/content/extract/338/feb24_1/b768

HSL15989
Noble JH Jr
Reframing relations with Pharma: Voluntarism is not enough
BMJ 2009 Feb 24;338(7693):b762
http://www.bmj.com/cgi/content/extract/338/feb24_3/b762

HSL15990
Anon (Name and address supplied to BMJ)
Reframing relations with Pharma: An insider writes
BMJ 2009 Feb 24;338(7693):b764
http://www.bmj.com/cgi/content/extract/338/feb24_1/b764

HSL15991
Damle A.
Reframing relations with Pharma: Build rather than burn bridges
BMJ 2009 Feb 24;338(7693):b765
http://www.bmj.com/cgi/content/extract/338/feb24_1/b765

HSL15992
Ball DR, Kamel Y, Perkins V.
Reframing relations with Pharma: Entanglement in Scotland
BMJ 2009 Feb 24;338(7693):b763
http://www.bmj.com/cgi/content/extract/338/feb24_1/b763

HSL15993
Mundorff MB.
Reframing relations with Pharma: Drug companies are not alone
BMJ 2009 Feb 24;338(7693):b761
http://www.bmj.com/cgi/content/extract/338/feb24_1/b761

HSL15899
Smith RD.
Trade, TRIPS, and pharmaceuticals
The Lancet 2009 Feb 21;373(9664):684 - 69
Link to source with long URL

HSL15903
Yawar A.
The fool on the hill
The Lancet 2009 Feb 21;373(9664):621 - 622
Link to source with long URL

HSL15880
Vitry A, Gilbert A, Mott K, Rao D, March G.
Provision of medicines information in Australian community pharmacies
Pharm World Sci 2009 Feb 20:epub ahead of print
Link to source with long URL

HSL15877
Post R.
Prescribing Records and the First Amendment — New Hampshire's Data-Mining Statute
The New England Journal of Medicine 2009 Feb 19;360(8):745-747
http://content.nejm.org/cgi/content/short/360/8/745?query=TOC

HSL15878
Grande D, Asch DA.
Commercial versus Social Goals of Tracking What Doctors Do
The New England Journal of Medicine 2009 Feb 19;360(8):747-749
http://content.nejm.org/cgi/content/short/360/8/747?query=TOC

HSL15881
Wood AJJ.
Progress and Deficiencies in the Registration of Clinical Trials
The New England Journal of Medicine 2009 Feb 19;360(8):824-830
http://content.nejm.org/cgi/content/full/360/8/824?query=TOC

HSL16301
Shipp DH, Mallarkey G.
Liaison between public hospital staff and the pharmaceutical industry: guidance from the NSW Therapeutic Advisory Group
MJA 2009 Feb 19;190(8):406-407
http://www.mja.com.au/public/issues/190_08_200409/shi11384_fm.html

HSL15864
Tanne JH.
Bayer to spend $20m to correct misleading advertising for oral contraceptive Yaz.
BMJ. 2009 Feb 17;338:b674
http://www.bmj.com/cgi/content/extract/338/feb17_1/b674?papetoc

HSL15908
Decullier E, Chan A, Chapuis F.
Inadequate Dissemination of Phase I Trials: A Retrospective Cohort Study
PLoS Med 2009 Feb 17;6(2):e34
Link to source with long URL

HSL15890
Vitry A, Lai YH.
Advertising of antihypertensive medicines and prescription sales in Australia
Internal Medicine Journal 2009 Feb 16:epub ahead of print
http://www3.interscience.wiley.com/journal/122205036/abstract

HSL16302
Alasdair Millar J.
Genesis of medical thromboprophylaxis guidelines in Australia: a need for transparency and standardisation in guideline development
MJA 2009 Feb 15;190(8):446-450
http://www.mja.com.au/public/issues/190_08_200409/mil10612_fm.html

HSL15855
Loewenberg S.
Sidney Wolfe
The Lancet 2009 Feb 14;373(9663):537
Link to source with long URL

HSL15830
Jefferson T, Di Pietrantonj, Debalini MG, Rivetti A, Demicheli V, .
Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review
BMJ. 2009 Feb 12;338
http://www.bmj.com/cgi/content/abstract/338/feb12_2/b354

HSL16215
[ACCOMPLISH and the risks with company sponsored clinical trials].
Furberg C.
Lakartidningen. 2009 Feb 11-17;106(7):450
http://www.ncbi.nlm.nih.gov/pubmed/19350775

HSL15954
Sismondo S, Doucet M.
Publication Ethics and The Ghost Management of Medical Publications
Bioethics. 2009 Feb 10
http://www.ncbi.nlm.nih.gov/pubmed/19222451

HSL15816
Banzi R, Moja L, Moschetti I, Liberati A, Gensini GF, Gusinu R.
Rimonabant for overweight and 'metabolic syndrome': the attempt to supersize disease and risk by pharmaceutical marketing
Internal and Emergency Medicine 2009 Feb 8;3(1)
http://www.springerlink.com/content/114105m150129402/

HSL15777
Horton R.
The UK's NHS and pharma: from schism to symbiosis
The Lancet 2009 Feb 7;373(9662):435 - 436
Link to source with long URL

HSL15778
Godlee F.
Doctors, patients, and the drug industry
BMJ. 2009 Feb 5;338
http://www.bmj.com/cgi/content/extract/338/feb05_1/b463

HSL15806
Steinbrook R.
Physician–Industry Relations — Will Fewer Gifts Make a Difference?
The New England Journal of Medicine 2009 Feb 5;360:557-559(6)
http://content.nejm.org/cgi/content/short/360/6/557?query=TOC

HSL15780
Kmietowicz Z.
Individual drug firms should stop paying for medical education
BMJ. 2009 Feb 4;338
http://www.bmj.com/cgi/content/extract/338/feb04_1/b442

HSL15766
Collier J.
Doctors, patients, and the pharmaceutical industry
BMJ 2009 Feb 3;338:b443
http://www.bmj.com/cgi/content/extract/338/feb03_2/b443

HSL15771
Gøtzsche PC, Kassirer JP, Woolley KL, Wager E, Jacobs A, Gertel A, Hamilton C.
What Should Be Done To Tackle Ghostwriting in the Medical Literature?
PLoS Med 2009 Feb 3;6(2)
Link to source with long URL

HSL15781
Krumholz HM, Ross JS.
Relationships with the drug industry: More regulation, greater transparency
BMJ. 2009 Feb 3;338
http://www.bmj.com/cgi/content/extract/338/feb03_2/b211

HSL15782
Angell M.
Relationships with the drug industry: Keep at arm’s length
BMJ. 2009 Feb 3;338
http://www.bmj.com/cgi/content/extract/338/feb03_2/b222

HSL15783
Coutts G.
Relationships with the drug industry: Collaboration to improve care
BMJ. 2009 Feb 3;338
http://www.bmj.com/cgi/content/extract/338/feb03_2/b232

HSL15784
Gottlieb S.
Relationships with the drug industry: Build trust based on good science
BMJ. 2009 Feb 3;338
http://www.bmj.com/cgi/content/full/338/feb03_2/b234

HSL15785
Tiner R.
Relationships with the drug industry: Focus on better information
BMJ. 2009 Feb 3;338
http://www.bmj.com/cgi/content/full/338/feb03_2/b252

HSL15791
Krumholz HM, Ross JS.
Relationships with the drug industry: More regulation, greater transparency
BMJ. 2009 Feb 3;338
http://www.bmj.com/cgi/content/extract/338/feb03_2/b211

HSL16095
Brown S
Striving for quality use of medicines: how effective is Australia's ban on direct-to-consumer prescription medicine advertising.
J Law Med 2009 Feb;16(4):666-83
http://www.ncbi.nlm.nih.gov/pubmed/19297873

HSL15823
Price check! An analysis of direct-to-consumer pharmaceutical marketing.
Wakeam E.
Acad Med. 2009 Feb;84(2):234-5
Link to source with long URL

HSL15851
Wong-Rieger D.
Should Canada allow direct-to-consumer advertising of prescription drugs? YES
The Canadian Family Physician 2009 Feb;55(2):130 - 132
www.cfp.ca/cgi/content/full/55/2/130

HSL15852
Mintzes B.
Should Canada allow direct-to-consumer advertising of prescription drugs? NO
The Canadian Family Physician 2009 Feb;55(2):131 - 133
www.cfp.ca/cgi/content/full/55/2/131

HSL15853
Wong-Rieger D, Mintzes B.
Should Canada allow direct-to-consumer advertising of prescription drugs?: CFPlus Rebuttal
The Canadian Family Physician 2009 Feb;55:130-3
http://www.cfp.ca/cgi/content/full/55/2/130/DC1

HSL15863
Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity.
McGoey L, Jackson E.
Journal of Medical Ethics 2009 Feb;35(2):107-12
http://jme.bmj.com/cgi/content/abstract/35/2/107

HSL15822
Sarikaya O, Civaner M, Vatansever K.
Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential.
Adv Health Sci Educ Theory Pract. 2009 Jan 30
http://www.springerlink.com/content/l351j16w01j24372/

HSL16016
Davis JJ, Meader A.
Beyond content analysis: Assessing fair balance in DTC pharmaceutical advertising
Journal of Medical Marketing 2009 Jan 30;9(1):57–66
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200831a.html

HSL15744
Currie JA, Preston H, Weerapperuma S.
EC, don't let drug companies give information to the public.
BMJ. 2009 Jan 27;338:b290
http://www.bmj.com/cgi/content/extract/338/jan27_2/b290?papetoc

HSL15824
Kudrin A.
Challenges in the Clinical Development Requirements for the Marketing Authorization of New Medicines in Southeast Asia.
J Clin Pharmacol 2009 Jan 22
http://jcp.sagepub.com/cgi/rapidpdf/0091270008329557v1

HSL15826
Psychiatrists' attitude towards and knowledge of clozapine treatment.
Nielsen J, Dahm M, Lublin H, Taylor D.
J Psychopharmacol. 2009 Jan 22
http://jop.sagepub.com/cgi/rapidpdf/0269881108100320v1

HSL15724
Barennes H, Srour LM.
Coffee creamer as infant food: Authors’ reply to Nestlé
BMJ. 2009 Jan 21;338
http://www.bmj.com/cgi/content/extract/338/jan21_1/b198

HSL15725
Stieger R.
Coffee creamer as infant food: Nestlé’s works to ensure appropriate use of milk products
BMJ. 2009 Jan 21;338
http://www.bmj.com/cgi/content/extract/338/jan21_1/b196

HSL15704
Kmietowicz Z.
Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine.
BMJ. 2009 Jan 20;338
http://www.bmj.com/cgi/content/extract/338/jan20_1/b217

HSL15714
Tanne JH.
FDA allows drug firms to distribute journal articles about unapproved uses.
BMJ. 2009 Jan 19;338:b187
http://www.bmj.com/cgi/content/extract/338/jan19_2/b187?papetoc

HSL15715
Finucane TE.
Men, androgen deficiency, and pharmaceutical promotion.
Arch Intern Med. 2009 Jan 12;169(1):88
http://archinte.ama-assn.org/cgi/content/full/169/1/88

HSL15658
Landefeld CS, Steinman MA.
The Neurontin Legacy: Marketing Misinformation and Manipulation
The New England Journal of Medicine 2009 Jan 8;360(2):103
http://content.nejm.org/cgi/content/full/360/2/103

HSL15672
Hirji KF.
No short-cut in assessing trial quality: a case study.
Trials 2009 Jan 7;10(1)
www.trialsjournal.com/content/10/1/1

HSL15673
Gøtzsche PC.
Readers as research detectives
Trials 2009 Jan 7;10(1)
www.trialsjournal.com/content/10/1/2

HSL15687
Hopkins Tanne J.
US university psychiatrist loses chairmanship over drug company payments..
BMJ. 2009 Jan 6;338:a3188
http://www.bmj.com/cgi/content/extract/338/jan05_3/a3188

HSL15652
Stepping into the therapeutics void.
Coombes R.
BMJ. 2009 Jan 5;338:a3179
http://www.bmj.com/cgi/content/full/338/jan05_2/a3179

HSL15682
Coombes R.
Stepping into the therapeutics void.
BMJ. 2009 Jan 5;338:a3179
http://www.bmj.com/cgi/content/extract/338/jan05_2/a3179

HSL15657
Kimmelman J, Weijer C, Meslin EM.
Helsinki discords: FDA, ethics, and international drug trials
The Lancet 2009 Jan 3;373(9657):13 - 14
Link to source with long URL

HSL15681
Tyrer P, Kendall T.
The spurious advance of antipsychotic drug therapy
The Lancet 2009 Jan 3;373(9657):4-5
Link to source with long URL

HSL15683
Kimmelman J, Weijer C, Meslin EM.
Helsinki discords: FDA, ethics, and international drug trials
The Lancet 2009 Jan 3;373(9657):13-4
Link to source with long URL

HSL15610
Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsis.
Poole D, Bertolini G, Garattini S.
Lancet Infect Dis 2009 Jan;9(1):67-72
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(08)70306-2

HSL15665
Kyle GJ, Nissen LM, Tett SE
The Australian rise of esomeprazole-was expenditure on samples a contributor?
Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):62-8
Link to source with long URL

HSL15679
Clauson KA, Khanfar NM, Polen HH, Gibson F.
Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives.
J Clin Nurs 2009 Jan;18(2):228-33
http://www3.interscience.wiley.com/journal/121562111/abstract

HSL15790
Thawani V, Gharpure K.
Monitoring misuse of the WHO name and emblem in medicine promotion in India
Indian Journal of Medical Ethics 2009 Jan-Mar;17(1):epub
http://www.ijme.in/171ar10

HSL15821
Klemperer D.
[Self-help groups conflicts of interest through sponsoring by the pharmaceutical industry].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009 Jan;52(1):71-6
http://www.springerlink.com/content/92x3337327075725/

HSL15827
Shankar PR, Piryani RM
Medical education and medical educators in South Asia - a set of challenges.
J Coll Physicians Surg Pak. 2009 Jan;19(1):52-6
http://www.ncbi.nlm.nih.gov/pubmed/19149982

HSL16014
Spake DF, Joseph M, Finney RZ.
Urban senior citizens' versus rural consumers' views of DTC advertising: A preliminary investigation
Journal of Medical Marketing 2009 Jan;9(1):21–28
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200817a.html

HSL16015
Kelly D, Rupert E.
Professional emotions and persuasion: Tapping non-rational drivers in health-care market research
Journal of Medical Marketing 2009 Jan;9(1):3–9
http://www.palgrave-journals.com/jmm/journal/v9/n1/abs/jmm200828a.html

HSL16102
Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
Joseph JN, Deaton D, Ehsan H, Bonanno MA
J Health Life Sci Law 2009 Jan;2(2):73-108
http://www.ncbi.nlm.nih.gov/pubmed/19288889

HSL16221
How do district nurses choose which products to prescribe.
Hall J, Noyce P, Cantrill J?
Br J Community Nurs. 2009 Jan;14(1):12,
http://www.ncbi.nlm.nih.gov/pubmed/19363864

HSL15701
Tattersall MHN, Dimoska A, Gan K.
Patients expect transparency in doctors’ relationships with the pharmaceutical industry
eMJA 2009;2:65-68
http://www.mja.com.au/public/issues/190_02_190109/tat10368_fm.html

HSL15702
Olver IN, Haines IE.
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?
eMJA 2009;190(2):74-77
http://www.mja.com.au/public/issues/190_02_190109/olv10224_fm.html

HSL15763
Sweet M.
Pharmaceutical marketing and the internet
Australian Prescriber 2009;23:2-4
http://www.australianprescriber.com/magazine/32/1/2/4/

HSL15813
Stockigt JR.
The quality of medication information in Australia: the need for more clinical expertise and accountability
eMJA 2009;190(3):110-111
http://www.mja.com.au/public/issues/190_03_020209/sto11172_fm.html

HSL15818
Mansell P, Read J.
Posttraumatic stress disorder, drug companies, and the internet.
J Trauma Dissociation 2009;10(1):9-23
http://www.ncbi.nlm.nih.gov/pubmed/19197709

HSL15819
Alkhateeb FM, Khanfar NM, Clauson KA.
Characteristics of physicians who frequently see pharmaceutical sales representatives.
J Hosp Mark Public Relations 2009;19(1):2-14
http://www.ncbi.nlm.nih.gov/pubmed/19197653

HSL15820
Polen HH, Khanfar NM, Clauson KA.
Impact of Direct-to-Consumer Advertising (DTCA) on Patient Health-Related Behaviors and Issues.
Health Mark Q. 2009;26(1):42-55
http://www.ncbi.nlm.nih.gov/pubmed/19197587

HSL15939
Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE.
Identifying existing health care services that do not provide value for money
Med J Aust 2009;190(5):269-273
http://www.mja.com.au/public/issues/190_05_020309/ell10663_fm.html

HSL15957
Aronson JK, Price D, Ferner RE
A strategy for regulatory action when new adverse effects of a licensed product emerge.
Drug Saf 2009;32(2):91-8
Link to source with long URL

HSL16164
Abelson J, Collins PA.
Media Hyping and the 'Herceptin Access Story': An Analysis of Canadian and UK Newspaper Coverage
Healthcare Policy / Politiques de Santé 2009;4(3):e113-e128
http://www.longwoods.com/product.php?productid=20474&cat=582

HSL16288
Mulki JP, Jaramillo JF, Locander WB.
Critical Role of Leadership on Ethical Climate and Salesperson Behaviors
Journal of Business Ethics 2009(86):125-141
http://www.springerlink.com/content/355705k570264364/

HSL16307
Jureidini J
How do we Safely Treat Depression in Children, Adolescents and Young Adults?
Drug Saf 2009;32(4):275-82
http://www.ncbi.nlm.nih.gov/pubmed/19388719

HSL16324
Rod M, Saunders S.
The informative and persuasive components of pharmaceutical
International Journal of Advertising 2009;28(2):313-349
http://www.internationaljournalofadvertising.com/

HSL16408
Molnar FJ, Man-son-hing M, Hutton B, Fergusson DA.
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review
Open Medicine 2009;3(2)
http://www.openmedicine.ca/article/view/245/230

HSL16409
Altman DG.
Missing outcomes in randomized trials: addressing the dilemma
Open Medicine 2009;3(2)
http://www.openmedicine.ca/article/view/323/232

HSL16483
Jureidini JN, McHenry LB.
Key Opinion Leaders and Paediatric Antidepressant Overprescribing
Psychotherapy and Psychosomatics 2009;78(4):197-201
Link to source with long URL

HSL16572
Vandereycken W.
[An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
Tijdschr Psychiatr. 2009;51(6):407-11
http://www.tijdschriftvoorpsychiatrie.nl/en/tijdschrift/artikel/TVPart_2796

HSL16573
Keeping modern in medicine: pharmaceutical promotion and physician education in postwar america.
Bull Hist Med 2009;83(2):331-77
Link to source with long URL

HSL16621
Liang BA, Mackey T.
Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.
Am J Law Med. 2009;35(1):125-84
http://www.ncbi.nlm.nih.gov/pubmed/19534258

HSL16668
Rojas M.
Price discrimination by pharmaceutical companies across Central American countries
International Journal of Pharmaceutical and Healthcare Marketing 2009;3(2):118 - 136
Link to source with long URL

HSL16669
Kalyanaram GK.
The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs
International Journal of Pharmaceutical and Healthcare Marketing 2009;3(2):137 - 148
Link to source with long URL

HSL15664
Santiago MG, Bucher HC, Nordmann AJ.
Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland.
BMC Med Inform Decis Mak 2008 Dec 31;8(1):61
http://www.biomedcentral.com/1472-6947/8/61

HSL15642
Beard K.
Commentary: The balance between marketing and safety.
BMJ 2008 Dec 24;337:a2996
http://www.bmj.com/cgi/content/extract/337/dec24_1/a2996

HSL15660
Clarke J, Gawley A.
The Triumph of Pharmaceuticals: The Portrayal of Depression from 1980 to 2005.
Adm Policy Ment Health. 2008 Dec 20
http://www.springerlink.com/link.asp?id=bp5n771x127221g1

HSL15596
Watson R.
Proposal to allow drug companies to give information to public sparks outcry.
BMJ. 2008 Dec 16;337:a3043
http://www.bmj.com/cgi/content/extract/337/dec16_2/a3043?papetoc

HSL15556
Transparency rules at the Cleveland Clinic
The Lancet 2008 Dec 13;372(9655):2002
Link to source with long URL

HSL15386
Go RS.
Issues Behind Disclosure of Conflicts of Interest
JAMA 2008 Dec 12;300(18)
http://jama.ama-assn.org/cgi/content/extract/300/18/2120-a?etoc

HSL15550
Sweet M.
Australian health professionals warned against featuring in advertisements
BMJ. 2008 Dec 11;337
http://www.bmj.com/cgi/content/extract/337/dec11_1/a2951?papetoc

HSL15571
Mitka M.
Industry Funding
JAMA 2008 Dec 10;300(22):2599
http://jama.ama-assn.org/cgi/content/extract/300/22/2599

HSL15572
Wollschlaeger B.
Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry
JAMA 2008 Dec 10;300(22):2675
http://jama.ama-assn.org/cgi/content/extract/300/22/2675

HSL15570
Tanne JH.
US psychiatrist is fired from radio programme for not disclosing drug company ties.
BMJ. 2008 Dec 9;337:a2934
http://www.bmj.com/cgi/content/extract/337/dec09_1/a2934

HSL15636
Hopkins Tanne J.
US psychiatrist is fired from radio programme for not disclosing drug company ties
BMJ 2008 Dec 9;337
http://www.bmj.com/cgi/content/extract/337/dec09_1/a2934

HSL15506
Gérvas J, Starfield B, Heath I.
Is clinical prevention better than cure?
Lancet 2008 Dec 6;372(9654):1997–99
Link to source with long URL

HSL15513
Chan A, Hróbjartsson A, Jørgensen KJ, Gøtzsche PC, Altman DG.
Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols
BMJ. 2008 Dec 4;337
http://www.bmj.com/cgi/content/abstract/337/dec04_1/a2299

HSL15487
Kao DP.
What can we learn from drug marketing efficiency?
BMJ 2008 Dec 2;337:a2591
http://www.bmj.com/cgi/content/short/337/dec02_2/a2591

HSL15498
Dobson R.
Eli Lilly encouraged patients to ask for a prescription only drug, says industry watchdog.
BMJ. 2008 Dec 2;337:a2824
http://www.bmj.com/cgi/content/full/337/dec02_4/a2824

HSL15538
Fugh-Berman AJ, Melnick D
Is long-term use of antismoking drugs consistent with public health goals or pharmaceutical marketing goals?
Ann Intern Med 2008 Dec 2;149(11):838
http://www.annals.org/cgi/content/full/149/11/838

HSL15609
Shuchman M.
Book Review: Spilling the beans on the pharmaceutical industry
CMAJ 2008 Dec 2;179(12):1309
http://www.cmaj.ca/cgi/content/full/179/12/1309

HSL15634
Dobson R.
Eli Lilly encouraged patients to ask for a prescription only drug, says industry watchdog
BMJ 2008 Dec 2;337
http://www.bmj.com/cgi/content/extract/337/dec02_4/a2824

HSL15481
Vlassov V.
Russia defies WHO antismoking convention by allowing misleading advertising
BMJ 2008 Dec 1;337
http://www.bmj.com/cgi/content/extract/337/dec01_2/a2837?papetoc

HSL15635
Jack A.
Legal tactics to delay launch of generic drugs cost Europe 3bn, report says
BMJ 2008 Dec 1;337
http://www.bmj.com/cgi/content/extract/337/dec01_2/a2817

HSL15404
Lim CW, Kirikoshi T.
Understanding the effects of pharmaceutical promotion: a neural network approach guided by genetic algorithm-partial least squares.
Health Care Manag Sci 2008 Dec;11(4):359-72
http://www.ncbi.nlm.nih.gov/pubmed/18998595

HSL15440
Walton SM, Schumock GT, Lee K, Alexander C, Meltzer D, Stafford RS.
Prioritizing Future Research on Off-Label Prescribing: Results of a Quantitative Evaluation
Pharmacotherapy 2008 Dec;28(12):1443-1452
http://www.atypon-link.com/PPI/doi/abs/10.1592/phco.28.12.1443

HSL15488
Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL.
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
Lancet Oncol 2008 Dec;9(12):1166-72
http://linkinghub.elsevier.com/retrieve/pii/S1470-2045(08)70305-X

HSL15552
Dyck C, Kvern B.
The PRESCRIBE acronym: A tool for appraising pharmaceutical industry–sponsored presentations
The Canadian Family Physician 2008 Dec;54(12):1701
http://www.cfp.ca/cgi/content/full/54/12/1701

HSL15579
Joyce GF, Goldman DP, Karaca-Mandic P, Lawless GD.
Impact of specialty drugs on the use of other medical services
Am J Manag Care 2008 Dec;14(12):821-8
http://www.ajmc.com/article.cfm?ID=10912&CFID=15325995&CFTOKEN=20444928

HSL15667
Goodman M.
Market watch : Pharma industry strategic performance: 2007-2012E.
Nat Rev Drug Discov 2008 Dec;7(12):967
http://www.nature.com/doifinder/10.1038/nrd2768

HSL15677
Shankar PR, Subish P.
Authors' reply. Medical journals and pharmaceutical marketing.
Singapore Med J 2008 Dec;49(12):1058
http://smj.sma.org.sg/4912/4912le2.pdf

HSL15678
Vuorenkoski L, Valta M, Helve O.
Effect of legislative changes in drug promotion on medical students: questionnaire survey.
Med Educ 2008 Dec;42(12):1172-7
Link to source with long URL

HSL15825
Kyle GJ, Nissen L, Tett S.
Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews.
Clin Ther 2008 Dec;30(12):2461-73
Link to source with long URL

HSL15490
Vasan A, Kim JY.
Essential medicines pricing-reform needed.
Lancet 2008 Nov 28
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61763-8

HSL15633
White C.
'Schmevidence' is hampering benefits of change in the health service
BMJ 2008 Nov 28;337
http://www.bmj.com/cgi/content/extract/337/nov28_1/a2782

HSL15486
Bubela T, Boon H, Caulfield T.
Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals.
BMC Med 2008 Nov 26;6(1):35
http://www.biomedcentral.com/1741-7015/6/35/abstract

HSL15444
Chan A.
Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results
PLoS Med 2008 Nov 25;5(11)
Link to source with long URL

HSL15446
Lean ME.
Trading regulations and health foods.
BMJ 2008 Nov 25;337:a2408
http://www.bmj.com/cgi/content/extract/337/nov25_2/a2408

HSL15447
Confusion from analyses and conflicts of interest.
Veerman JL, Vos T.
BMJ 2008 Nov 25;337:a2683
http://www.bmj.com/cgi/content/extract/337/nov25_1/a2683

HSL15632
Confusion from analyses and conflicts of interest.
Veerman JL, Vos T.
BMJ 2008 Nov 25;337:a2683
http://www.bmj.com/cgi/content/full/337/nov25_1/a2683

HSL15613
Reseland S.
[Pharmaceutical consultants don't give neutral information].
Tidsskr Nor Laegeforen 2008 Nov 20;128(22):2620
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1770704

HSL15427
Schwartz LM, Woloshin S, Moynihan R
Who's watching the watchdogs?
BMJ 2008 Nov 19;337:a2535
http://www.bmj.com/cgi/content/extract/337/nov19_1/a2535

HSL15614
Rabin A.
ADVANTAGE: Merck does say 'no'.
Ann Intern Med. 2008 Nov 18;149(10):774
http://www.annals.org/cgi/content/full/149/10/774

HSL15615
Edelman JM.
ADVANTAGE: Merck does say 'no'.
Ann Intern Med. 2008 Nov 18;149(10):774-5
http://www.annals.org/cgi/content/full/149/10/774-a

HSL15616
Edelman JM.
ADVANTAGE: science first, marketing second.
Ann Intern Med. 2008 Nov 18;149(10):773
http://www.annals.org/cgi/content/full/149/10/773

HSL15858
Clauson KA, Polen HH, Kamel BOULOS, Dzenowagis JH.
Scope, Completeness, and Accuracy of Drug Information in Wikipedia
Ann Pharmacother 2008 Nov 18;42(12):1814-1821.
www.theannals.com/cgi/content/full/42/12/1814

HSL15391
Islam F.
Pipe dreamer.
BMJ 2008 Nov 12;337:a2236
http://www.bmj.com/cgi/content/extract/337/nov12_1/a2236?papetoc

HSL15607
Ringart T.
[Merck & Co: Lakartidningen is wrong about us]
Lakartidningen. 2008 Nov 12-18;105(46):3358; author reply 3358-9
http://ltarkiv.lakartidningen.se/2008/temp/pda35825.pdf

HSL15383
Wilkes M, Johns M.
Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions
PLoS Med 2008 Nov 11;5(11):223
Link to source with long URL

HSL15374
Jarvis LM.
The New Deal: Seeking closer ties, drug companies and universities shake up the model for research alliances
C&EN 2008 Nov 10;86(45):13-20
http://pubs.acs.org/cen/coverstory/86/8645cover.html

HSL16291
Huber N.
Health Social Networks: Support Groups
newmediaage.com 2008 Nov 9
http://www.nma.co.uk/features/health-social-networks/40321.article

HSL15363
Hall J, Noyce P, Cantrill J.
Why do district nurse prescribers alter their prescribing patterns?
Br J Community Nurs. 2008 Nov 7;13(11):507-513
http://www.ncbi.nlm.nih.gov/pubmed/18981966

HSL15345
Singh S, Ernst E.
Trick or Treatment: The Undeniable Facts about Alternative Medicine
The New England Journal of Medicine 2008 Nov 6;359(19):2076-2077
http://content.nejm.org/cgi/content/short/359/19/2076?query=TOC

HSL15329
Ross JS, Nazem AG, Lurie P, Lackner JE, Krumholz HM.
Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont
JAMA 2008 Nov 5;300(17):1998-2000
http://jama.ama-assn.org/cgi/content/extract/300/17/1998-a?etoc

HSL15330
Mitka M.
Direct-to-Consumer Advertising of Medical Devices Under Scrutiny
JAMA 2008 Nov 5;300(17):1985-1986.
http://jama.ama-assn.org/cgi/content/extract/300/17/1985?etoc

HSL15331
Tanne JH.
US senators inquire into ties between stent makers and doctors.
BMJ 2008 Nov 4;337:a2363
http://www.bmj.com/cgi/content/extract/337/nov04_3/a2363?papetoc

HSL15338
Kmietowicz Z.
FDA warns Bayer about illegally marketing two over the counter products containing aspirin
BMJ 2008 Nov 4;337
http://www.bmj.com/cgi/content/full/337/nov04_3/a2402

HSL15669
Nesi T.
Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf.
US News World Rep 2008 Nov 3-10;145(10):64
http://www.ncbi.nlm.nih.gov/pubmed/18998444

HSL15700
Dyer C.
Cardiologist is sued for comments on potential migraine device
BMJ. 2008 Nov 3;337
http://www.bmj.com/cgi/content/extract/337/nov03_4/a2412

HSL15360
Montoya ID.
E-detailing: information technology applied to pharmaceutical detailing.
Expert Opin Drug Saf 2008 Nov;7(6):635-41
http://www.informapharmascience.com/doi/abs/10.1517/14740338.7.6.635

HSL15459
Lichter PR
Continuing medical education, physicians, and Pavlov: can we change what happens when industry rings the bell?
Arch Ophthalmol. 2008 Nov;126(11):1593-7
http://archopht.ama-assn.org/cgi/content/full/126/11/1593

HSL15535
Canudas Canadell J, Ricart Muns S, Sayós Freixer G, Zapata Romero E, Figueras A.
[Signs of drugs promotion in the clinic.An innocent presence?].
Aten Primaria 2008 Nov;40(11):581-2
http://www.ncbi.nlm.nih.gov/pubmed/19055902

HSL15580
[Food, health claims and drugs].
Bourlioux P.
Ann Pharm Fr. 2008 Nov-Dec;66(5-6):e5-7
http://www.masson.fr/masson/S0003-4509(08)00013-8

HSL15670
Rinaldi A.
Healing beauty? More biotechnology cosmetic products that claim drug-like properties reach the market.
EMBO Rep. 2008 Nov;9(11):1073-7
http://www.nature.com/doifinder/10.1038/embor.2008.200

HSL15306
European Medicines Agency approves POM-to-P orlistat switch
The Pharmaceutical Journal 2008 Oct 30;281(495)
Link to source with long URL

HSL15309
Christakis NA.
Does this work for you?
BMJ 2008 Oct 30;337:a2281
http://www.bmj.com/cgi/content/extract/337/oct30_1/a2281

HSL15310
Kmietowicz Z.
GlaxoSmithKline to limit payments it makes to US doctors to $150,000 a year.
BMJ 2008 Oct 30;337:a2315
http://www.bmj.com/cgi/content/full/337/oct30_1/a2315

HSL15611
Brun J
[Pfizer: We commit ourselves to developing new therapeutics where possible].
Lakartidningen. 2008 Oct 29-Nov
http://www.ncbi.nlm.nih.gov/pubmed/19035010

HSL15276
Fugh-Berman A, Melnick D.
Off-Label Promotion, On-Target Sales.
PLoS Med 2008 Oct 28;5(10):e210
Link to source with long URL

HSL15296
Timimi S, Jureidini J, Leo J.
NICE recommendations are not evidence based and could expose many to unnecessary harm.
BMJ 2008 Oct 28;337:a2284
http://www.bmj.com/cgi/content/extract/337/oct27_2/a2284?papetoc

HSL15299
So AD, Sampat BN, Rai AK, Cook-Deegan R, Reichman JH, Weissman R, Kapczynski A.
Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience.
PLoS Biol. 2008 Oct 28;6(10):e262
Link to source with long URL

HSL15405
Wadman M.
Pharma payment probe widens its net.
Nature 2008 Oct 23;455(7216):1017
http://www.nature.com/news/2008/081022/full/4551017a.html

HSL15242
Dobson R.
Atorvastatin advertising misled over benefits for women, study claims
BMJ 2008 Oct 22;337:a2209 epub ahead of print
http://www.bmj.com/cgi/content/extract/337/oct22_1/a2209?papetoc

HSL15304
Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Schellekens H, Leufkens HG, Egberts AC.
Safety-related regulatory actions for biologicals approved in the United States and the European Union.
JAMA 2008 Oct 22;300(16):1887-96
http://jama.ama-assn.org/cgi/content/full/300/16/1887

HSL15239
Tanne JH.
US university sets up conflict of interest office after investigation into drug company payments
BMJ 2008 Oct 21;337:a2200 epub ahead of print
http://www.bmj.com/cgi/content/extract/337/oct21_3/a2200

HSL15364
Freedhoff Y.
Vetting journal advertisements.
CMAJ 2008 Oct 21;179(9):931
Link to source with long URL

HSL15201
Editorial .
More than one bad apple
Nature 2008 Oct 16;455(7215):835
http://www.nature.com/nature/journal/v455/n7215/full/455835a.html

HSL15272
Hopkins Tanne J.
US psychiatrist steps down after questions about drug company payments.
BMJ 2008 Oct 16;337:a2088
http://www.bmj.com/cgi/content/full/337/oct16_1/a2088

HSL15210
Montori VM, Guyatt GH.
Progress in Evidence-Based Medicine
JAMA 2008 Oct 15;300(15):1814-1816
http://jama.ama-assn.org/cgi/content/full/300/15/1814

HSL15252
Hitchen L.
Drug firms and regulatory agencies must consider how drugs are used.
BMJ 2008 Oct 14;337:a2083
http://www.bmj.com/cgi/content/extract/337/oct14_1/a2083?papetoc

HSL15250
Ernst E.
Alternatives to debate: 'Treating evidence with contempt'.
BMJ 2008 Oct 13;337:a2063
http://www.bmj.com/cgi/content/extract/337/oct13_2/a2063?papetoc

HSL15269
Vitiello B.
Letters: Truly independent research? Treatment for Adolescents with Depression Study (TADS)
BMJ 2008 10 13;337
http://www.bmj.com/cgi/content/extract/337/oct13_2/a2070

HSL15204
Read all about it: media reports of drug studies
The Lancet 2008 Oct 11;372(9646):1274
Link to source with long URL

HSL15365
Read all about it: media reports of drug studies.
Lancet 2008 Oct 11;372(9646):1274
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61529-9

HSL15229
Reynolds L, McKee M.
Factors influencing antibiotic prescribing in China: An exploratory analysis.
Health Policy 2008 Oct 10:epub ahead of print
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(08)00206-6

HSL15295
Young NS, Ioannidis JP, Al-Ubaydli O.
Why current publication practices may distort science.
PLoS Med 2008 Oct 7;5(10):e201
Link to source with long URL

HSL15141
Sakel M.
Truly independent research is impossible.
BMJ 2008 Oct 1;337:a1881
http://www.bmj.com/cgi/content/full/337/oct01_3/a1881

HSL15163
Hochman M, Hochman S, Bor D, McCormic D.
Reporting Pharmaceutical Company Funding and Use of Generic Medication Names
JAMA 2008 Oct 1;300(13):1544-1550.
http://jama.ama-assn.org/cgi/content/abstract/300/13/1544?etoc

HSL15205
Hochman M, Hochman S, Bor D, McCormick D.
News Media Coverage of Medication Research
JAMA 2008 Oct 1;300(13):1544-1550.
http://jama.ama-assn.org/cgi/content/abstract/300/13/1544?etoc

HSL15317
Kvesic DZ.
Product lifecycle management: marketing strategies for the pharmaceutical industry
Journal of Medical Marketing 2008 Oct 1(8):293–301
http://www.palgrave-journals.com/jmm/journal/v8/n4/abs/jmm200823a.html

HSL15366
Colley P.
More on ads in veterinary publications.
J Am Vet Med Assoc. 2008 Oct 1;233(7):1059
http://www.ncbi.nlm.nih.gov/pubmed/18839493

HSL15179
Cutrona SL, Woolhandler S, Lasser KE, Bor DH, Himmelstein DU, Shrank WH, LeLeiko NS.
Free drug samples in the United States: characteristics of pediatric recipients and safety concerns.
Pediatrics 2008 Oct;122(4):736-42
http://pediatrics.aappublications.org/cgi/content/full/122/4/736

HSL15114
Martell J.
Buy me, I’ll change your life
Student BMJ 2008 Oct;16(350):10
http://student.bmj.com/issues/08/10/life/350.php

HSL15196
Vitry A.
Time for transparency at the TGA
Australian Prescriber 2008 Oct;31:114-6
http://www.australianprescriber.com/magazine/31/5/114/6/

HSL15197
Rutter P, Gilbody S.
The European pharmaceutical industry: coming to a screen near you?
J R Soc Med 2008 Oct;101(10):485-8
http://jrsm.rsmjournals.com/cgi/content/full/101/10/485

HSL15209
Kyle GJ, Nissen LM, Tett SE.
Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines.
J Clin Pharm Ther 2008 Oct;33(5):553-9
http://www3.interscience.wiley.com/journal/121411215/abstract

HSL15228
Baker-Smith CM, Benjamin DK Jr, Grabowski HG, Reid ED, Mangum B, Goldsmith JV, Murphy MD, Edwards R, Eisenstein EL, Sun J, Califf RM, Li JS.
The economic returns of pediatric clinical trials of antihypertensive drugs.
Am Heart J 2008 Oct;156(4):682-8
http://linkinghub.elsevier.com/retrieve/pii/S0002-8703(08)00351-7

HSL15232
Eichler HG, Pignatti F, Flamion B, Leufkens H, Breckenridge A.
Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.
Nat Rev Drug Discov 2008 Oct;7(10):818-26
http://www.nature.com/nrd/journal/v7/n10/abs/nrd2664.html

HSL15277
Wadman M.
Straight talk with...Charles Grassley
Nature Medicine 2008 Oct;14(10):1006 - 1007
http://www.nature.com/nm/journal/v14/n10/full/nm1008-1006.html

HSL15336
Hall DV, Jones SC.
Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
Aust N Z J Public Health 2008 Oct;32(5):471-8
http://www.ncbi.nlm.nih.gov/pubmed/18959553

HSL15361
Palmer JA, Timm AR, Neumann PJ.
Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999.
J Manag Care Pharm 2008 Oct;14(8):749-55
http://www.amcp.org/data/jmcp/749-755.pdf

HSL15403
Washlick JR, Welch SS.
Physician-vendor marketing and financial relationships under attack.
J Health Life Sci Law 2008 Oct;2(1):151,
http://www.ncbi.nlm.nih.gov/pubmed/19004300

HSL15458
Faunce T, Vines T, Gibbons H.
New forms of evergreening in Australia: misleading advertising, enantiomers and data exclusivity: Apotex v Servier and Alphapharm v Lundbeck.
J Law Med. 2008 Oct;16(2):220-32
http://www.ncbi.nlm.nih.gov/pubmed/19010001

HSL15619
Mamdani B.
The ethics of industry support for professional education in medicine.
Indian J Med Ethics. 2008 Oct-Dec;5(4):177-80
http://www.ncbi.nlm.nih.gov/pubmed/18988379

HSL15668
Willard MJ.
What is the cost of a free lunch? Taking time to assess hospitals' conflict-of-interest policies.
Mater Manag Health Care 2008 Oct;17(10):24-8
http://www.ncbi.nlm.nih.gov/pubmed/19025169

HSL15318
Alkhateeb FM, Clauson KA, Khanfar NM, Latif DA.
Legal and regulatory risk associated with Web 2.0 adoption by pharmaceutical companies
Journal of Medical Marketing 2008 Sep 26(8):311–318
http://www.palgrave-journals.com/jmm/journal/v8/n4/abs/jmm200820a.html

HSL15116
Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC.
A three-country comparison of psychotropic medication prevalence in youth.
Child and Adolescent Psychiatry and Mental Health 2008 Sep 25;2(1):26
http://www.capmh.com/content/2/1/26

HSL15135
Renfrew M, Hall D.
Enabling women to breast feed.
BMJ 2008 Sep 25;337:a1570
http://www.bmj.com/cgi/content/full/337/sep25_2/a1570

HSL15278
Håkansson J, Hernborg A, Olsson P.
[Advertising or science?]
Lakartidningen 2008 Sep 24-30;105(39):2710
http://www.ncbi.nlm.nih.gov/pubmed/18846885

HSL15136
Moncrieff J, Thomas P, Huws R.
Some progress in UK psychiatry.
BMJ 2008 Sep 23;337:a1780
http://www.bmj.com/cgi/content/extract/337/sep23_2/a1780

HSL15138
Ramogi MO.
Who else but pharma will fund medical education?
BMJ 2008 Sep 23;337:a1778
http://www.bmj.com/cgi/content/extract/337/sep23_2/a1778

HSL15139
Mathew JL.
Matters arising from industry link to education.
BMJ 2008 Sep 23;337:a1781
http://www.bmj.com/cgi/content/extract/337/sep23_2/a1781

HSL15140
Bamji AN.
More reasons for caution with statins and other such.
BMJ 2008 Sep 23;337:a1782
http://www.bmj.com/cgi/content/full/337/sep23_2/a1782

HSL15231
Eaton L.
Europeans claim industry handouts are not a problem.
CMAJ 2008 Sep 23;179(7):642-3
http://www.cmaj.ca/cgi/content/full/179/7/642

HSL15091
Van Zee A.
The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy.
Am J Public Health. 2008 Sep 17
http://www.ncbi.nlm.nih.gov/pubmed/18799767

HSL15230
Bernadotte K, Bergström R.
[MSD and LIF on marketing studies: all clinical trials can be used in marketing]
Lakartidningen. 2008 Sep 17;105(38):2594-5
http://www.ncbi.nlm.nih.gov/pubmed/18846867

HSL15118
Hall DV.
High levels of confusion for cholesterol awareness campaigns.
MJA 2008 Sep 15;189(6):326-8
http://www.mja.com.au/public/issues/189_06_150908/hal10349_fm.html

HSL15190
Lindberg M.
[Ezetimibe=cost effectiveness. Science or a debate contribution from MSD?]
Ugeskr Laeger. 2008 Sep 15;170(38):2987
http://www.ncbi.nlm.nih.gov/pubmed/18816890

HSL15049
Reed T.
The new Access to Medicine Index
The Lancet 2008 Sep 13;372(9642):890-891
Link to source with long URL

HSL15119
Ali MK, Narayan KM.
The new Access to Medicine Index.
Lancet 2008 Sep 13;372(9642):891
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61396-3

HSL15120
Reed T.
The new Access to Medicine Index.
Lancet 2008 Sep 13;372(9642):890-1
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61395-1

HSL15054
White C.
Academics draft protocol for handling research misconduct
BMJ 2008 Sep 11;337:a1612
http://www.bmj.com/cgi/content/extract/337/sep11_1/a1612

HSL15070
Ghaemi SN, Shirzadi AA, Filkowski M.
Publication Bias and the Pharmaceutical Industry: The Case of Lamotrigine in Bipolar Disorder
Medscape J Med 2008 Sep 10;10(9):211
http://www.medscape.com/viewarticle/579046

HSL15159
Pickar D, Vinik J, Bartko JJ.
Pharmacotherapy of Schizophrenic Patients: Preponderance of Off-Label Drug Use
PLoS One 2008 Sep 10;3(9):3150
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0003150

HSL15087
Jorgensen AW, Maric KL, Tendal B, Faurschou A, Gotzsche PC.
Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: Differences in methodological quality and conclusions.
BMC Med Res Methodol 2008 Sep 9;8(1):60
http://www.biomedcentral.com/1471-2288/8/60

HSL15121
Barennes H, Andriatahina T, Latthaphasavang V, Anderson M, Srour LM.
Misperceptions and misuse of Bear Brand coffee creamer as infant food: national cross sectional survey of consumers and paediatricians in Laos.
BMJ 2008 Sep 9;337:a1379
http://www.bmj.com/cgi/content/full/337/sep09_2/a1379

HSL15032
Jara M.
Spanish doctors say 'no thank you' to drug industry gifts
BMJ 2008 Sep 8;337
http://www.bmj.com/cgi/content/extract/337/sep08_1/a1579?papetoc

HSL15069
Conen D, Torres J, Ridker PM.
Differential Citation Rates of Major Cardiovascular Clinical Trials According to Source of Funding. A Survey From 2000 to 2005
Circulation. 2008 Sep 8:epub ahead of print
Link to source with long URL

HSL15072
Eisenberg T, Wells MT.
Statins and Adverse Cardiovascular Events in Moderate-Risk Females: A Statistical and Legal Analysis with Implications for FDA Preemption Claims
Journal of Empirical Legal Studies 2008 Sep 5;5(3):507 - 550
http://www3.interscience.wiley.com/journal/121400492/abstract

HSL15319
Bates AK.
Implementing a pre-launch named patient programme: Evidence of increased market share
Journal of Medical Marketing 2008 Sep 4(8):319–324
http://www.palgrave-journals.com/jmm/journal/v8/n4/abs/jmm200825a.html

HSL14980
Rothman DJ, Chimonas S.
New Developments in Managing Physician-Industry Relationships
JAMA 2008 Sep 3;300(9):1067
http://jama.ama-assn.org/cgi/content/extract/300/9/1067

HSL14982
Relman AS.
Industry Support of Medical Education
JAMA 2008 Sep 3;300(9):1071-1073
http://jama.ama-assn.org/cgi/content/extract/300/9/1071

HSL15056
Maisonneuve H, Touboul C, Bonnelye G, Bertrand D.
[French hospital doctors attend many educational programmes but have organisational and financial difficulties for their continuing medical education.]
Presse Med 2008 Sep 3:epub ahead of print
http://www.em-consulte.com/article/181774

HSL15097
Ross K.
Crackdown on unproven cancer treatments focuses on internet marketers.
J Natl Cancer Inst. 2008 Sep 3;100(17):1200-2
http://jnci.oxfordjournals.org/cgi/content/full/100/17/1200

HSL15122
Lee AC, Radford J.
The ranibizumab saga of drug profiteering.
BMJ 2008 Sep 3;337:a1532
http://www.bmj.com/cgi/content/full/337/sep03_3/a1532

HSL14978
Piwowar HA, Becich BJ, Bilofsky H, Crowley RS.
Towards a Data Sharing Culture: Recommendations for Leadership from Academic Health Centers
PLoS Med. 2008 Sep 2;5(9)
Link to source with long URL

HSL14981
Angell M.
Industry-Sponsored Clinical Research: A Broken System
JAMA 2008 Sep 2;300(9):1069
http://jama.ama-assn.org/cgi/content/extract/300/9/1069

HSL14985
Law MR, Majumdar SR, Soumerai SB, .
Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
BMJ 2008 Sep 2;337
http://www.bmj.com/cgi/content/abstract/337/sep02_1/a1055

HSL14986
Mintzes B.
Direct to consumer advertising of prescription drugs
BMJ 2008 Sep 2;337
http://www.bmj.com/cgi/content/extract/337/sep02_1/a985

HSL14935
Sufrin CB, Ross JS.
Pharmaceutical Industry Marketing: Understanding Its Impact on Women's Health.
Obstet Gynecol Surv. 2008 Sep;63(9):585-596
Link to source with long URL

HSL14955
Editorial .
Credibility crisis in pediatric psychiatry
Nature Neuroscience 2008 Sep;11(9):983
http://www.nature.com/neuro/journal/v11/n9/index.html

HSL15006
Jones K.
In whose interest? Relationships between health consumer groups and the pharmaceutical industry in the UK.
Sociol Health Illn. 2008 Sep;30(6):929-43
Link to source with long URL

HSL15007
Abraham J.
Sociology of pharmaceuticals development and regulation: a realist empirical research programme.
Sociol Health Illn. 2008 Sep;30(6):869-85
http://www3.interscience.wiley.com/journal/121390260/abstract

HSL15009
Conrad P, Leiter V.
From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation.
Sociol Health Illn 2008 Sep;30(6):825-38
http://www3.interscience.wiley.com/journal/121390265/abstract

HSL15030
Miller DP, Mansfield RJ, Woods JB, Wofford JL, Moran WP.
The Impact of Drug Samples on Prescribing to the Uninsured.
South Med J. 2008 Sep;101(9):888-893
Link to source with long URL

HSL15042
Downey LV.
What is the impact of free drug samples on patients?
South Med J 2008 Sep;101(9):879-80
Link to source with long URL

HSL15096
Smith PB, Benjamin DK Jr, Murphy MD, Johann-Liang R, Iyasu S, Gould B, Califf RM, Li JS, Rodriguez W.
Safety monitoring of drugs receiving pediatric marketing exclusivity.
Pediatrics 2008 Sep;122(3):e628-33
http://pediatrics.aappublications.org/cgi/content/full/122/3/e628

HSL15115
Liesegang TJ.
Commercialism, Loss of Professionalism, and the Effect on Journals
Archives of Ophthalmology 2008 Sep;126(9):1292-1295.
http://archopht.ama-assn.org/cgi/content/extract/126/9/1292

HSL15117
Zhang Y.
Cost-saving effects of olanzapine as long-term treatment for bipolar disorder.
The Journal of Mental Health Policy and Economics 2008 Sep;11(3):135-46
Link to source with long URL

HSL15124
Coleman DL.
Establishing policies for the relationship between industry and clinicians: lessons learned from two academic health centers.
Acad Med. 2008 Sep;83(9):882-7
Link to source with long URL

HSL15125
Liesegang TJ, Albert DM, Schachat AP.
How to ensure our readers' trust: the proper attribution of authors and contributors.
Am J Ophthalmol. 2008 Sep;146(3):337-40
http://linkinghub.elsevier.com/retrieve/pii/S0002-9394(08)00459-5

HSL15233
Steiner TJ.
Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry--report and recommendations of the Ethics Subcommittee of the International Headache Society.
Cephalalgia 2008 Sep;28:Suppl 3:1-25
http://www3.interscience.wiley.com/cgi-bin/fulltext/120776174/PDFSTART

HSL15279
Miao-Sheng C, Yu-Ti S.
Pricing of prescription drugs and its impact on physicians' choice behavior.
Health Care Manag Sci 2008 Sep;11(3):288-95
http://www.ncbi.nlm.nih.gov/pubmed/18826006

HSL15337
Strehl E.
[Surveillance--more than a marketing instrument?].
Med Monatsschr Pharm. 2008 Sep;31(9):346-50
http://www.ncbi.nlm.nih.gov/pubmed/18831466

HSL15367
Tomaszewski C.
Blinding in peer review.
J Med Toxicol. 2008 Sep;4(3):147-8
Link to source with long URL

HSL15401
Mastroianni FC, Noto AR.
Newsmaking on drugs: a qualitative study with journalism professionals.
J Psychoactive Drugs 2008 Sep;40(3):293-300
http://www.ncbi.nlm.nih.gov/pubmed/19004421

HSL15626
Peddecord KM, Jacobson IG, Engelberg M, Kwizera L, Macias V, Gustafson KW.
Can movie theater advertisements promote health behaviors? Evaluation of a flu vaccination pilot campaign.
J Health Commun. 2008 Sep;13(6):596-613
Link to source with long URL

HSL15627
Freeman B, Chapman S.
Gone viral? Heard the buzz? A guide for public health practitioners and researchers on how Web 2.0 can subvert advertising restrictions and spread health information.
J Epidemiol Community Health 2008 Sep;62(9):778-82
http://jech.bmj.com/cgi/content/full/62/9/778

HSL15628
Filippini G, Moja L, Liberati A, Gensini GF, Gusinu R, Conti AA.
When drug companies select what they want to publish patients are denied relevant therapeutic information.
Intern Emerg Med 2008 Sep;3(3):255-7
http://www.springerlink.com/content/h4h89873k570r710/

HSL15005
Gulhati CM.
Illegal Approval to Market Letrozole for Infertility in India
Monthly Index of Medical Specialities - India 2008 Aug 31

HSL15008
Fox NJ, Ward KJ.
Pharma in the bedroom. . . and the kitchen. . . . The pharmaceuticalisation of daily life
Sociol Health Illn 2008 Aug 28;30(6):856 - 868
http://www3.interscience.wiley.com/journal/121390267/abstract

HSL15123
Dompé S.
Changes in the rules now governing Italy's drug industry.
Nature 2008 Aug 28;454(7208):1049
http://www.nature.com/doifinder/10.1038/4541049c

HSL15353
Williams SJ, Gabe J, Davis P.
The sociology of pharmaceuticals: progress and prospects
Sociology of Health & Illness 2008 Aug 28;30(6):813 - 824
Link to source with long URL

HSL15011
Lachenbruch PA, Wasserstein R.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):904
http://jama.ama-assn.org/cgi/content/full/300/8/904

HSL15012
Maisonneuve H.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):903
http://jama.ama-assn.org/cgi/content/full/300/8/903

HSL15013
Ong HT, Cheah JS.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):903-4
http://jama.ama-assn.org/cgi/content/full/300/8/903-a

HSL15014
Balon R.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):902
http://jama.ama-assn.org/cgi/content/full/300/8/902

HSL15015
Costa SD.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):902-3
http://jama.ama-assn.org/cgi/content/full/300/8/902-a

HSL15016
Patrono C.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):901
http://jama.ama-assn.org/cgi/content/full/300/8/901

HSL15017
Hawkey CJ.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):901
http://jama.ama-assn.org/cgi/content/full/300/8/901-a

HSL15018
Ferris S, Galasko D, Kirby L.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):901-2
http://jama.ama-assn.org/cgi/content/full/300/8/901-b

HSL15019
Johnson KR, Lassere MN.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):900
http://jama.ama-assn.org/cgi/content/full/300/8/900

HSL15020
FitzGerald GA.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27;300(8):900-1
http://jama.ama-assn.org/cgi/content/full/300/8/900-a

HSL15213
Hariz M.
[Medically dangerous advertising of Treo].
Lakartidningen. 2008 Aug 27-Sep;105(35):2349
http://www.ncbi.nlm.nih.gov/pubmed/18833634

HSL15214
Forslund L, Gerdén B.
[It's only afterwards the Medical Products Agency can scrutinize advertisements].
Lakartidningen. 2008 Aug 27-Sep;105(35):2348
http://www.ncbi.nlm.nih.gov/pubmed/18833633

HSL15022
Gould M.
End of the free lunch?
BMJ 2008 Aug 26;337:a1399
http://www.bmj.com/cgi/content/full/337/aug26_1/a1399

HSL14925
Kim JJ, Goldie SJ.
Health and Economic Implications of HPV Vaccination in the United States.
NEJM 2008 Aug 21;359(8):821-32
http://content.nejm.org/cgi/content/full/359/8/821

HSL15023
Lenzer J.
Truly independent research?
BMJ 2008 Aug 21;337:a1332
http://www.bmj.com/cgi/content/full/337/aug21_1/a1332

HSL14934
Dumville JC, Petherick ES, O'Meara S, Raynor P, Cullum N.
How is research evidence used to support claims made in advertisements for wound care products?
J Clin Nurs 2008 Aug 20
Link to source with long URL

HSL14906
Hill KP, Ross JS, Egilman DS, Krumholz HM.
The ADVANTAGE seeding trial: a review of internal documents.
Annals of Internal Medicine 2008 Aug 19;149(4):251-8
http://www.annals.org/cgi/content/full/149/4/251

HSL14909
Sox HC, Rennie D.
Seeding trials: just say 'no'
Annals of Internal Medicine 2008 Aug 19;149(4):279-80
http://www.annals.org/cgi/content/full/149/4/279

HSL14913
Moynihan R.
Is the relationship between pharma and medical education on the rocks?
BMJ 2008 Aug 14;337:a925
http://www.bmj.com/cgi/content/short/337/aug14_1/a925

HSL14914
Fletcher S.
Pharma and CME: View from the US.
BMJ 2008 Aug 14;337:a1023
http://www.bmj.com/cgi/content/short/337/aug14_1/a1023

HSL14915
Pisacane A.
Rethinking continuing medical education.
BMJ 2008 Aug 14;337:a973
http://www.bmj.com/cgi/content/short/337/aug14_1/a973

HSL14933
Mastroianni PC, Vaz AC, Noto AR, Galduróz JC.
[Psychoactive drug advertising: content analysis].
Rev Saude Publica. 2008 Aug 14
Link to source with long URL

HSL14971
Kormeset PO.
[Pharmaceutical consultants and drug information].
Tidsskr Nor Laegeforen 2008 Aug 14;128(15):1684-5
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1716767

HSL14895
Kermode-Scott B.
Harm from prescription drugs likely to grow, claims US sociologist.
BMJ 2008 Aug 13;337:a1280
http://www.bmj.com/cgi/content/full/337/aug13_3/a1280

HSL15191
Meijman FJ.
[Health communication and public media: professionals need to be heard].
Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1760-4
http://www.ncbi.nlm.nih.gov/pubmed/18754306

HSL14865
Editorial .
Clean hands, please
Nature 2008 Aug 7;454(7205):667
http://www.nature.com/nature/journal/v454/n7205/full/454667b.html

HSL15098
Clean hands, please.
Nature 2008 Aug 7;454(7205):667
http://www.nature.com/doifinder/10.1038/454667b

HSL14845
Reed SD, Anstrom KJ, Seils DM, .
Use Of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs
Health Affairs 2008 Aug 5
http://content.healthaffairs.org/cgi/content/full/hlthaff.27.5.w360/DC1

HSL14867
Tanne JH.
FDA oversight of drug company promotion of off-label use is poor, US watchdog says.
BMJ 2008 Aug 5;337:a1163
http://www.bmj.com/cgi/content/full/337/aug05_2/a1163

HSL14869
Bandler LG.
Misleading advertising of PI-based drug information?
Med J Aust. 2008 Aug 4;189(3):181
http://www.mja.com.au/public/issues/189_03_040808/letters_040808_fm-5.html

HSL14720
Chauhan D, Mason A.
Factors affecting the uptake of new medicines in secondary care - a literature review.
J Clin Pharm Ther 2008 Aug;33(4):339-48
Link to source with long URL

HSL14848
Doucet M, Sismondo S.
Evaluating solutions to sponsorship bias.
BMJ 2008 Aug;34(8):627-30
http://jme.bmj.com/cgi/content/abstract/34/8/627

HSL14870
Berger E.
Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.
Ann Emerg Med. 2008 Aug;52(2):137-9
http://www.ncbi.nlm.nih.gov/pubmed/18672488

HSL14898
Vincent WR, Wiesner AM, Steinke DT.
'Free' prescription drug samples are not free.
Am J Public Health. 2008 Aug;98(8):1348-9
http://www.ajph.org/cgi/content/full/98/8/1348

HSL14938
Whitehead J, Cobo E.
Stopping a trial early in oncology: for patients or for industry?
Ann Oncol. 2008 Aug;19(8):1512-3
http://annonc.oxfordjournals.org/cgi/content/full/19/8/1512-a

HSL15283
Torrey EF.
A question of disclosure.
Psychiatr Serv 2008 Aug;59(8):935
http://ps.psychiatryonline.org/cgi/content/full/59/8/935

HSL15406
Ratner M, Gura T.
Off-label or off-limits?
Nature 2008 Aug;26(8):867-75
http://www.nature.com/nbt/journal/v26/n8/abs/nbt0808-867.html

HSL15407
Mitchell P.
UK strong arms industry over drug pricing.
Nat Biotechnol. 2008 Aug;26(8):846-7
http://www.nature.com/doifinder/10.1038/nbt0808-846c

HSL15621
Agarwal RK.
Why physician's sample? Else they are trade promotional material!
J Indian Med Assoc. 2008 Aug;106(8):543
http://www.ncbi.nlm.nih.gov/pubmed/18979615

HSL14832
Troy DE, Gottlieb S.
Pharmaceutical promotion and First Amendment rights.
N Engl J Med 2008 Jul 31;359(5):536
http://www.ncbi.nlm.nih.gov/pubmed/18669437

HSL14861
Kuriya B, Schneid EC, Bell CM.
Quality of Pharmaceutical Industry Press Releases Based on Original Research
PLoS ONE 2008 July 30;3(7):e2828
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0002828

HSL14834
Gilstad JR, Finucane TE.
Results, Rhetoric, and Randomized Trials: The Case of Donepezil.
J Am Geriatr Soc. 2008 Jul 24
Link to source with long URL

HSL14753
Lenzer J, Brownlee S.
Naming names: is there an (unbiased) doctor in the house?
BMJ 2008 Jul 23;337
http://www.bmj.com/cgi/content/extract/337/jul23_3/a930

HSL15010
Linnersten L.
[Is household-targeted Gardasil advertising in accordance with the intentions of the legislators?].
Lakartidningen. 2008 Jul 23;105(30-31):2121
http://www.ncbi.nlm.nih.gov/pubmed/18751457

HSL14871
Tanne JH.
Senator asks psychiatrists' association about drug company funding.
BMJ 2008 Jul 21;337:a929
http://www.bmj.com/cgi/content/full/337/jul21_2/a929

HSL15192
Reeve JF, Mackson JM, Sweidan M, Williamson M.
The effect of advertising in clinical software on general practitioners' prescribing behaviour.
Med J Aust 2008 Jul 21;189(2):85
http://www.mja.com.au/public/issues/189_02_210708/ree10190_fm.html

HSL14742
Al-Marzouki S, Roberts I, Evans S, Marshall T.
Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet
The Lancet 2008 Jul 19;372(9634):201
Link to source with long URL

HSL14743
McNamee D, James A, Kleinert S.
Protocol review at The Lancet
The Lancet 2008 Jul 19;372(9634):189-190
Link to source with long URL

HSL14778
Abel GA, Neufeld EJ, Sorel M, Weeks JC.
Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims.
J Thromb Haemost 2008 Jul 18
http://www3.interscience.wiley.com/journal/120835477/abstract

HSL14761
Sorensen L, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB.
Laypersons' understanding of relative risk reductions: a randomised cross-sectional study.
BMC Med Inform Decis Mak 2008 Jul 17;8(1):31
http://www.biomedcentral.com/1472-6947/8/31

HSL14839
Dobson R.
Roche is suspended from ABPI for 'actions likely to bring discredit' on the industry.
BMJ 2008 Jul 16;337:a835
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632675

HSL14794
The PLoS Medicine Editors.
Next Stop, Don't Block the Doors: Opening Up Access to Clinical Trials Results.
PLoS Med. 2008 Jul 15;5(7):e160
Link to source with long URL

HSL14835
Reynolds CJ, Yates T, Hughes R.
Key opinion leaders: Getting them while they're young.
BMJ 2008 Jul 15;337:a792
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632710

HSL14836
Spiers AS.
Key opinion leaders: How to spot one.
BMJ 2008 Jul 15;337:a790
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632709

HSL14837
Fugh-Berman A.
Key opinion leaders: Thus are our medical meetings managed.
BMJ 2008 Jul 15;337:a789
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632708

HSL14838
Carroll BJ.
How it really works.
BMJ 2008 Jul 15;337:a788
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18632707

HSL14872
Kaufert P, Kaufert J.
Distressing news on the Therapeutics Initiative.
CMAJ 2008 Jul 15;179(2):164
Link to source with long URL

HSL14873
Hébert PC.
Direct-to-consumer advertising: end the compromise.
CMAJ 2008 Jul 15;179(2):119
Link to source with long URL

HSL14897
Marek K.
Reader objects to increasing ads in veterinary publications.
J Am Vet Med Assoc 2008 Jul 15;233(2):224-5
http://www.ncbi.nlm.nih.gov/pubmed/18642410

HSL14779
Dyer C.
Prosecution over drug price fixing collapses.
BMJ 2008 Jul 14;337:a814
http://www.bmj.com/cgi/content/full/337/jul14_2/a814

HSL14780
Tanne JH.
Pfizer stops funding medical education provided by profit making companies.
BMJ 2008 Jul 8;337:a708
http://www.bmj.com/cgi/content/full/337/jul08_2/a708

HSL14781
Stafford N.
German watchdog investigates drug company's online education courses.
BMJ 2008 Jul 8;337:a723
http://www.bmj.com/cgi/content/full/337/jul08_1/a723

HSL14782
Tanne JH.
US doctors display
BMJ 2008 Jul 8;337:a711
http://www.bmj.com/cgi/content/full/337/jul08_1/a711

HSL15217
Radcliff M.
'We should question the power of drug companies'.
Nurs Times. 2008 Jul 8-14;104(27):52
http://www.ncbi.nlm.nih.gov/pubmed/18683392

HSL14896
West D.
The frequency of medicines advertising on New Zealand television.
N Z Med J 2008 Jul 4;121(1277):97-8
http://www.ncbi.nlm.nih.gov/pubmed/18677339

HSL14783
Tuffs A.
German soap opera has thinly veiled references to branded drugs, regulator says.
BMJ 2008 Jul 1;337:a619
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=18595910

HSL14840
Brooks JR.
Pens, mugs, clocks, notepads and other handouts.
CMAJ 2008 Jul 1;179(1):28-9
Link to source with long URL

HSL14841
Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO.
Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.
Neurology 2008 Jul 1;71(1):57-63
http://www.neurology.org/cgi/content/full/71/1/57

HSL14874
Rosenberg RN.
Unreported financial disclosures.
Arch Neurol 2008 Jul;65(7):992
http://archneur.ama-assn.org/cgi/content/full/65/7/992

HSL14876
Bastawrous A, Smith MC.
We are part of the problem.
Br J Ophthalmol 2008 Jul;92(7):1010
http://bjo.bmj.com/cgi/content/full/92/7/1010

HSL14969
Islam MS, Farah SS.
Sources of information in drug advertisements: evidence from the drug indexing journal of Bangladesh.
Indian J Med Ethics 2008 Jul-Sep;5(3):136-7
http://www.ncbi.nlm.nih.gov/pubmed/18754240

HSL14973
Tyndall A.
Why do we need noncommercial, investigator-initiated clinical trials?
Nature 2008 Jul;4(7):354-5
http://www.nature.com/doifinder/10.1038/ncprheum0814

HSL15103
Somberg JC.
The sins of ghostwriting.
Am J Ther 2008 Jul-Aug;15(4):297-8
Link to source with long URL

HSL15215
Rivkees SA.
The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate.
J Pediatr Endocrinol Metab. 2008 Jul;21(7):607-9
http://www.ncbi.nlm.nih.gov/pubmed/18780592

HSL15368
McHenry LB, Jureidini JN.
Industry-sponsored ghostwriting in clinical trial reporting: a case study.
Account Res 2008 Jul-Sep;15(3):152-67
http://www.ncbi.nlm.nih.gov/pubmed/18792536

HSL15369
Nayak BK.
Finer nuances of clinical study agreements for research trials.
Indian J Ophthalmol 2008 Jul-Aug;56(4):267-8
Link to source with long URL

HSL15629
Kaplan DL, Graff KM.
Marketing breastfeeding--reversing corporate influence on infant feeding practices.
2008 Jul;85(4):486-504
http://www.springerlink.com/content/82277g292095x388/

HSL14784
Moynihan R.
Drug maker's PR firm is force behind blood clot awareness campaign.
BMJ 2008 Jun 28;336(7659):1460-1
http://www.bmj.com/cgi/content/full/336/7659/1460-a

HSL14760
Kaiser J.
Ethics. Senate inquiry on research conflicts shifts to grantees
Science. 2008 Jun 27;320(5884):1708
http://www.sciencemag.org/cgi/content/full/320/5884/1708

HSL14693
Cowen PJ.
Serotonin and depression: pathophysiological mechanism or marketing myth?
Trends Pharmacol Sci. 2008 Jun 26
Link to source with long URL

HSL15216
Wink K.
[Do patients understand special terms in the product information?]
MMW Fortschr Med. 2008 Jun 26;150
http://www.ncbi.nlm.nih.gov/pubmed/18712123

HSL14773
Cain DM, Detsky AS.
Everyone's a Little Bit Biased (Even Physicians)
JAMA. 2008 Jun 25;299(24):2893-2895
Link to source with long URL

HSL14573
Moynihan R.
Key opinion leaders: independent experts or drug representatives in disguise?
BMJ 2008 Jun 21;336(7658):1402-3
http://www.bmj.com/cgi/content/extract/336/7658/1402

HSL14574
Godlee F.
Key opinion leaders, your time is up
BMJ 2008 Jun 21;336(7658)
http://www.bmj.com/cgi/content/extract/336/7658/0

HSL14575
Buckwell C.
Should the drug industry work with key opinion leaders? Yes
BMJ 2008 Jun 21;336(7658):1404
http://www.bmj.com/cgi/content/full/336/7658/1404

HSL14576
Fava GA.
Should the drug industry work with key opinion leaders? No
BMJ 2008 Jun 21;336(7658):1405
http://www.bmj.com/cgi/content/full/336/7658/1405

HSL14767
Jack A.
Europe's drug companies are better than those in US in making drugs accessible to poor countries.
BMJ 2008 Jun 21;336(7658):1396
http://www.bmj.com/cgi/content/extract/336/7658/1396

HSL14695
Fitzgerald GA.
Drugs, industry, and academia.
Science. 2008 Jun 20;320(5883):1563
http://www.sciencemag.org/cgi/content/full/320/5883/1563

HSL14562
Titus SL, Wells JA, Rhoades LJ.
Repairing research integrity
Nature 2008 Jun 19;453:980-982
http://www.nature.com/nature/journal/v453/n7198/full/453980a.html

HSL14581
Tinetti ME.
Over-the-counter sales of statins and other drugs for asymptomatic conditions.
N Engl J Med 2008 Jun 19;358(25):2728-32
http://content.nejm.org/cgi/content/extract/358/25/2728

HSL14828
Ledford H.
Institutes in pharma cash probe.
Nature 2008 Jun 19;453(7198):963
http://www.nature.com/news/2008/080618/full/453963a.html

HSL14829
[No authors listed].
Anti-AIDS vitamin advertising banned.
Nature 2008 Jun 19;453(7198):969
http://www.nature.com/news/2008/080618/full/453969c.html

HSL14830
Mejia R.
Taking the industry road.
Nature 2008 Jun 19;453(7198):1138-9
http://www.nature.com/naturejobs/2008/080619/full/nj7198-1138a.html

HSL14567
Ledford H.
Institutes in pharma cash probe: Universities under pressure to investigate researchers' industry funding.
Nature 2008 Jun 18;453(963)
http://www.nature.com/news/2008/080618/full/453963a.html

HSL14641
Kuehn BM.
Companies’ Use of Web to Recruit Patients for Studies Brings Opportunities, Risks
JAMA 2008 Jun 18;299(23):2733
http://jama.ama-assn.org/cgi/content/full/299/23/2733

HSL14543
Vollmar HC, Ostermann T, Hinz A, Rieger MA, Butzlaff ME.
[Primary care physicians, internet and educational media. Preferences, usages and appraisal in a 6-year comparison]
Med Klin (Munich). 2008 Jun 15;103(6):425-32
http://www.ncbi.nlm.nih.gov/pubmed/18548212

HSL14537
Editorial .
Direct-to-consumer advertising under a different name
The Lancet 2008 Jun 14;371(9629):1972
Link to source with long URL

HSL14608
Lenzer J.
Review launched after Harvard psychiatrist failed to disclose industry funding.
BMJ 2008 Jun 14;336(7657):1327
Link to source with long URL

HSL14646
Direct-to-consumer advertising under a different name.
Lancet 2008 Jun 14;371(9629):1972
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)60843-0

HSL14763
Winkler JT.
Law on unjustified health claims: Member states must enforce ban on dubious products.
BMJ 2008 Jun 14;336(7657):1324-5
http://www.bmj.com/cgi/content/extract/336/7657/1324-c

HSL14541
Gérvas J.
Human papillomavirus vaccines. Three decent proposals .
CMAJ 2008 Jun 13:epub
http://www.cmaj.ca/cgi/eletters/177/12/1527

HSL14629
Goozner M.
A prescription for public health
Nature 2008 Jun 12;453:855-856
http://www.nature.com/nature/journal/v453/n7197/full/453855a.html

HSL14623
Light D.
Missing the real issue about the pneumo AMC
Development Today 2008 Jun 11;XVIII(8):11
http://www.development-today.com/magazine/2008/DT_8/Opinion/3490

HSL14513
Moynihan R.
Independent drug watchdog in Canada under funding threat
BMJ 2008 Jun 7;336(7656):1270
http://www.bmj.com/cgi/content/extract/336/7656/1270-a

HSL14514
Burton B.
Drug industry weakens US bill about disclosure of gifts
BMJ 2008 Jun 7;336(7656):1268
http://www.bmj.com/cgi/content/extract/336/7656/1268-a

HSL14765
Hickman L.
Product placement in the waiting room.
BMJ 2008 Jun 7;336(7656):1274-5
http://www.bmj.com/cgi/content/extract/336/7656/1274

HSL14766
Tanne JH.
US branded drug makers pay to prevent generic competition.
BMJ 2008 Jun 7;336(7656):1266-7
http://www.bmj.com/cgi/content/extract/336/7656/1266-b

HSL14546
Lichter PR.
Debunking Myths in Physician-Industry Conflicts of Interest.
Am J Ophthalmol. 2008 Jun 5
http://linkinghub.elsevier.com/retrieve/pii/S0002-9394(08)00276-6

HSL14530
Stockigt JR.
Misleading advertising of PI-based drug information?
Med J Aust 2008 Jun 2;188(11):679-80
http://www.mja.com.au/public/issues/188_11_020608/letters_020608_fm-6.html

HSL15393
Javitt G, Berkowitz D, Gostin LO.
Assessing Mandatory HPV Vaccination: Who Should Call the Shots?
The Journal of Law, Medicine & Ethics 2008 Jun 2;36(2):384 - 395
Link to source with long URL

HSL14786
Cudny ME, Graham AS.
Adverse-drug-event data provided by pharmaceutical companies.
Am J Health Syst Pharm. 2008 Jun 1;65(11):1071-5
http://www.ajhp.org/cgi/content/full/65/11/1071

HSL14339
Mastroianni PC, Noto AR, Galduróz JC.
[Psychoactive drug advertising: analysis of scientific information].
Rev Saude Publica 2008 Jun;42(3):epub ahead of print
Link to source with long URL

HSL14586
Lado E, Vacariza M, Fernández-González C, Gestal-Otero JJ, Figueiras A.
Influence exerted on drug prescribing by patients' attitudes and expectations and by doctors' perception of such expectations: a cohort and nested case-control study.
J Eval Clin Pract. 2008 Jun;14(3):453-9
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2007.00901.x

HSL14605
Sharma AM.
Response
Can Fam Physician 2008 Jun;54(6):849 - 850
http://www.cfp.ca/cgi/content/full/54/6/849?etoc

HSL14606
Kelsall DL.
Editor’s response
Can Fam Physician 2008 Jun;54(6):850 - 851
http://www.cfp.ca/cgi/content/full/54/6/850?etoc

HSL14604
Lexchin J, Basset K, Biron P, Mansfield PR, Mintzes B.
Medications for obesity
Can Fam Physician 2008 Jun;54(6):848 - 849
http://www.cfp.ca/cgi/content/full/54/6/848-a?etoc

HSL14643
Green S.
Ethics and the pharmaceutical industry.
Australas Psychiatry. 2008 Jun;16(3):158-65
Link to source with long URL

HSL14692
Tavcar R, Dernovsek MZ.
Clinically tested toothpaste and other fairy tales - A critical approach to reading pharmaceutical advertisements and professional papers.
Psychiatr Danub 2008 Jun;20(2):249-50
http://www.ncbi.nlm.nih.gov/pubmed/18587300

HSL14746
Bhangale V.
Pharma marketing in India: Opportunities, challenges and the way forward
Journal of Medical Marketing 2008 Jun;8(3):205–210
http://www.palgrave-journals.com/jmm/journal/v8/n3/abs/5050121a.html

HSL14748
Joseph M, Spake DF, Godwin DM.
Aging consumers and drug marketing: Senior citizens' views on DTC advertising, the medicare prescription drug programme and pharmaceutical retailing
Journal of Medical Marketing 2008 Jun;8(3):221–228
http://www.palgrave-journals.com/jmm/journal/v8/n3/abs/jmm20084a.html

HSL14749
Singh R.
Network connectedness of pharmaceutical sales rep (FLE)-physician dyad and physician prescription behaviour: A conceptual model
J Med Market 2008 Jun;8(3):257-268
http://www.palgrave-journals.com/jmm/journal/v8/n3/abs/jmm200814a.html

HSL14759
Whittle J, Good CB.
Prescription drug samples: making decisions with imperfect data.
J Gen Intern Med 2008 Jun;23(6):890-2
http://www.springerlink.com/content/246544r5343x74t6/fulltext.pdf

HSL14788
Tjia J, Briesacher BA, Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Gurwitz JH.
Medicare beneficiaries and free prescription drug samples: a national survey.
J Gen Intern Med. 2008 Jun;23(6):709-14
http://www.springerlink.com/content/9871685172880q62/

HSL14790
Luevorasirikul K, Gray NJ, Anderson CW.
Developing a consumer evaluation tool of weight control strategy advertisements on the Internet.
Health Educ Res. 2008 Jun;23(3):567-75
http://her.oxfordjournals.org/cgi/content/full/23/3/567

HSL14820
Lexchin J.
Doctors and Industry Funding of Continuing Medical Education: Guilty as Charged
The Israeli Journal of Emergency Medicine 2008 Jun;8(2):23-25
http://isrjem.org/Isrjem_June08.Funding%20Lexchin_Postprod.pdf

HSL14972
Hammerschmidt D.
Bias in the design, interpretation, and publication of industry-sponsored clinical research.
Minn Med. 2008 Jun;91(6):46-7
http://www.ncbi.nlm.nih.gov/pubmed/18616022

HSL14995
Joseph M, Spake DF, Godwin DM.
Aging consumers and drug marketing: Senior citizens’ views on DTC advertising, the medicare prescription drug programme and pharmaceutical retailing.
Journal of Medical Marketing 2008 Jun;8(3):221-228
Link to source with long URL

HSL15024
Tsai HJ.
Physician-industry interactions: there is no such thing as a free lunch.
Taiwan J Obstet Gynecol 2008 Jun;47(2):252-5
http://ajws.elsevier.com/ajws3/abstract.asp?art_id=4411&art_journals=5

HSL15025
Loncarek K.
How to say 'thanks' in Phoenician.
Croat Med J. 2008 Jun;49(3):441-3
Link to source with long URL

HSL15057
Kerridge I.
Comment: interactions between the medical profession and the pharmaceutical industry in Australia.
Australas Psychiatry 2008 Jun;16(3):166-8
Link to source with long URL

HSL15058
Green S.
Ethics and the pharmaceutical industry.
Australas Psychiatry 2008 Jun;16(3):158-65
Link to source with long URL

HSL15099
Kohr R.
Taking issue with 'lets do lunch.'
Can Nurse. 2008 Jun;104(6):5-6
http://www.ncbi.nlm.nih.gov/pubmed/18646299

HSL15100
Macdonald G.
Taking issue with 'lets do lunch.'
Can Nurse. 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18646298

HSL15101
Meyouhas V.
Taking issue with 'lets do lunch.'
Can Nurse. 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18646297

HSL15102
Gheseger J.
Taking issue with 'lets do lunch.'
Can Nurse. 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18646296

HSL15104
McCall J.
Taking issue with "Let's do lunch".
Can Nurse 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18642492

HSL15105
McCall J.
Taking issue with 'Let's do lunch'.
Can Nurse. 2008 Jun;104(6):5
http://www.ncbi.nlm.nih.gov/pubmed/18642492

HSL15111
Lloyd S.
Morals, medicine and change: morality brokers, social phobias, and French psychiatry.
Cult Med Psychiatry. 2008 Jun;32(2):279-97
http://www.springerlink.com/content/hh8k583l8p1r375t/

HSL15131
Sandall J.
No such thing as a free lunch.
Midwifery. 2008 Jun;24(2):123-5
Link to source with long URL

HSL15218
Fisher JA.
Practicing research ethics: private-sector physicians & pharmaceutical clinical trials.
Soc Sci Med. 2008 Jun;66(12):2495-505
Link to source with long URL

HSL15281
Rohra DK, Bashir MU, Khwaja UA, Nazir MR.
Critical appraisal of apparently evidence-based written advertising in Pakistan.
Pharm World Sci 2008 Jun;30(3):216-21
http://www.springerlink.com/content/c1576830414g6157/

HSL15370
Bucher HC.
[Surrogate endpoint trials: benefit and pitfalls for clinical decision making].
Internist (Berl). 2008 Jun;49(6):681-7
http://www.springerlink.com/content/k127706732328k06/

HSL16010
Wibulpolprasert S; Subcommittee for Development of the National List of Essential Drugs.
The need for guidelines and the use of economic evidence in decision-making in Thailand: lessons learnt from the development of the national list of essential drugs.
2008 Jun;91
http://www.ncbi.nlm.nih.gov/pubmed/19255984

HSL14547
Charatan F.
Merck to pay $58m in settlement over rofecoxib advertising.
BMJ 2008 May 31;336(7655):1208-9
http://www.bmj.com/cgi/content/full/336/7655/1208-a

HSL14638
Silversides A.
Highly-lauded drug assessment program under attack.
CMAJ 2008 May 28
http://www.cmaj.ca/cgi/content/full/179/1/26?etoc

HSL14485
Ioannidis JP.
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?
Philos Ethics Humanit Med 2008 May 27;3:14
http://www.peh-med.com/content/3/1/14

HSL14687
PLoS Medicine Editors, Barbour V, Clark J, Peiperl L, Veitch E, Wong M, Yamey G.
False hopes, unwarranted fears: the trouble with medical news stories.
PLoS Med. 2008 May 27;5(5):e118
Link to source with long URL

HSL14688
Schwitzer G.
How do US journalists cover treatments, tests, products, and procedures? An evaluation of 500 stories
PLoS Med. 2008 May 27;5(5):95
Link to source with long URL

HSL14689
Moynihan R, Doran E, Henry D.
Disease mongering is now part of the global health debate.
PLoS Med. 2008 May 27;5(5):e106
Link to source with long URL

HSL14756
Watson R.
New law bans selling of products with unjustified health claims
BMJ 2008 May 24;336(7654):1150
http://www.bmj.com/cgi/content/extract/336/7654/1150-a?etoc

HSL14757
Moszynski P.
Alliance aims to help health workers in poor countries challenge corruption, excessive pricing, and waste of drugs
BMJ 2008 May 24;336(7654):1155
http://www.bmj.com/cgi/content/extract/336/7654/1155-a?etoc

HSL14758
Mayor S.
Cancer charity starts research programme with drug "borrowed" from industry
BMJ 2008 May 24;336(7654):1155
http://www.bmj.com/cgi/content/extract/336/7654/1155-c?etoc

HSL14458
Montgomery BD, Mansfield PR, Spurling GK, Ward AM.
Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study
BMC Public Health 2008 May 20;8(1):167 [Epub ahead of print]
http://www.biomedcentral.com/content/pdf/1471-2458-8-167.pdf

HSL14419
Day M.
Drug industry is partly to blame for overdiagnosis of bipolar disorder, researchers claim.
BMJ 2008 May 17;336(7653):1092-3
http://www.bmj.com/cgi/content/extract/336/7653/1092

HSL14486
Dyer O.
Drug companies must be open about using doctors as consultants, new code of practice demands.
BMJ 2008 May 17;336(7653):1095
http://www.bmj.com/cgi/content/extract/336/7653/1095-c

HSL14457
De Jonge, Bockting CL.
Selective Publication of Antidepressant Trials
NEJM 2008 May 15;358(20):2180-2182
http://content.nejm.org/cgi/content/extract/358/20/2180

HSL14648
Schwarz LR.
Industry promotion of unlabeled uses.
Am J Health Syst Pharm. 2008 May 15;65(10):908-10
http://www.ajhp.org/cgi/content/full/65/10/908

HSL14940
Chon SH, Lösche P, Christ H, Lehmacher W, Griebenow R.
[Comparative evaluation of sponsored and unsponsored continuing medical education].
Med Klin (Munich). 2008 May 15;103(5):341-5
http://www.ncbi.nlm.nih.gov/pubmed/18484220

HSL14390
Boden WE, Diamond GA.
DTCA for PTCA — Crossing the Line in Consumer Health Education?
NEJM 2008 May 22;358(21):2197-200
http://content.nejm.org/cgi/content/full/NEJMp0801433

HSL14393
Fugh-Berman A.
Prescription Tracking and Public Health
Journal of General Internal Medicine 2008 May 13:epub ahead of print
http://www.blackwell-synergy.com/loi/JGI

HSL14420
Donohue JM, Fischer MA, Huskamp HA, Weissman JS.
Potential Savings from an Evidence-Based Consumer-Oriented Public Education Campaign on Prescription Drugs.
Health Serv Res 2008 May 13
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1475-6773.2008.00858.x

HSL14511
Fugh-Berman A.
Prescription Tracking and Public Health.
J Gen Intern Med 2008 May 13:epub ahead of print
http://www.springerlink.com/content/w332410717763632/

HSL14361
Montgomery BD.
Free lunches are not the answer
BMJ 2008 May 10;336(7652):1034
Link to source with long URL

HSL14489
Tanne JH.
US medical schools should say no to pharma support.
BMJ 2008 May 10;336(7652):1035
http://www.bmj.com/cgi/content/extract/336/7652/1035

HSL14490
Sie AH.
Why I love a free lunch: You must be joking.
BMJ 2008 May 10;336(7652):1034
http://www.bmj.com/cgi/content/extract/336/7652/1034-c

HSL14661
Bergström S, Aronsson A.
Misoprostol in resource poor countries.
BMJ 2008 May 10;336(7652):1032
http://www.bmj.com/cgi/content/extract/336/7652/1032?etoc

HSL14398
Weinfurt KP, Seils DM, Tzeng JP, Lin L, Schulman KA, Califf RM.
Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary Stents
PLoS ONE 2008 May 7;3(5):e2128
http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0002128

HSL14694
Bergström R.
[The journals must honestly tell who is doing the job].
Lakartidningen. 2008 May 7-13;105(19):1406-7
http://www.ncbi.nlm.nih.gov/pubmed/18574981

HSL14352
Collier J.
An end in sight for the secretive drug price fixing pact between government and industry
BMJ Blogs 2008 May 6
Link to source with long URL

HSL14460
Kamerow D.
Who wrote that article?
BMJ 2008 May 3;336(7651):989
http://www.bmj.com/cgi/content/full/336/7651/989

HSL14461
Mathew JL.
Global access to vaccines: Vaccine science and commerce: never the twain shall meet?
BMJ 2008 May 3;336(7651):974
http://www.bmj.com/cgi/content/extract/336/7651/974-b

HSL14475
Puliyel JM, Shrivastava A.
Global access to vaccines: Poor nations are being lured into a debt trap
BMJ 2008 May 3;336(7651):974
http://www.bmj.com/cgi/content/extract/336/7651/974-c?etoc

HSL14476
Mathew A.
Global access to vaccines: Vaccine sale is not tailored to improving India’s health
BMJ 2008 May 3;336(7651):975
http://www.bmj.com/cgi/content/extract/336/7651/975?etoc

HSL14477
Mittal O.
Global access to vaccines: Vaccine requirements compete with basic needs of poor people
BMJ 2008 May 3;336(7651):975
http://www.bmj.com/cgi/content/extract/336/7651/975-a?etoc

HSL14478
Stafford N.
MEPs shun cancer advocacy group because of industry funding
BMJ 2008 May 3;336(7651):980
http://www.bmj.com/cgi/content/extract/336/7651/980-a?etoc

HSL14374
Fortuna RJ, Ross-Degnan D, Finkelstein J, Zhang F, Campion FX, Simon SR.
Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice.
J Eval Clin Pract 2008 May 2
Link to source with long URL

HSL14560
Haug C.
[Ghostwriting].
Tidsskr Nor Laegeforen 2008 May 1;128(9):1039
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1683144

HSL13804
Sismondo S.
How pharmaceutical industry funding affects trial outcomes: Causal structures and responses.
Soc Sci Med 2008 May Epub 2008 Ma;66(9):1909-14
Link to source with long URL

HSL14173
Civaner M, Sarikaya O, Alici SU, Bozkurt G.
Exposing nursing students to the marketing methods of pharmaceutical companies.
Nurs Ethics 2008 May;15(3):396-410
http://nej.sagepub.com/cgi/content/abstract/15/3/396

HSL14309
Jureidini JN, McHenry LB, Mansfield PR.
Clinical trials and drug promotion: Selective reporting of study 329
The International Journal of Risk and Safety in Medicine 2008 May;20(1-2):73-81
Link to source with long URL

HSL14319
Burashnikova IS, Ziganshin AU, Ziganshina LE.
Attitudes to pharmaceutical promotion techniques among healthcare professionals in the Republic of Tatarstan, Russia
The International Journal of Risk and Safety in Medicine 2008 May;20(1-2):57-71
Link to source with long URL

HSL14370
Kirkpatrick JS, Stevens T.
The FDA process for the evaluation and approval of orthopaedic devices.
J Am Acad Orthop Surg 2008 May;16(5):260-7
http://www.jaaos.org/cgi/content/abstract/16/5/260

HSL14373
Varenicline for smoking cessation
Drug and Therapeutics Bulletin 2008 May;46(5):33-36
http://dtb.bmj.com/cgi/content/abstract/46/5/33

HSL14423
Berger E.
Leak: Avandia and the integrity of the peer review process.
Ann Emerg Med 2008 May;51(5):636-8
http://www.annemergmed.com/article/S0196-0644(08)00603-3/fulltext

HSL14467
Sajid MS, Iftikhar M, Monteiro RS, Miles AF, Woods WG, Baig MK.
Internet information on colorectal cancer: commercialization and lack of quality control.
Colorectal Dis 2008 May;10(4):352-6
http://www.ncbi.nlm.nih.gov/pubmed/17645570

HSL14493
McLennan M, Leong FC, Steele A, Harris J.
The influence of industry sponsorship on the acceptance of abstracts and their publication.
Am J Obstet Gynecol 2008 May;198(5):579
http://linkinghub.elsevier.com/retrieve/pii/S0002-9378(07)02344-7

HSL14529
Turkoski BB.
Drugs used to treat erectile dysfunction.
Orthop Nurs 2008 May-Jun;27(3):201-4
Link to source with long URL

HSL14531
Gura T.
Courts deny Pfizer access.
Nat Biotechnol 2008 May;26(5):480
http://www.nature.com/doifinder/10.1038/nbt0508-480

HSL14550
Knapp S, Vandecreek L.
The ethics of advertising, billing, and finances in psychotherapy.
J Clin Psychol 2008 May;64(5):613-25
Link to source with long URL

HSL14696
Garnier JP.
Rebuilding the R&D engine in big pharma.
Harv Bus Rev. 2008 May;86(5):68-70,
http://www.ncbi.nlm.nih.gov/pubmed/18543809

HSL14697
Mamdani M, Ching A, Golden B, Melo M, Menzefricke U.
Challenges to evidence-based prescribing in clinical practice.
Ann Pharmacother. 2008 May;42(5):704-7
http://www.theannals.com/cgi/content/full/42/5/704

HSL14787
Cairns A, Yarker YE.
The role of healthcare communications agencies in maintaining compliance when working with the pharmaceutical industry and healthcare professionals.
Curr Med Res Opin. 2008 May;24(5):1371-8
Link to source with long URL

HSL14941
Cesario J, Higgins ET.
Making message recipients
Psychol Sci 2008 May;19(5):415-20
http://www3.interscience.wiley.com/journal/119410470/abstract

HSL14974
Miller DR.
Disclosure of conflicts of interest in biomedical publications.
Can J Anaesth 2008 May;55(5):265-7,
http://www.ncbi.nlm.nih.gov/pubmed/18451113

HSL15106
Stockigt JR.
Comparison of consumer medication information in the United States, Europe, and Australia.
J Am Pharm Assoc 2008 May-Jun;48(3):326
Link to source with long URL

HSL15109
Howland RH.
The need to guard against pharmaceutical industry influence.
Psychiatr Serv 2008 May;59(5):566
http://ps.psychiatryonline.org/cgi/content/full/59/5/566

HSL15110
Arbuckle MR, Gameroff MJ, Marcus SC, West JC, Wilk J, Olfson M.
Psychiatric opinion and antipsychotic selection in the management of schizophrenia.
Psychiatr Serv. 2008 May;59(5):561-5
http://ps.psychiatryonline.org/cgi/content/full/59/5/561

HSL15354
Williams SJ, Seale C, Boden S, Lowe P, Steinberg DL.
Waking up to sleepiness: Modafinil, the media and the pharmaceuticalisation of everyday/night life
Sociology of Health & Illness 2008 Apr 28;30(6):839 - 855
http://www3.interscience.wiley.com/journal/120121716/abstract

HSL15445
Rising K, Bacchetti P, Bero L.
Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
PLoS Med 2008 Apr 28;5(11)
Link to source with long URL

HSL14360
Patel K.
Why I love a free lunch
BMJ 2008 Apr 26;336(7650):962
http://www.bmj.com/cgi/content/extract/336/7650/962-a

HSL14376
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ.
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
BMJ 2008 Apr 26;336(7650):924
http://www.bmj.com/cgi/content/extract/336/7650/924?etoc

HSL14377
Spence D.
X ray specs
BMJ 2008 Apr 26;336(7650):962
http://www.bmj.com/cgi/content/extract/336/7650/962

HSL14340
Psaty BM, Ray W.
FDA guidance on off-label promotion and the state of the literature from sponsors.
JAMA 2008 Apr 23;299(16):1949-51
http://jama.ama-assn.org/cgi/content/full/299/16/1949

HSL14877
Silversides A.
Abramson: direct-to-consumer advertising will erode health care.
CMAJ 2008 Apr 22;178(9):1126-7
Link to source with long URL

HSL14270
Editorial .
Stopping trials early for benefit: too good to be true
The Lancet 2008 Apr 19;371(9621):1310
Link to source with long URL

HSL14311
Tanne JH.
Merck used ghostwriters and selective data in Vioxx publications, JAMA says.
BMJ 2008 Apr 19;336(7649):849
http://www.bmj.com/cgi/content/full/336/7649/849

HSL14469
Burton B.
Australian drug industry seeks to improve its image
BMJ 2008 Apr 19;336(7649):850
http://www.bmj.com/cgi/content/extract/336/7649/850-a

HSL14470
Lenzer J.
Direct to Consumer Genetic Testing: Knowing me, knowing you
BMJ 2008 Apr 19;336(7649):858-860
http://www.bmj.com/cgi/content/extract/336/7649/858

HSL14278
Kesselheim AS, Avorn J.
Pharmaceutical promotion to physicians and first amendment rights.
NEJM 2008 Apr 17;358(16):1727-32
http://content.nejm.org/cgi/content/extract/358/16/1727

HSL14463
Cressey D.
Merck accused of disguising its role in research.
Nature 2008 Apr 17;452(7189):791
http://www.nature.com/news/2008/080416/full/452791b.html

HSL14260
Psaty BM, Kronmal RA.
Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation.
JAMA 2008 Apr 16;299(15):1813-7
http://jama.ama-assn.org/cgi/content/full/299/15/1813

HSL14261
DeAngelis CD, Fontanarosa PB.
Impugning the integrity of medical science: the adverse effects of industry influence.
JAMA 2008 Apr 16;299(15):1833-5
http://jama.ama-assn.org/cgi/content/extract/299/15/1833

HSL14262
Mitka M.
Critics say FDA's off-label guidance allows marketing disguised as science.
JAMA 2008 Apr 16;299(15):1759-61
http://jama.ama-assn.org/cgi/content/extract/299/15/1759

HSL14273
Ross JS, Hill KP, Egilman DS, Krumholz HM.
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
JAMA 2008 Apr 16;299(15):1800-12
http://jama.ama-assn.org/cgi/content/full/299/15/1800

HSL14471
Leff B, Finucane TE.
Gizmo Idolatry
JAMA. 2008 Apr 16;299(15):1830-1832
http://jama.ama-assn.org/cgi/content/extract/299/15/1830

HSL14248
Howe RA.
Don't include trimethoprim.
BMJ 2008 Apr 12;336(7648):787
http://www.ncbi.nlm.nih.gov/pubmed/18403503

HSL14249
Medawar C.
A cynical consultation exercise?
BMJ 2008 Apr 12;336(7648):787
http://www.bmj.com/cgi/content/extract/336/7648/787-a?etoc

HSL14250
Glaser AN.
Include cost of treatment.
BMJ 2008 Apr 12;336(7648):788
http://www.bmj.com/cgi/content/extract/336/7648/788?etoc

HSL14251
Burton B.
Roche fined for breaching direct to consumer advertising ban and publishing unbalanced advertisements.
BMJ 2008 Apr 12;336(7648):792
http://www.bmj.com/cgi/content/extract/336/7648/792?etoc

HSL14252
Watson R.
EC proposals fail to distinguish between information and advertising.
BMJ 2008 Apr 12;336(7648):792-3
http://www.bmj.com/cgi/content/extract/336/7648/792-b?etoc

HSL14253
Jack A.
Donors agree financial arrangement to stimulate vaccine development
BMJ 2008 Apr 12;336(7648):797
http://www.bmj.com/cgi/content/extract/336/7648/797?etoc

HSL14254
Lenzer J.
Company’s decision to lengthen lipid lowering trial causes controversy
BMJ 2008 Apr 12;336(7648):797
http://www.bmj.com/cgi/content/extract/336/7648/797-a?etoc

HSL14208
Trotta F, Apolone G, Garattini S, Tafuri G.
Stopping a trial early in oncology: for patients or for industry?
Annals of Oncology 2008 Apr 9:epub ahead of print
http://annonc.oxfordjournals.org/cgi/content/full/mdn042v4

HSL14221
Chester MR, Bridson J.
When will NICE or the FDA make stent manufacturers prove they are not merely latter day snake oil salesmen?
BMJ 2008 Apr 9:epub
http://www.bmj.com/cgi/eletters/336/7647/743#193170

HSL14237
Kemper KJ, Hood KL.
Does pharmaceutical advertising affect journal publication about dietary supplements?
BMC Complement Altern Med. 2008 Apr 9;8(1):11
http://www.biomedcentral.com/1472-6882/8/11

HSL14224
Simmonds H.
It takes two to tango
BMJ 2008 Apr 8:epub
http://www.bmj.com/cgi/eletters/336/7647/776#193296

HSL14151
Sweet M.
Academic freedom is at risk in dispute over Gardasil, lecturers say
BMJ 2008 Apr 5;336(7647):741
http://www.bmj.com/cgi/content/extract/336/7647/741-a

HSL14152
Burton B.
Australian drug industry gives details of money spent courting doctors
BMJ 2008 Apr 5;336(7647):742
http://www.bmj.com/cgi/content/extract/336/7647/742-a

HSL14168
Sale of infant cough medicines splutters to a halt
The Lancet 2008 Apr 5;371(9619):1138
Link to source with long URL

HSL14219
Aronson JK.
Too high a pedestal
BMJ 2008 Apr 5;336(7647):735
http://www.bmj.com/cgi/content/extract/336/7647/735

HSL14222
Lenzer J.
Longer, better studies of coronary stents are needed, FDA tells industry
BMJ 2008 Apr 5;336(7647):743
http://www.bmj.com/cgi/content/extract/336/7647/743

HSL14223
Spence D.
Bend it like . . . ?
BMJ 2008 Apr 5;336(7647):776
http://www.bmj.com/cgi/content/extract/336/7647/776

HSL14225
Farrell L.
The Best Medicine: Passion required
BMJ 2008 Apr 5;336(7647):776
http://www.bmj.com/cgi/content/extract/336/7647/776-a

HSL14226
Bewley S.
Getting to the bottom of evidence based medicine
BMJ 2008;336(7647):764 (5 April), 2008 Apr 5;336(7647):764
http://www.bmj.com/cgi/content/extract/336/7647/764

HSL14281
Sale of infant cough medicines splutters to a halt.
Lancet 2008 Apr 5;371(9619):1138
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)60497-3

HSL14341
Wijesinghe PR, Norris P.
Increased advertising of medicines on New Zealand television since 2001.
N Z Med J 2008 Apr 4;121(1271):121-2
http://www.ncbi.nlm.nih.gov/pubmed/18392070

HSL13822
Light DW.
Reply to DiMasi, Hansen, and Grabowski.
J Health Polit Policy Law 2008 Apr;33(2):325-7
http://jhppl.dukejournals.org/cgi/reprint/33/2/325?view=long&pmid=18325905

HSL14174
Schowalter JE.
How to manage conflicts of interest with industry?
Int Rev Psychiatry 2008 Apr;20(2):127-33
http://www.informaworld.com/smpp/content?content=10.1080/09540260801887728

HSL14177
Cross J.
DxS Ltd.
Pharmacogenomics 2008 Apr;9(4):463-7
http://www.futuremedicine.com/doi/abs/10.2217/14622416.9.4.463

HSL14235
Editorial .
A double-edged sword
Nature Reviews Drug Discovery 2008 Apr;7(4):275
http://www.nature.com/nrd/journal/v7/n4/index.html

HSL14275
Spielmans GI, Thielges SA, Dent AL, Greenberg RP.
The accuracy of psychiatric medication advertisements in medical journals.
J Nerv Ment Dis. 2008 Apr;196(4):267-73
Link to source with long URL

HSL14276
Matter A, Keller TH.
Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
Drug Discov Today. 2008 Apr;13(7-8):347-52
Link to source with long URL

HSL14287
Sharfstein SS.
Big Pharma and American Psychiatry.
The Journal of Nervous and Mental Disease 2008 Apr;196(4):265
Link to source with long URL

HSL14299
Waldinger MD, Schweitzer DH.
Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
Journal of Sexual Medicine 2008 Apr;5(4):966-97
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1743-6109.2008.00633.x

HSL14300
Goldstein I.
Regarding Waldinger and Schweitzer's
J Sex Med 2008 Apr;5(4):965
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1743-6109.2008.00808.x

HSL14342
Alpert JS.
Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
Am J Med 2008 Apr;121(4):253-5
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(08)00053-3

HSL14428
Mennuti M.
Are doctors prepared for direct-to-consumer advertising of genetic tests?
Obstet Gynecol 2008 Apr;111(4):991,
http://www.greenjournal.org/cgi/content/full/111/4/991

HSL14459
Hagen B, Pijl-Zieber EM, Souveny K, Lacroix A.
Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry
Can Nurse. 2008 Apr;104(4):30-5
http://www.ncbi.nlm.nih.gov/pubmed/18488765

HSL14464
Alexander GC, Zhang J, Basu A.
Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs.
Med Care 2008 Apr;46(4):394-402
Link to source with long URL

HSL14494
Niebyl JR.
The pharmaceutical industry: friend or foe?
Am J Obstet Gynecol 2008 Apr;198(4):435-9
http://linkinghub.elsevier.com/retrieve/pii/S0002-9378(07)02228-4

HSL14533
Doran E, Henry DA.
Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
J Public Health Policy 2008 Apr;29(1):106-20
http://www.palgrave-journals.com/jphp/journal/v29/n1/full/3200170a.html

HSL14544
Gniady JA.
Regulating direct-to-consumer genetic testing: protecting the consumer without quashing a medical revolution.
Fordham Law Rev. 2008 Apr;76(5):2429-75
http://www.ncbi.nlm.nih.gov/pubmed/18546580

HSL14545
Pouillot R, Bilong C, Boisier P, Ciss M, Moumouni A, Amani I, Nabeth P.
[Illicit drug trade on the markets of Yaounde (Cameroon) and Niamey (Niger): characteristics of salesmen and quality of drugs].
Bull Soc Pathol Exot. 2008 Apr;101(2):113-8
http://www.ncbi.nlm.nih.gov/pubmed/18543704

HSL14561
Schowalter JE.
How to manage conflicts of interest with industry?
Int Rev Psychiatry. 2008 Apr;20(2):127-33
Link to source with long URL

HSL14617
Egilman DS, Bohme SR.
IJOEH and the critique of bias.
Int J Occup Environ Health 2008 Apr-Jun;14(2):147-51
http://www.ncbi.nlm.nih.gov/pubmed/18507293

HSL14649
Shankar PR.
PharmedOut.
Singapore Med J 2008 Apr;49(4):363-5
http://smj.sma.org.sg/4904/4904le2.pdf

HSL14723
Bell H.
Thanks, but no thanks.
Minn Med 2008 Apr;91(4):26-30
Link to source with long URL

HSL14725
Stout MM.
Reader feedback on commercialism in dentistry article.
J Calif Dent Assoc 2008 Apr;36(4):240
Link to source with long URL

HSL14726
Hordiner P, Saroyan J.
Readers Voice Concerns Over Ad
J Calif Dent Assoc 2008 Apr;36(4):240
Link to source with long URL

HSL14768
Robinson S, Delongeas JL, Donald E, Dreher D, Festag M, Kervyn S, Lampo A, Nahas K, Nogues V, Ockert D, Quinn K, Old S, Pickersgill N, Somers K, Stark C, Stei P, Waterson L, Chapman K.
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.
Regul Toxicol Pharmacol 2008 Apr;50(3):345-52
Link to source with long URL

HSL14843
Davis JM, Chen N, Glick ID.
Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect.
Nature 2008 Apr;33(5):971-5
Link to source with long URL

HSL14899
Aitken P.
The ABPI code of practice: controls on the promotion of prescription medicines.
Clin Med. 2008 Apr;8(2):128-9
Link to source with long URL

HSL14937
Malhotra P.
The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.
Indian J Med Ethics. 2008 Apr-Jun;5(2):61-5
http://www.ncbi.nlm.nih.gov/pubmed/18624153

HSL15128
Liu Y, Doucette WR.
Does direct-to-consumer advertising affect patients' choice of pain medications?
Curr Pain Headache Rep. 2008 Apr;12(2):89-93
http://www.ncbi.nlm.nih.gov/pubmed/18474186

HSL15193
Caldeira TR, Neves ER, Perini E.
[Historical evolution of package inserts in Brazil].
Cad Saude Publica 2008 Apr;24(4):737-43
Link to source with long URL

HSL15236
Light DW, Warburton RN.
Ethical Standards for Healthcare Journal Editors: A Case Report and Recommendations
Harvard Health Policy Review 2008 Spring;9(1):46-55
http://www.hhpr.org/currentissue/archives.php

HSL15280
de Wildt G, Khoon CC.
Patents or patients? Global access to pharmaceuticals and social justice
Med Confl Surviv. 2008 Apr;24(Suppl 1):S52-61
http://www.ncbi.nlm.nih.gov/pubmed/18771195

HSL14176
Compagni A, Cavalli L, Jommi C.
Pharmaceutical companies and Italian Regional Governments: Managing relationships in an increasing institutional complexity.
Health Policy 2008 Mar 31:epub ahead of print
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(08)00057-2

HSL14124
Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM.
Use of Ezetimibe in the United States and Canada
NEJM 2008 Mar 30:epub ahead of print
http://content.nejm.org/cgi/content/full/NEJMsa0801461v1

HSL14141
Richards T.
Purely medicinal?
BMJ 2008 Mar 29;336(7646):693
http://www.bmj.com/cgi/content/extract/336/7646/693

HSL14214
Delamothe T.
Of medicine and medicines
BMJ 2008 Mar 29;336(7646)
http://www.bmj.com/cgi/content/full/336/7646/0

HSL14215
Cole A.
Drug industry anxious about scrapping price regulation scheme
BMJ 2008 Mar 29;336(7646):686
http://www.bmj.com/cgi/content/extract/336/7646/686-a

HSL14216
Mayor S.
Opening the lid on open access
BMJ 2008 Mar 29;336(7646):688
http://www.bmj.com/cgi/content/extract/336/7646/688

HSL14217
Dyer O.
GP advised patients to take pills made by company she worked for
BMJ 2008 Mar 29;336(7646):689
http://www.bmj.com/cgi/content/full/336/7646/689-e

HSL14218
Ferner RE, Beard K.
Over the counter medicines: proceed with caution
BMJ 2008 Mar 29;336(7646):694
http://www.bmj.com/cgi/content/full/336/7646/694

HSL14056
Carpenter D, Zucker EJ, Avorn J.
Drug-Review Deadlines and Safety Problems
NEJM 2008 Mar 27;358(13):1354-1361
http://content.nejm.org/cgi/content/abstract/358/13/1354

HSL14132
Hébert PC.
The need for an Institute of Continuing Health Education
CMAJ 2008 Mar 25;178(7):805-6, 809-810
http://www.cmaj.ca/cgi/content/full/178/7/805

HSL14137
Murray DM, Pals SL, Blitstein JL, Alfano CM, Lehman J.
Design and Analysis of Group-Randomized Trials in Cancer: A Review of Current Practices
JNCI 2008 Mar 25;100(7):483-491
http://jnci.oxfordjournals.org/cgi/content/abstract/100/7/483

HSL14647
Cranston L, Allen M, Bugden S, Nguyen A, Bunka D, Regier L, Bean T, Jin M, Campbell C, Marlow BA, Mongeau I, Stern S, Murray S, Becker AB, Marlow BA, Sinclair D, Falz S.
Funding for continuing medical education.
CMAJ 2008 Mar 25;178(7):805-6, 809-10
http://www.cmaj.ca/cgi/content/full/178/12/1578

HSL13999
DeAngelis CD, Thornton JP.
Preserving Confidentiality in the Peer Review Process
JAMA 2008 Mar 24;299(16):epub ahead of print
http://jama.ama-assn.org/cgi/content/full/299.16.jed80000

HSL14118
Reinarman C.
Cannabis policies and user practices: Market separation, price, potency, and accessibility in Amsterdam and San Francisco.
Int J Drug Policy 2008 Mar 24
http://www.ncbi.nlm.nih.gov/pubmed/18367390

HSL14210
Antonuccio DO, Healy D.
Moving beyond depression: The researcher’s credo
BMJ 2008 Mar 22;336(7645):629
http://www.bmj.com/cgi/content/extract/336/7645/629

HSL14211
Steer P.
Follies and Fallacies in Medicine
BMJ 2008 Mar 22;336(7645):673
http://www.bmj.com/cgi/content/extract/336/7645/673-a

HSL13936
Kaiser J.
Pfizer Denied Access to Journals' Files
Science 2008 Mar 21;319(5870):1601
http://www.sciencemag.org/cgi/content/summary/319/5870/1601a

HSL14119
Warrell DA.
Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product-'What's in a name?
Trans R Soc Trop Med Hyg 2008 Mar 20:epub ahead of print
Link to source with long URL

HSL14178
Tracey WR.
Letter by Tracey regarding article,
Circulation 2008 Mar 18;117(11):e194
http://circ.ahajournals.org/cgi/content/full/117/11/e194

HSL13899
Kmietowicz Z.
Company accused of exploiting unique features of drug to retain market share
BMJ 2008 Mar 15;336(7644):576
http://www.bmj.com/cgi/content/extract/336/7644/576-a

HSL13974
Godlee F.
A legal framework for drug safety
BMJ 2008 Mar 15;336(7644)
http://www.bmj.com/cgi/content/full/336/7644/0

HSL13975
Coombes R.
UK government tightens rules on drug trial results
BMJ 2008 Mar 15;336(7644):576
http://www.bmj.com/cgi/content/extract/336/7644/576-b

HSL13976
Hawkes N.
Biologically speaking, parliament decides there is no alternative
BMJ 2008 Mar 15;336(7644):588
http://www.bmj.com/cgi/content/extract/336/7644/588

HSL13977
Burton B.
The return of the spoof
BMJ 2008 Mar 15;336(7644):589
http://www.bmj.com/cgi/content/extract/336/7644/589

HSL13978
Iheanacho I.
The scourge of the drug pirates
BMJ 2008 Mar 15;336(7644):617
http://www.bmj.com/cgi/content/extract/336/7644/617

HSL14112
Charatan F.
94% of patients suing Merck over rofecoxib agree to company's offer.
BMJ 2008 Mar 15;336(7644):580-1
http://www.bmj.com/cgi/content/extract/336/7644/580

HSL14113
Johansen R.
[The health food product Noni--does marketing harmonize with the current status of research?]
Tidsskr Nor Laegeforen. 2008 Mar 13;128(6):694-7
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1666432

HSL13833
Vandenbroucke JP.
Observational Research, Randomised Trials, and Two Views of Medical Science.
PLoS Med 2008 Mar 11;5(3):e67
Link to source with long URL

HSL13857
Vitry A, Lexchin J, Sasich L, Dupin-spriet T, Reed T, Bertele V, Garattini S, Toop L, Hurley E.
Provision of information on regulatory authorities’ websites
Internal Medicine Journal 2008 Mar 11:epub ahead of print
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01588.x

HSL13873
Mayor S.
UK experts call for national system to evaluate diagnostic tests
BMJ 2008 Mar 11:epub ahead of print
http://www.bmj.com/cgi/content/extract/bmj.39517.609294.DBv1

HSL13754
Raya RR.
The Philippine breastfeeding struggle continues
The Lancet 2008 Mar 8;371(9615):794-795
Link to source with long URL

HSL13771
Lenzer J, Brownlee S.
An untold story?
BMJ 2008 Mar 8;336(7643):532-4
http://www.bmj.com/cgi/content/full/336/7643/532

HSL13922
Simon G.
Antidepressants and suicide
BMJ 2008 Mar 8;336(7643):515
http://www.bmj.com/cgi/content/extract/336/7643/515

HSL13923
Turner EH.
Efficacy of antidepressants
BMJ 2008 Mar 8;336(7643):516
http://www.bmj.com/cgi/content/extract/336/7643/516

HSL13924
De Maeseneer J, Van Weel C, Egilman D, Mfenyana K, Kaufman A, Sewankambo N, Flinkenflögel M.
Funding for primary health care in developing countries
BMJ 2008 Mar 8;336(7643):518
http://www.bmj.com/cgi/content/extract/336/7643/518

HSL13925
Singh H.
Doctors’ education: Conflicts are everywhere
BMJ 2008 Mar 8;336(7643):522
http://www.bmj.com/cgi/content/extract/336/7643/522-b

HSL13926
Arnold PC.
Doctors’ education: Sponsored medical tourism
BMJ 2008 Mar 8;336(7643):522
http://www.bmj.com/cgi/content/extract/336/7643/522-c

HSL13927
Kmietowicz Z.
GMC will take responsibility for postgraduate medical training from 2010
BMJ 2008 Mar 8;336(7643):523
http://www.bmj.com/cgi/content/extract/336/7643/523

HSL13928
US drug industry spent $22m (£11m; 14m) on lobbying in 2007
BMJ 2008 Mar 8;336(7643):524
http://www.bmj.com/cgi/content/extract/336/7643/524

HSL13929
Watson R.
European Commission looks into possible restrictive practices by drug companies
BMJ 2008 Mar 8;336(7643):524
http://www.bmj.com/cgi/content/extract/336/7643/524-a

HSL13930
Tanne JH.
Pfizer ends advertisements featuring inventor of artificial heart
BMJ 2008 Mar 8;336(7643):525
http://www.bmj.com/cgi/content/extract/336/7643/525

HSL13931
Tanne JH.
Congress asks for investigation of FDA resources and staffing
BMJ 2008 Mar 8;336(7643):525
http://www.bmj.com/cgi/content/extract/336/7643/525-a

HSL13932
Spence D.
Bitter sweets
BMJ 2008 Mar 8;336(7643):562
http://www.bmj.com/cgi/content/extract/336/7643/532

HSL14650
Zamarriego Izquierdo JF.
[Relationship between healthcare professionals and pharmaceutical industry? How it should be]
Med Clin (Barc). 2008 Mar 8;130(8):298-9.
Link to source with long URL

HSL13825
Kalisch LM, Roughead EE, Gilbert AL.
Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia
Pharmacoepidemiol Drug Saf. 2008 March 6
Link to source with long URL

HSL13879
Steinbrook R.
Financial Support of Continuing Medical Education
JAMA 2008 Mar 5;299(9):1060-1062
http://jama.ama-assn.org/cgi/content/extract/299/9/1060

HSL13880
Hampton T.
Experts Debate Need to Improve Quality and Oversight of Continuing Education
JAMA 2008 Mar 5;299(9):1003-1004
http://jama.ama-assn.org/cgi/content/extract/299/9/1003

HSL13881
Waber RL, Shiv B, Carmon Z, Ariely D.
Commercial Features of Placebo and Therapeutic Efficacy
JAMA 2008 Mar 5;299(9):1016-1017
http://jama.ama-assn.org/cgi/content/extract/299/9/1016

HSL13693
McLay J, Ross S.
Medication errors caused by junior doctors.
BMJ 2008 Mar 1;336(7642):456
http://www.bmj.com/cgi/content/extract/336/7642/456?etoc

HSL13695
Lee K.
Has the hunt for conflicts of interest gone too far? No.
BMJ 2008 Mar 1;336(7642):477
http://www.bmj.com/cgi/content/full/336/7642/477?etoc

HSL13698
Sokol DK.
The dilemma of authorship.
BMJ 2008 Mar 1;336(7642):478
http://www.bmj.com/cgi/content/extract/336/7642/478?etoc

HSL13700
Fitzpatrick M.
From hero to zero.
BMJ 2008 Mar 1;336(7642):479
http://www.bmj.com/cgi/content/extract/336/7642/479?etoc

HSL13702
Fahrenkopf AM, Sectish TC, Barger LK, Sharek PJ, Lewin D, Chiang VW, Edwards S, Wiedermann BL, Landrigan CP.
Rates of medication errors among depressed and burnt out residents: prospective cohort study.
BMJ 2008 Mar 1;336(7642):488-491
http://www.bmj.com/cgi/content/abstract/336/7642/488?etoc

HSL13704
Iheanacho I.
We're all pharmacologists now.
BMJ 2008 Mar 1;336(7642):510
http://www.bmj.com/cgi/content/extract/336/7642/510-a?etoc/

HSL13583
Munro G, de Wever J.
Culture clash: alcohol marketing and public health aspirations.
Drug Alcohol Rev 2008 Mar;27(2):204-11
http://www.informaworld.com/smpp/content?content=10.1080/09595230701827136

HSL13584
Lutsenko H, Doran CM, Hall WD.
Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
Drug Alcohol Rev 2008 Mar;27(2):160-4
http://www.informaworld.com/smpp/content?content=10.1080/09595230701829462

HSL13630
Cohen AL, Budnitz DS, Weidenbach KN, Jernigan DB, Schroeder TJ, Shehab N, Pollock DA.
National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.
J Pediatr 2008 Mar;152(3):416-21
http://linkinghub.elsevier.com/retrieve/pii/S0022-3476(07)00703-2

HSL13678
Geier DA, King PG, Sykes LK, Geier MR.
RotaTeq vaccine adverse events and policy considerations.
Med Sci Monit 2008 Mar;14(3):PH9-16
http://www.medscimonit.com/fulltxt.php?ICID=836566

HSL13679
Babor TF, Xuan Z, Proctor D.
Reliability of a rating procedure to monitor industry self-regulation codes governing alcohol advertising content.
J Stud Alcohol Drugs. 2008 Mar;69(2):235-42
http://www.ncbi.nlm.nih.gov/pubmed/18299764

HSL13781
Shaw A.
Direct-to-Consumer Advertising (DTC) of Pharmaceuticals
ProQuest Discovery Guides 2008 Mar
http://www.csa.com/discoveryguides/direct/review.php

HSL13828
Smith JJ, Henderson JA.
Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.
J Am Coll Radiol 2008 Mar;5(3):189-92
http://www.ncbi.nlm.nih.gov/pubmed/18312966

HSL13895
Woo J, Wolfgang S, Batista H.
The effect of globalization of drug manufacturing, production, and sourcing and challenges for American drug safety.
Clin Pharmacol Ther 2008 Mar;83(3):494-7
http://www.nature.com/clpt/journal/v83/n3/abs/6100493a.html

HSL13983
Long SS.
Off-label use and evidence of efficacy and safety for drugs in a tertiary-care neonatal intensive care unit.
J Pediatr 2008 Mar;152(3):A2
http://linkinghub.elsevier.com/retrieve/pii/S0022-3476(08)00016-4

HSL14114
Luce BR, Paramore LC, Parasuraman B, Liljas B, de Lissovoy G.
Can managed care organizations partner with manufacturers for comparative effectiveness research?
Am J Manag Care 2008 Mar;14(3):149-56
http://www.ajmc.com/article.cfm?ID=10069&CFID=10776678&CFTOKEN=50788056

HSL14117
Morrison MA, Krugman DM, Park P.
Under the radar: smokeless tobacco advertising in magazines with substantial youth readership.
Am J Public Health 2008 Mar;98(3):543-8
http://www.ajph.org/cgi/content/abstract/98/3/543

HSL14126
Parikh RK.
Fighting for the Reputation of Vaccines: Lessons From American Politics
Pediatrics 2008 Mar;121(3):621-622
http://pediatrics.aappublications.org/cgi/content/full/121/3/621

HSL14175
Erlen JA.
Conflict of Interest: Nurses at Risk!
Orthop Nurs. 2008 Mar;27(2):135-139
Link to source with long URL

HSL14302
Samji HA, Jackler RK.
'Not one single case of throat irritation': misuse of the image of the otolaryngologist in cigarette advertising.
Laryngoscope 2008 Mar;118(3):415-27
Link to source with long URL

HSL14303
Rowland D, Cooper S, Macias L.
Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation.
Int J Impot Res. 2008 Mar-Apr;20(2):115-20
Link to source with long URL

HSL14372
Friedman JH.
My ties to big pharma.
Med Health R I 2008 Mar;91(3):70-1
http://www.rimed.org/pdf/mhri/m08Marmhri.pdf

HSL14465
Wallace LS, Keenum AJ, Roskos SE, Blake GH, Colwell ST, Weiss BD.
Suitability and readability of consumer medical information accompanying prescription medication samples.
Patient Educ Couns 2008 Mar;70(3):420-5
Link to source with long URL

HSL14491
Snyder L, Mueller PS.
Research in the physician's office: navigating the ethical minefield.
Hastings Cent Rep 2008 Mar-Apr;38(2):23-5
http://www.thehastingscenter.org/publications/hcr/hcr.asp

HSL14492
Gilbert S.
Trials and tribulations.
Hastings Cent Rep 2008 Mar-Apr;38(2):14-8
http://www.thehastingscenter.org/publications/hcr/hcr.asp

HSL14497
Sismondo S.
Pharmaceutical company funding and its consequences: a qualitative systematic review.
Contemp Clin Trials 2008 Mar;29(2):109-13
Link to source with long URL

HSL14534
American College of Clinical Pharmacy, Hatton RC, Chavez ML, Jackson E, Maurey J, Barriere SL, Couchenour R, Evens RP, Gunning K, Hume AL, Hutchison LC, Matzke GR, Noviasky JA, Rospond RM, Kelloway JS, Stevenson JG, Vanderveen RP, Verme-Gibboney CN, Walte
Pharmacists and industry: guidelines for ethical interactions.
Pharmacotherapy 2008 Mar;28(3):410-20
http://www.atypon-link.com/doi/abs/10.1592/phco.28.3.410

HSL14535
Montague BT, Fortin AH 6th, Rosenbaum J.
A systematic review of curricula on relationships between residents and the pharmaceutical industry.
Med Educ 2008 Mar;42(3):301-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2923.2007.02998.x

HSL14551
Geransar R, Einsiedel E.
Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware?
Genet Test. 2008 Mar;12(1):13-23
http://www.liebertonline.com/doi/abs/10.1089/gte.2007.0024

HSL14587
Cook JM, Weingardt KR, Jaszka J, Wiesner M.
A content analysis of advertisements for psychotherapy workshops: implications for disseminating empirically supported treatments.
J Clin Psychol 2008 Mar;64(3):296-307
Link to source with long URL

HSL14651
García-Alonso MD, García-Mariñoso B.
The strategic interaction between firms and formulary committees: effects on the prices of new drugs.
J Health Econ 2008 Mar;27(2):377-404
Link to source with long URL

HSL14789
Garattini L, Motterlini N, Cornago D.
Prices and distribution margins of in-patent drugs in pharmacy: a comparison in seven European countries.
Health Policy. 2008 Mar;85(3):305-13
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(07)00194-7

HSL14833
Greco D, Diniz NM.
Conflicts of interest in research involving human beings.
J Int Bioethique. 2008 Mar-Jun;19(1-2):143-54,
http://www.ncbi.nlm.nih.gov/pubmed/18664007

HSL14939
Gass A, Wilson J.
Marketing off-label uses to physicians: FDA's draft (mis)guidance.
Am J Bioeth. 2008 Mar;8(3):1-3
Link to source with long URL

HSL14942
Whitehouse PJ.
Why I no longer consult for drug companies.
Cult Med Psychiatry. 2008 Mar;32(1):4-10
http://www.springerlink.com/content/9201224651102257/

HSL15536
Disseminating findings from a drug class review: using best practices to inform prescription of antiepileptic drugs for bipolar disorder.
Melvin CL, Ranney LM, Carey TS, Evans WD, AED Dissemination Panel, Kreps G, Linden T, Oldham J.
J Psychiatr Pract. 2008 Mar;14:44-56.
http://www.ncbi.nlm.nih.gov/pubmed/19034209

HSL15537
Kish-Doto J, Evans WD, Squire C, Williams P, Ranney LM, Melvin CL.
Patterns of prescribing antiepileptic drugs for bipolar disorder.
J Psychiatr Pract. 2008 Mar;14:35-43.
http://www.ncbi.nlm.nih.gov/pubmed/19034208

HSL13778
Andersson KA, Petzold MG, Allebeck P, Carlsten A.
Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.
BMC Health Serv Res 2008 Feb 29;8(1):50
http://www.biomedcentral.com/1472-6963/8/50/abstract

HSL13829
Straand J, Christensen IJ.
[Quality of pharma rep meetings in general practice].
Tidsskr Nor Laegeforen 2008 Feb 28;128(5):555-7
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1660000

HSL13827
Heldens JG, Patel JR, Chanter N, Ten Thij GJ, Gravendijck M, Schijns VE, Langen A, Schetters TP.
Veterinary vaccine development from an industrial perspective.
Vet J 2008 Feb 28
Link to source with long URL

HSL13889
Rørtveit G.
[Physicians and drug industry--one more time].
Tidsskr Nor Laegeforen 2008 Feb 28;128(5):553
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1659900

HSL13735
Greenland P, Lloyd-jones D.
Critical Lessons From the ENHANCE Trial
JAMA 2008 Feb 27;299(8):953-5
http://jama.ama-assn.org/cgi/content/extract/299/8/953

HSL13650
Kirsch I, Deacon BJ, Huedo-medina TB, Scoboria A, Moore TJ, Johnson BT.
Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
PLoS 2008 Feb 26;5(2)
Link to source with long URL

HSL13676
Vamvakopoulos JE, Kountouri M, Marshall T, Greenfield SM.
Lifestyle or Life-Saving Medicines: A Primary Healthcare Professional and Consumer Opinion Survey on Over-the-Counter Statins (March).
Ann Pharmacother 2008 Feb 26
http://www.theannals.com/cgi/content/full/42/3/413

HSL13612
Sidley P.
South African drug companies are found guilty of price fixing
BMJ 2008 Feb 23;336(7641):413
http://www.bmj.com/cgi/content/extract/336/7641/413-c?etoc

HSL13613
Moynihan R.
Doctors’ education: the invisible influence of drug company sponsorship
BMJ 2008 Feb 23;336(7641):416-417
http://www.bmj.com/cgi/content/extract/336/7641/416?etoc

HSL13614
Jack A.
Balancing Big Pharma’s books
BMJ 2008 Feb 23;336(7641):418
http://www.bmj.com/cgi/content/extract/336/7641/418?etoc

HSL13686
Morgan S, McMahon M, Greyson D.
Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia.
Health Policy. 2008 Feb 22;87(2):133-145
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(08)00010-9

HSL14110
Magnusson PA.
[Drug industry's misuse of patents must be prevented].
Lakartidningen. 2008 Feb 20-26;105(8):555
http://www.ncbi.nlm.nih.gov/pubmed/18363299

HSL13628
Stebbing J, Wood C, Atkins M, Bukowski R, Litwin S, Bower M, Parsa A, Levitsky H.
Cancer vaccines: Clinical development challenges and proposed regulatory approaches for patient access to promising treatments.
Cancer 2008 Feb 19;112(5):955-961
http://www.ncbi.nlm.nih.gov/pubmed/18286505

HSL13683
Gommans J, McIntosh P, Bee S, Allan W.
Improving the quality of written prescriptions in a general hospital: the influence of 10 years of serial audits and targeted interventions.
Intern Med J. 2008 Feb 19
http://www.blackwell-synergy.com/toc/imj//?cookieSet=1

HSL13576
Groves T.
Stronger European medical research.
BMJ 2008 Feb 16;336(7640):341-342
http://www.bmj.com/cgi/content/extract/336/7640/341?etoc

HSL13577
Stanton R.
Put declaration in abstracts.
BMJ 2008 Feb 16;336(7640):345
http://www.bmj.com/cgi/content/extract/336/7640/345-d?etoc

HSL13578
Spurgeon D.
Commercialisation of health care in US distorts resource allocation, expert says.
BMJ 2008 Feb 16;336(7640):349
http://www.bmj.com/cgi/content/extract/336/7640/349?etoc

HSL13579
Day M.
Industry's push to woo nurse prescribers has been at 'expense of nursing integrity'
BMJ 2008 Feb 16;336(7640):352
http://www.bmj.com/cgi/content/extract/336/7640/352-a?etoc

HSL13580
Bell KJ, Irwig L, Craig JC, Macaskill P.
Use of randomised trials to decide when to monitor response to new treatment.
BMJ 2008 Feb 16;336(7640):361-365
http://www.bmj.com/cgi/content/extract/336/7640/361?etoc

HSL13984
Stanton R.
Drug company payments: Put declaration in abstracts.
BMJ 2008 Feb 16;336(7640):345
http://www.bmj.com/cgi/content/extract/336/7640/345-d

HSL13532
Ehringhaus SH, Weissman JS, Sears JL, Goold SD, Feibelmann S, Campbell EG.
Responses of medical schools to institutional conflicts of interest.
JAMA 2008 Feb 13;299(6):665-71
http://jama.ama-assn.org/cgi/content/full/299/6/665

HSL13533
Rothman DJ.
Academic medical centers and financial conflicts of interest.
JAMA 2008 Feb 13;299(6):695-7
http://jama.ama-assn.org/cgi/content/full/299/6/695

HSL13550
Newton PN, Fernández FM, Plançon A, Mildenhall DC, Green MD, Ziyong L, Christophel EM, Phanouvong S, Howells S, McIntosh E, Laurin P, Blum N, Hampton CY, Faure K, Nyadong L, Soong CW, Santoso B, Zhiguang W, Newton J, Palmer K.
A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia.
PLoS Med 2008 Feb 12;5(2):e32
Link to source with long URL

HSL13905
Dhalla I, Laupacis A.
Moving from opacity to transparency in pharmaceutical policy
CMAJ 2008 Feb 12;178(4):428-31
http://www.cmaj.ca/cgi/content/full/178/4/428

HSL13593
Peinemann F, McGauran N, Sauerland S, Lange S.
Negative pressure wound therapy: Potential publication bias caused by lack of access to unpublished study results data.
BMC Med Res Methodol 2008 Feb 11;8(1):4
http://www.biomedcentral.com/1471-2288/8/4/abstract

HSL13474
Mladovsky P, Mossialos E, McKee M.
Improving access to research data in Europe
BMJ 2008 Feb 9;336(7639):287
http://www.bmj.com/cgi/content/extract/336/7639/287?etoc

HSL13476
Kmietowicz Z.
Make patient safety part of everyday routines, says watchdog
BMJ 2008 Feb 9;336(7639):294
http://www.bmj.com/cgi/content/extract/336/7639/294?etoc

HSL13477
Hitchen L.
England launches scheme to encourage use of "care bundles"
BMJ 2008 Feb 9;336(7639):294
http://www.bmj.com/cgi/content/extract/336/7639/294-a?etoc

HSL13478
Watson R.
European Commission opts against traffic light system for food labelling
BMJ 2008 Feb 9;336(7639):296
http://www.bmj.com/cgi/content/extract/336/7639/296-a?etoc

HSL13479
Sheldon T.
Dutch trial of probiotics in acute pancreatitis is to be investigated after deaths
BMJ 2008 Feb 9;336(7639):296-7
http://www.bmj.com/cgi/content/extract/336/7639/296-b?etoc

HSL13480
Hopkins Tanne J.
FDA is failing to inspect drug and device makers, government reports say
BMJ 2008 Feb 9;336(7639):297
http://www.bmj.com/cgi/content/extract/336/7639/297?etoc

HSL13481
Hitchen L.
Most doctors still don’t report adverse reactions to drugs
BMJ 2008 Feb 9;336(7639):299
http://www.bmj.com/cgi/content/extract/336/7639/299-a?etoc

HSL13482
Mannion R, Davies HTO.
Payment for performance in health care
BMJ 2008 Feb 9;336(7639):306-8
http://www.bmj.com/cgi/content/extract/336/7639/306?etoc

HSL13483
Cave J, Dacre J.
The Competent Novice: Dealing with complaints
BMJ 2008 Feb 9;336(7639):326
http://www.bmj.com/cgi/content/extract/336/7639/326?etoc

HSL13484
Spence D.
From the Frontline: The perils of commissioning bias
BMJ 2008 Feb 9;336(7639):332
http://www.bmj.com/cgi/content/extract/336/7639/332?etoc

HSL13594
Parens E, Johnston J.
Understanding the agreements and controversies surrounding childhood psychopharmacology.
Child Adolesc Psychiatry Ment Health 2008 Feb 8;2(1):5
http://www.capmh.com/content/2/1/5

HSL13636
Travis J.
Research funding: Prizes eyed to spur medical innovation.
Science 2008 Feb 8;319(5864):713
http://www.sciencemag.org/cgi/content/full/319/5864/713

HSL13595
Moore RA, Derry S, McQuay HJ, Paling J.
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs.
Arthritis Res Ther 2008 Feb 7;10(1):R20
http://arthritis-research.com/content/10/1/R20

HSL13443
Jutel A, Menkes DB.
Soft Targets: Nurses and the Pharmaceutical Industry
PLoS Medicine 2008 Feb 5;5(2):5
Link to source with long URL

HSL15779
Gilmore I.
Build bridges with the drugs industry—but keep patients in mind
BMJ. 2008 Feb 4;338
http://www.bmj.com/cgi/content/extract/338/feb04_1/b439

HSL13392
Coaching to support patients in making decisions
BMJ 2008 Feb 2;336(7638):228
http://www.bmj.com/cgi/content/extract/336/7638/228?etoc

HSL13393
Drug company payments: Speakers should declare funding
BMJ 2008 Feb 2;336(7638):234
http://www.bmj.com/cgi/content/extract/336/7638/234?etoc

HSL13394
Stone JA.
Testosterone supplementation: An unfortunate juxtaposition
BMJ 2008 Feb 2;336(7638):234
http://www.bmj.com/cgi/content/extract/336/7638/234-c?etoc

HSL13395
Hopkins Tanne J.
NIH needs to raise oversight of conflicts of interest among researchers, report says
BMJ 2008 Feb 2;336(7638):235
http://www.bmj.com/cgi/content/extract/336/7638/235?etoc

HSL13396
Hopkins Tanne J.
US Institute of Medicine recommends new body to assess what works in health care
BMJ 2008 Feb 2;336(7638):236
http://www.bmj.com/cgi/content/extract/336/7638/236?etoc

HSL13397
Roehr B.
Pressure mounts to cut US spending on health care
BMJ 2008 Feb 2;336(7638):236-7
http://www.bmj.com/cgi/content/extract/336/7638/236-a?etoc

HSL13398
Kmietowicz Z.
Double blind peer reviews are fairer and more objective, say academics
BMJ 2008 Feb 2;336(7638):238
http://www.bmj.com/cgi/content/extract/336/7638/241?etoc

HSL13399
Hawkes N.
Body Politic: How do we get the measure of patient care?
BMJ 2008 Feb 2;336(7638):249
http://www.bmj.com/cgi/content/extract/336/7638/249?etoc

HSL13400
Hughes S.
Open Letter: European regulatory agencies should employ full time statisticians
BMJ 2008 Feb 2;336(7638):250
http://www.bmj.com/cgi/content/extract/336/7638/250?etoc

HSL13401
Claxton K, Briggs A, Buxton MJ, Culyer AJ, McCabe C, Walker S, Sculpher MJ.
Value based pricing for NHS drugs: an opportunity not to be missed?
BMJ 2008 Feb 2;336(7638):251
http://www.bmj.com/cgi/content/extract/336/7638/251?etoc

HSL13402
Degos L, Romaneix F, Michel P, Bacou J.
Looking to Europe: Can France keep its patients happy?
BMJ 2008 Feb 2;336(7638):254-7
http://www.bmj.com/cgi/content/extract/336/7638/254?etoc

HSL13418
Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Grim P, Hunkler RJ, Hontz KM, Schumock GT.
Projecting future drug expenditures--2008.
Am J Health Syst Pharm 2008 Feb 1;65(3):234-53
http://www.ajhp.org/cgi/content/full/65/3/234

HSL13462
Bate A, Lindquist M, Edwards IR.
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
Fundam Clin Pharmacol 2008 Feb 1
http://www.ncbi.nlm.nih.gov/pubmed/18248442

HSL13896
Roy P, Buch AN, Javaid A, Okabe T, Raya V, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Gevorkian N, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
Impact of 'off-label' utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Am J Cardiol 2008 Feb 1;101(3):293-9
http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(07)01903-0

HSL13897
Ting HH, Roe MT, Gersh BJ, Spertus JA, Rumsfeld JS, Ou FS, Kao J, Long KH, Holmes DR Jr, Peterson ED; National Cardiovascular Data Registry (NCDR).
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction.
Am J Cardiol 2008 Feb 1;101(3):286-92
http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(07)01901-7

HSL13290
Saginur M, Graham ID, Forster AJ, Boucher M, Wells GA.
The uptake of technologies designed to influence medication safety in Canadian hospitals.
J Eval Clin Pract 2008 Feb;14(1):27-35
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2007.00780.x

HSL13291
Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC.
Prevalence and determinants of pharmacy shopping behaviour.
J Clin Pharm Ther 2008 Feb;33(1):17-23
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2008.00878.x

HSL13292
Mason A.
New medicines in primary care: a review of influences on general practitioner prescribing.
J Clin Pharm Ther 2008 Feb;33(1):1-10
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2008.00875.x

HSL13301
Siracuse MV, Vuchetich PJ.
Impact of Medicaid Prior Authorization Requirement for COX-2 Inhibitor Drugs in Nebraska.
Health Serv Res 2008 Feb;43(1)
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1475-6773.2007.00766.x

HSL13437
Pearce N.
Corporate influences on epidemiology.
Int J Epidemiol 2008 Feb;37(1):46-53
http://www.ncbi.nlm.nih.gov/pubmed/18245050?dopt=Abstract

HSL13438
Haas J.
Commentary: Epidemiology and the pharmaceutical industry: an inside perspective.
Int J Epidemiol 2008 Feb;37(1):53-5
http://ije.oxfordjournals.org/cgi/content/extract/37/1/53

HSL13439
White A, Robinson N, Egger P, Stender M, Davis K, Weil J, Bowlin S.
Commentary: Collaboration between industry-based and academic epidemiologists.
Int J Epidemiol 2008 Feb;37(1):56-7
http://ije.oxfordjournals.org/cgi/content/extract/37/1/56

HSL13440
Greenland S.
Commentary: addressing corporate influence through ethical guidelines.
Int J Epidemiol 2008 Feb;37(1):57-9
http://ije.oxfordjournals.org/cgi/content/extract/37/1/57

HSL13441
Phillips CV.
Commentary: Lack of scientific influences on epidemiology.
Int J Epidemiol 2008 Feb;37(1):59-64
http://ije.oxfordjournals.org/cgi/content/extract/37/1/59

HSL13442
Pearce N.
Response: The distribution and determinants of epidemiologic research.
Int J Epidemiol 2008 Feb;37(1):65-8
http://ije.oxfordjournals.org/cgi/content/extract/37/1/65

HSL13500
Millard WB.
Dispatch from the pharmasphere: an industry's fault lines on display.
Ann Emerg Med 2008 Feb;51(2):175-80
http://www.ncbi.nlm.nih.gov/pubmed/18217227?dopt=Abstract

HSL13562
Kaufman SR.
Bias and sponsored research.
Ophthalmology 2008 Feb;115(2):412-3
http://linkinghub.elsevier.com/retrieve/pii/S0161-6420(07)00852-4

HSL13667
Herxheimer A, Sanz E.
Social, cultural and ethical aspects of drug use—changes over 40 years: a personal look back
European Journal of Clinical Pharmacology 2008 Feb;64(2):107-114
http://www.springerlink.com/content/u2rn52n6x15x71h6/fulltext.html

HSL13757
Hayden EC.
Battle over eye medicine gives drugmaker a dose of reality
Nat Med 2008 Feb;14(2):108
http://www.nature.com/doifinder/10.1038/nm0208-108

HSL13758
Hughes V.
Europe pledges billions to solve its drug development woes.
Nat Med 2008 Feb;14(2):107
http://www.nature.com/doifinder/10.1038/nm0208-107

HSL14115
[No authors listed]
ADA advertising standards.
J Am Dent Assoc. 2008 Feb;139(2):204-5

HSL14243
Gibson BR, Suh R, Tilson H.
The US drug safety system: role of the pharmaceutical industry.
Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):110-4
Link to source with long URL

HSL14282
Kahn M, Gastrow M.
Pharmacologically active: clinical trials and the pharmaceutical industry.
S Afr Med J 2008 Feb;98(2):114-6

HSL14424
Bruce S.
Cosmeceuticals for the attenuation of extrinsic and intrinsic dermal aging.
J Drugs Dermatol 2008 Feb;7(2)
http://www.ncbi.nlm.nih.gov/pubmed/18404867

HSL14429
Shoenfeld Y.
[Doctors as naive (innocent) drug advertisers].
Harefuah 2008 Feb;147(2):98-9
http://www.ncbi.nlm.nih.gov/pubmed/18357661

HSL14496
Trabert G.
[The development of the public health system between an increasing market orientation (commercialisation) and social responsibility].
Zentralbl Chir 2008 Feb;133(1):39-45
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1004667

HSL14548
Juni S, Gross JS.
Emotional and persuasive perception of fonts.
Percept Mot Skills 2008 Feb;106(1):35-42
http://www.ncbi.nlm.nih.gov/pubmed/18459353

HSL14585
Berg TL.
The creation of the medical consumer.
S D Med 2008 Feb;61(2):42
http://www.ncbi.nlm.nih.gov/pubmed/18432148

HSL14962
Demortain D.
From drug crises to regulatory change: The mediation of expertise
Health, Risk & Society 2008 Feb;10(1):37-51
http://www.tandf.co.uk/journals/journal.asp?issn=1369-8575&linktype=9

HSL13279
Groves T.
Mandatory disclosure of trial results for drugs and devices.
BMJ 2008 Jan 26;336(7637):170
http://www.bmj.com/cgi/content/full/336/7637/170

HSL13281
Davies PG.
The interpretation of evidence.
BMJ 2008 Jan 26;336(7637):174
http://www.bmj.com/cgi/content/full/336/7637/174-a

HSL13282
Williams NR.
Not necessarily.
BMJ 2008 Jan 26;336(7637):174
http://www.bmj.com/cgi/content/extract/336/7637/174-b?etoc

HSL13283
Kendrick M.
Not treating, delaying.
BMJ 2008 Jan 26;336(7637):174
http://www.bmj.com/cgi/content/extract/336/7637/174-d?etoc

HSL13284
Lewis LS.
Pills in the sky.
BMJ 2008 Jan 26;336(7637):174
http://www.bmj.com/cgi/content/extract/336/7637/174-e?etoc

HSL13285
Lenzer J.
US Congress and European Research Council insist on open access to research results.
BMJ 2008 Jan 26;336(7637):176-7
http://www.bmj.com/cgi/content/extract/336/7637/176?etoc

HSL13286
Lenzer J.
Unreported cholesterol drug data released by company.
BMJ 2008 Jan 26;336(7637):180-1
http://www.bmj.com/cgi/content/extract/336/7637/180-a?etoc

HSL13287
Tonks A.
Safer by design.
BMJ 2008 Jan 26;336(7637):186-8
http://www.bmj.com/cgi/content/extract/336/7637/186?etoc

HSL13374
Woloshin S, Schwartz LM.
A genetic risk factor for periodic limb movements in sleep.
N Engl J Med 2008 Jan 24;358(4):427-8
http://www.ncbi.nlm.nih.gov/pubmed/18219744

HSL13376
Carrozza JP Jr.
Drug-eluting stents--pushing the envelope beyond the labels?
N Engl J Med 2008 Jan 24;358(4):405-7
http://content.nejm.org/cgi/content/extract/358/4/405

HSL13255
Fisk NM.
Market Failure and the Poverty of New Drugs in Maternal Health
PLoS Medicine 2008 Jan 22;5(1):22
Link to source with long URL

HSL13256
Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schulz KF.
CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration
PLoS Medicine 2008 Jan 22;5(1):20
Link to source with long URL

HSL13293
Heemstra HE, de Vrueh RL, van Weely S, Büller HA, Leufkens HG.
Predictors of orphan drug approval in the European Union.
Eur J Clin Pharmacol 2008 Jan 22
http://www.springerlink.com/content/b2k6r35x27082322/

HSL13261
Alonso-Coello P, García-Franco AL, Guyatt G, Moynihan R.
Drugs for pre-osteoporosis: prevention or disease mongering?
BMJ 2008 Jan 19;336(7636):126-9
http://www.bmj.com/cgi/content/full/336/7636/126

HSL13300
Kmietowicz Z.
MPs' report criticises influence of drugs industry on GP prescribing.
BMJ 2008 Jan 19;336(7636):111
http://www.bmj.com/cgi/content/full/336/7636/111

HSL13297
Goff SL, Mazor KM, Meterko V, Dodd K, Sabin J.
Patients' Beliefs and Preferences Regarding Doctors' Medication Recommendations.
J Gen Intern Med 2008 Jan 18
http://www.springerlink.com/content/r187028538726163/

HSL13135
Turner EH.
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
NEJM 2008 Jan 17;358(3):252-260
http://content.nejm.org/cgi/content/abstract/358/3/252

HSL13299
Bachmann CS, Berg EA, Spigset O, Slørdal L.
[Benzodiazepine-like hypnotics - attitudes and prescription practice among general practioners.]
Tidsskr Nor Laegeforen 2008 Jan 17;128(2):166-70
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1641672

HSL13502
Roland PC.
[Patients, patents and profits].
Tidsskr Nor Laegeforen. 2008 Jan 17;128(2):205
http://www.tidsskriftet.no/index.php?vp_SEKS_ID=1645080

HSL13761
Abbott A.
Novartis Foundation to close its doors.
Nature 2008 Jan 17;451(7176):233
http://www.nature.com/news/2008/080116/full/451233a.html

HSL13762
.
Philanthropy needed.
Nature. 2008 Jan 17;451(7176):224
http://www.nature.com/doifinder/10.1038/451224a

HSL13123
O'Neil P.
Ethics guidelines for clinical trials to be revised
CMAJ 2008 Jan 15
http://www.cmaj.ca/cgi/content/full/178/2/138

HSL13245
Plassmann H, O'Doherty J, Shiv B, Rangel A.
Marketing actions can modulate neural representations of experienced pleasantness.
Proc Natl Acad Sci U S A 2008 Jan 14
http://www.pnas.org/cgi/content/full/105/3/1050

HSL13067
Collier J.
Parliamentary review asks NICE to do better still.
BMJ 2008 Jan 12;336(7635):56-7
http://www.bmj.com/cgi/content/extract/336/7635/56?etoc

HSL13068
Noble JH Jr.
Delve deeper to find the links.
BMJ 2008 Jan 12;336(7635):59
http://www.bmj.com/cgi/content/full/336/7635/59

HSL13069
Chester MR.
Consider palliative coronary intervention.
BMJ 2008 Jan 12;336(7635):59
http://www.bmj.com/cgi/content/full/336/7635/59-a

HSL13070
Grol R, Berwick DM, Wensing M.
On the trail of quality and safety in health care.
BMJ 2008 Jan 12;336(7635):74-6
http://www.bmj.com/cgi/content/extract/336/7635/74?etoc

HSL13280
Spence D.
The treatment paradox.
BMJ 2008 Jan 12;336(7635):100
Link to source with long URL

HSL13890
Kramers C, Wuis E, Schouwenberg B.
[The influence of the pharmaceutical industry on treatment guidelines].
Ned Tijdschr Geneeskd 2008 Jan 12;152(2):114
http://www.ncbi.nlm.nih.gov/pubmed/18265803

HSL13144
Jacobson PD.
Transforming clinical practice guidelines into legislative mandates: proceed with abundant caution.
JAMA 2008 Jan 9;299(2):208-10
http://jama.ama-assn.org/cgi/reprint/299/2/208

HSL13016
From Theory to Practice: Translating Research into Health Outcomes
PLoS Medicine 2008 Jan 8;5(1)
Link to source with long URL

HSL13640
Barbour V, Chinnock P, Peiperl L, Veitch E, Yamey G.
From theory to practice: translating research into health outcomes.
PLoS Med 2008 Jan 8;5(1):e15
Link to source with long URL

HSL12980
Mansfield PR.
Do advertisements in clinical software influence prescribing?
Med J Aust 2008 Jan 7;188(1):13-14
http://www.mja.com.au/public/issues/188_01_070108/man11083_fm.html

HSL13184
Vickers AJ.
Stats for the Health Professional - Statistics Is Unscientific! (Well, as Clinicians See it, Anyway)
Medscape Business of Medicine 2008 Jan 7

HSL13375
Dejgaard A.
[Coloured attitudes].
Ugeskr Laeger 2008 Jan 7;170(1):66
http://www.ncbi.nlm.nih.gov/pubmed/18219742?dopt=Abstract

HSL13635
By the numbers: Top 20 pharmaceutical companies ranked by US sales, October 2006 to September 2007.
Mod Healthc 2008 Jan 7;38(1):31
http://www.ncbi.nlm.nih.gov/pubmed/18271198

HSL13085
Gibson L.
South Africa is to publish complaints about drug marketing.
BMJ 2008 Jan 5;336(7634):15
http://www.bmj.com/cgi/content/full/336/7634/15-d

HSL13099
Godlee F.
Doctors and the drug industry
BMJ 2008 Jan 5;336
Link to source with long URL

HSL13100
Bruzzi P.
Non-drug industry funded research.
BMJ 2008 Jan 5;336(7634):1-2
Link to source with long URL

HSL13101
Forgacs I, Loganayagam A.
Overprescribing proton pump inhibitors.
BMJ 2008 Jan 5;336(7634):2-3
Link to source with long URL

HSL13102
Mozley C.
People should be free to spend their money as they wish.
BMJ 2008 Jan 5;336(7634):7
Link to source with long URL

HSL13103
Connery TP.
Is it worth it?
BMJ 2008 Jan 5;336(7634):7
Link to source with long URL

HSL13199
Lenzer J, Brownlee S.
Doctor takes "march of shame" to atone for drug company payments.
BMJ 2008 Jan 5;336(7634):20-1
http://www.bmj.com/cgi/content/full/336/7634/20

HSL13200
Lenzer J.
Nigerian judge orders arrests of Pfizer officials.
BMJ 2008 Jan 5;336(7634):11
http://www.bmj.com/cgi/content/full/336/7634/11

HSL12973
Guyatt GH, Mills EJ, Elbourne D.
In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter
PLoS Medicine 2008 Jan 3;5(1)
Link to source with long URL

HSL14242
Gagnon MA, Lexchin J.
The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States.
PLoS Med. 2008 Jan 3;5(1):e1
Link to source with long URL

HSL12979
Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU.
Characteristics of Recipients of Free Prescription Drug Samples: A Nationally Representative Analysis
American Journal of Public Health 2008 Jan 2
http://www.ajph.org/cgi/content/abstract/AJPH.2007.114249v1

HSL13045
Sonnenschein C.
Book review of 'The estrogen elixir: A history of hormone replacement therapy in America' by Elizabeth Siegel Watkins
Philosophy, Ethics, and Humanities in Medicine 2008 Jan 2;3(1)
http://www.peh-med.com/content/3/1/1/abstract

HSL13086
Kirk SM.
Prescriber profiling.
Ann Intern Med 2008 Jan 1;148(1):82
http://www.annals.org/cgi/content/full/148/1/82

HSL13087
Fugh-Berman A.
Prescriber profiling.
Ann Intern Med 2008 Jan 1;148(1):82
http://www.annals.org/cgi/content/full/148/1/82-a

HSL13088
Tsai AC.
Prescriber profiling.
Ann Intern Med 2008 Jan 1;148(1):81
http://www.annals.org/cgi/content/full/148/1/81

HSL13089
Pratt SE.
Prescriber profiling.
Ann Intern Med 2008 Jan 1;148(1):81-2
http://www.ncbi.nlm.nih.gov/pubmed/18166762

HSL12790
Jones SC, Hall D, Munro G.
How effective is the revised regulatory code for alcohol advertising in Australia?
Drug Alcohol Rev 2008 Jan;27(1):29-38
http://www.informaworld.com/smpp/content?content=10.1080/09595230701499175

HSL13005
Olfson M, Marcus SC, Druss BG
Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample
Arch Gen Psychiatry 2008 Jan;65(1):94-101
http://archpsyc.ama-assn.org/cgi/content/abstract/65/1/94

HSL13150
Rottlaender D, Hoppe UC.
[Risks of non-prescription medication, Clobutinol cough syrup as a recent example].
Dtsch Med Wochenschr 2008 Jan;133(4):144-6
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1017490

HSL13198
Senior K.
Pharmaceutical downsizing and oncology drug development.
Lancet Oncol 2008 Jan;9(1):11
http://www.ncbi.nlm.nih.gov/pubmed/18183658

HSL13298
Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR.
Race, Medical Researcher Distrust, Perceived Harm, and Willingness to Participate in Cardiovascular Prevention Trials.
Medicine (Baltimore) 2008 Jan;87(1):1-9
Link to source with long URL

HSL13308
Breckenridge A.
Post-marketing strategies for medicines.
Clin Pharmacol Ther 2008 Jan;83(1):24-5
Link to source with long URL

HSL13377
Schneider PJ, Murphy JE, Pedersen CA.
Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients.
J Am Pharm Assoc (2003) 2008 Jan-Feb;48(1):58-63
http://www.ncbi.nlm.nih.gov/pubmed/18192132

HSL13379
Singh S, Trivedi AN.
Spontaneous reports as evidence of adverse drug reactions.
South Med J 2008 Jan;101(1):16
Link to source with long URL

HSL13415
Getz K, Faden L.
Racial disparities among clinical research investigators.
Am J Ther 2008 Jan-Feb;15(1):3-11
Link to source with long URL

HSL13419
Freidin B, Timmermans S.
Complementary and alternative medicine for children's asthma: satisfaction, care provider responsiveness, and networks of care.
Qual Health Res 2008 Jan;18(1):43-55
http://qhr.sagepub.com/cgi/reprint/18/1/43

HSL13461
McLay R, Klinski A.
Changes in prescription habits with the introduction of generic fluoxetine.
Mil Med 2008 Jan;173(1):100-4
http://www.ncbi.nlm.nih.gov/pubmed/18251340

HSL13463
Tobin L, de Almedia Neto AC, Wutzke S, Patterson C.
Influences on the prescribing of new drugs.
Aust Fam Physician 2008 Jan-Feb;37(1-2):78-81
http://www.ncbi.nlm.nih.gov/pubmed/18239759

HSL13501
Weinstein J.
Bias-free health care.
Can Fam Physician 2008 Jan;54(1):27
http://www.cfp.ca/cgi/pmidlookup?view=long&pmid=18208947

HSL13503
Sim I.
Trial registration for public trust: making the case for medical devices.
J Gen Intern Med 2008 Jan;23
http://www.springerlink.com/content/t07wuu73t920gl03/

HSL13585
Sanfélix J, Palop V, Pereiró I, Rubio E, Gosalbes V, Martínez-Mir I.
Gender influence in the quantity of drugs used in primary care.
Gac Sanit 2008 Jan;22(1):11-19

HSL13592
De Almeida Neto AC, Chen TF.
When pharmacotherapeutic recommendations may lead to the reverse effect on physician decision-making
Pharmacy World and Science. 2008 Jan;30(1):3-8
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2082656

HSL13637
Winkler AL, Finegold D.
Giving patients a say: how to work with patient advocacy groups.
Nat Biotechnol 2008 Jan;26(1):23-6
http://www.ncbi.nlm.nih.gov/pubmed/18251047?dopt=Abstract

HSL13641
Bohrer RA.
Reach-through claims for drug target patents: Rx for pharmaceutical policy.
Nat Biotechnol 2008 Jan;26(1):55-6
Link to source with long URL

HSL13642
Frew SE, Sammut SM, Shore AF, Ramjist JK, Al-Bader S, Rezaie R, Daar AS, Singer PA.
Chinese health biotech and the billion-patient market.
Nat Biotechnol 2008 Jan;26(1):37-53
http://www.nature.com/nbt/journal/v26/n1/abs/nbt0108-37.html

HSL13643
.
The regulator disapproves.
Nat Biotechnol 2008 Jan;26(1):1
http://www.nature.com/nbt/journal/v26/n1/abs/nbt0108-1.html

HSL13681
Al-Jazairi AS, Bhareth S, Eqtefan IS, Al-Suwayeh SA.
Brand and generic medications: Are they interchangeable?
Ann Saudi Med. 2008 Jan-Feb;28(1):33-41
http://www.ncbi.nlm.nih.gov/pubmed/18299655

HSL13690
Moran N.
Fractured European market undermines biosimilar launches.
Nat Biotechnol. 2008 Jan;26(1):5-6
http://www.nature.com/doifinder/10.1038/nbt0108-5

HSL13780
Puliyel JM, Madhavi Y.
Vaccines: Policy for public good or private profit?
Indian J Med Res 2008 Jan;127(1):1-3
www.icmr.nic.in/ijmr/2008/january/editorial1.pdf

HSL13987
Schetky DH.
Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
Child Adolesc Psychiatr Clin N Am 2008 Jan;17(1):113-25,
http://linkinghub.elsevier.com/retrieve/pii/S1056-4993(07)00075-2

HSL14116
Outterson K, Kesselheim AS.
Market-based licensing for HPV vaccines in developing countries.
Health Aff (Millwood) 2008 Jan-Feb;27(1):130-9
http://content.healthaffairs.org/cgi/content/abstract/27/1/130

HSL14120
Goldman DP, Jena AB, Philipson T, Sun E.
Drug licenses: a new model for pharmaceutical pricing.
Health Aff (Millwood) 2008 Jan-Feb;27(1):122-9
http://content.healthaffairs.org/cgi/content/abstract/27/1/122

HSL14179
Hartley H, Coleman CL.
News media coverage of direct-to-consumer pharmaceutical advertising: implications for countervailing powers theory.
Health (London) 2008 Jan;12(1):107-32
http://hea.sagepub.com/cgi/content/abstract/12/1/107

HSL14236
Caulin C.
[History of the evaluation of medicines aiming for marketing authorization].
J Fr Ophtalmol. 2008 Jan;31(1):71-4
Link to source with long URL

HSL14532
Dens N, Eagle LC, De Pelsmacker P.
Attitudes and self-reported behavior of patients, doctors, and pharmacists in New Zealand and Belgium toward direct-to-consumer advertising of medication.
Health Commun 2008 Jan-Feb;23(1):45-61
Link to source with long URL

HSL14549
Grosjean OV.
The resistible growth of health care costs.
Acta Chir Belg 2008 Jan-Feb;108(1):4-14
http://www.ncbi.nlm.nih.gov/pubmed/18411565

HSL14698
Mohapatra PR.
Interaction between medical practitioners & pharmaceutical industry.
Indian J Med Res. 2008 Jan;127(1):93
http://www.icmr.nic.in/ijmr/2008/january/0115.pdf

HSL14724
Boyd MA, Roth K, Ralls SA, Chambers DW.
Beginning the discussion of commercialism in dentistry.
J Calif Dent Assoc 2008 Jan;36(1):57-65
http://www.cda.org/page/Library/cda_member/pubs/journal/jour0108/boyd.pdf

HSL16007
Islam MS, Farah SS.
Characteristics and Reliability of Online References Cited in the Pharmaceutical Promotional Brochures of Bangladesh
eHealth International Journal 2008 Jan;4(1):1-5
http://www.ehealthinternational.org/vol4num1/Vol4Num1p01.pdf

HSL16040
Islam MS, Farah SS.
Drug promotional brochure as a source of drug information in Bangladesh: a critical analysis of the brochures for the authenticity of information.
Calicut Medical Journal 2008 Jan-Mar;6(1):e5
http://www.calicutmedicaljournal.org/2008/1/e5.pdf

HSL16041
Thomas V.
Drugs: prescription and promotion in third world countries
Calicut Medical Journal 2008 Jan-Mar;6(1):e1
http://www.calicutmedicaljournal.org/2008/1/e1.pdf

HSL15671
Lexchin J
Clinical trials in Canada: whose interests are paramount?
Int J Health Serv 2008;38(3):525-42
http://www.ncbi.nlm.nih.gov/pubmed/18724580

HSL12981
Henderson J, Miller G, Pan Y, Britt H.
The effect of advertising in clinical software on general practitioners’ prescribing behaviour
The Medical Journal of Australia 2008;188(1):15-20
http://www.mja.com.au/public/issues/188_01_070108/hen10412_fm.html

HSL12982
Harvey K, Korczak VS, Marron LJ, Newgreen DB.
Commercialism, choice and consumer protection: regulation of complementary medicines in Australia
The Medical Journal of Australia 2008;188(1):21-25
http://www.mja.com.au/public/issues/188_01_070108/har10522_fm.html

HSL12983
Raftery JP.
Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand
The Medical Journal of Australia 2008;188(1):26-28
http://www.mja.com.au/public/issues/188_01_070108/raf10125_fm.html

HSL13081
Lin HY, Liao CC, Cheng SH, Wang PC, Hsueh YS.
Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases: experience in a taiwanese medical setting.
Drugs Aging 2008;25(1):49-59
Link to source with long URL

HSL13151
Adler NE, Koschorreck J, Rechenberg B.
Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies.
Water Sci Technol 2008;57(1):91-7
http://www.ncbi.nlm.nih.gov/pubmed/18192745

HSL13154
Woodcock J, Woosley R.
The FDA critical path initiative and its influence on new drug development.
Annu Rev Med 2008;59:1-12
Link to source with long URL

HSL13218
Coombes ID, Stowasser DA, Coombes JA, Mitchell C.
Why do interns make prescribing errors? A qualitative study
MJA 2008;18(2):89-94
http://www.mja.com.au/public/issues/188_02_210108/coo10971_fm.html

HSL13219
Millar JA, Silla RC, Lee GE, Berwick A.
The national inpatient medication chart: critical audit of design and performance at a tertiary hospital
MJA 2008;188(2):95-99
http://www.mja.com.au/public/issues/188_02_210108/mil10878_fm.html

HSL13220
Hassali MAA, Stewart K, Kong DCM.
A national survey on knowledge and perceptions of senior medical students in Australia about generic medicines
MJA 2008;188(2):123-4
http://www.mja.com.au/public/issues/188_02_210108/letters_210108_fm-4.html

HSL13241
Loewenberg S.
Drug company trials come under increasing scrutiny
The Lancet 2008;371(9608):191-2
Link to source with long URL

HSL13416
Etwel FA, Rieder MJ, Bend JR, Koren G.
A Surveillance Method for the Early Identification of Idiosyncratic Adverse Drug Reactions.
Drug Saf 2008;31(2):169-180
http://www.ncbi.nlm.nih.gov/pubmed/18217792

HSL13417
Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AC.
Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users : A Cohort Study Using Pharmacy Dispensing Data in The Netherlands.
Drug Saf 2008;31(2):143-58
http://www.ncbi.nlm.nih.gov/pubmed/18217790

HSL13475
Donner-banzhoff N, Sönnichsen A.
Strategies for prescribing statins
BMJ 2008;336(7639):288
http://www.bmj.com/cgi/content/extract/336/7639/288?etoc

HSL13634
Kapsak WR, Schmidt D, Childs NM, Meunier J, White C.
Consumer perceptions of graded, graphic and text label presentations for qualified health claims.
Crit Rev Food Sci Nutr 2008;48(3):248-56
http://www.informaworld.com/smpp/content?content=10.1080/10408390701286058

HSL13658
Matthews RA.
Medical progress depends on animal models - doesn't it?
J R Soc Med 2008;101(2):95-98
http://www.jrsm.org/cgi/content/full/101/2/95

HSL13907
Morgan S, Lopert R, Greyson D.
Toward a definition of pharmaceutical innovation
Open Medicine 2008;2(1):epub
http://www.openmedicine.ca/article/view/153/106

HSL13943
Griffiths S.
Pharmaceutical branding: 'To brand or not to brand'
Journal of Medical Marketing 2008;8(2):113–118
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050125a.html

HSL13944
Raasch C.
Launching a fighter brand to cushion patent expiry: The case of Zocor
Journal of Medical Marketing 2008;8(2):119–126
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050140a.html

HSL13945
Ware C, Buckwell C, Small S, Wood R.
Activation of evidence: A new approach to knowledge translation and closing the clinical care gap
Journal of Medical Marketing 2008;8(2):127–136
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050142a.html

HSL13948
Naboko D, Petkova V, Dimitrova Z.
Combination of marketing strategies for increase of anti-smoking drugs sales
Journal of Medical Marketing 2008;8(2):144–150
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050097a.html

HSL13947
Heiens RA, McGrath LC, Leach RT.
The impact of intangible assets and expenditures on holding period returns in the pharmaceutical industry
Journal of Medical Marketing 2008;8(2):151–158
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050131a.html

HSL13949
Ham CD, Jun JW, Lee H-S.
How to reach consumers in a market where DTC is not allowed
Journal of Medical Marketing 2008;8(2):159–168
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050123a.html

HSL14159
Kruszewski SP, Paczynski RP, Marzana BIALY.
State Medical Board Responses To An Inquiry On Physician Researcher Misconduct
Journal of Medical Licensure and Discipline 2008;94(1)
http://www.journalonline.org/index.cfm

HSL14990
Haines IE, Olver IN.
Are self-regulation and declaration of conflict of interest still the benchmark for relationships between physicians and industry?
eMJA 2008;189(5):263-266
http://www.mja.com.au/public/issues/189_05_010908/hai10221_fm.html

HSL14371
Huddle TS.
Drug Reps and the Academic Medical Center: a case for management rather than prohibition.
Perspect Biol Med 2008 Spr;51(2):251-60
Link to source with long URL

HSL14375
Bush A.
Regulating spoons
Eur Respir J 2008;31(4):699-700
http://erj.ersjournals.com/cgi/content/full/31/4/699

HSL14407
Ta S, Frosch DL.
Pharmaceutical Product Placement: Simply Script or Prescription for Trouble?
Journal of Public Policy & Marketing 2008 Spring;27(1):98–106
http://www.marketingpower.com/content17870.php

HSL14426
Weinbach D.
10 steps to reaching physicians.
Mark Health Serv 2008 Spr;28(1):41-2
http://www.marketingpower.com/content67241.php

HSL14430
Lexchin J.
Drug Approval Times and User Fees: An International Perspective in a Changing World
Pharm Med 2008;22(1):1-11
http://www.ingentaconnect.com/content/adis/ipm

HSL14431
Cassels A, Lexchin J.
How well do Canadian media outlets convey medical treatment information?
Open Medicine 2008;2(2):epub
http://www.openmedicine.ca/article/view/170/131

HSL14582
Huskamp HA, Donohue JM, Koss C, Berndt ER, Frank RG.
Generic Entry, Reformulations and Promotion of SSRIs in the US.
Pharmacoeconomics 2008;26(7):603-16
http://www.ncbi.nlm.nih.gov/pubmed/18563951

HSL14583
Schwartz MI.
To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
Food Drug Law J 2008;63(1):1-33
http://www.ncbi.nlm.nih.gov/pubmed/18561453

HSL14762
Montoya ID, Lee-Dukes G, Shah D.
Direct-to-consumer advertising: its effects on stakeholders.
J Allied Health 2008 Sum;37(2):116-20
Link to source with long URL

HSL14816
Ecks S.
Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis' anti-cancer drug Glivec
Biosocieties 2008(3):165-181
Link to source with long URL

HSL14831
Giampaolo V, Riccardo R, Roberto S.
Drugs in the newspapers.
Drugs 2008;68(7):1017-8
http://drugs.adisonline.com/pt/re/drugs/toc.00003495-200868070-00000.htm

HSL14842
Nguyen ES.
Weight loss testimonials: a critique of potential FTC restrictions on diet advertising.
Food Drug Law J. 2008;63(2):493-507
http://www.ncbi.nlm.nih.gov/pubmed/18561474

HSL14886
B Freeman, S Chapman.
Gone viral? Heard the buzz? A guide for public health practitioners and researchers on how Web 2.0 can subvert advertising restrictions and spread health information.
Journal of Epidemiology and Community Health 2008;62:778-782

HSL14975
Carrigan N, Raynor DK, Knapp P.
Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UK.
Drug Saf 2008;31(4):305-12
http://www.ncbi.nlm.nih.gov/pubmed/18366241

HSL14996
Joseph M, Spake DF, Finney Z.
Consumer attitudes toward pharmaceutical direct-to-consumer advertising: An empirical study and the role of income
International Journal of Pharmaceutical and Healthcare Marketing 2008;2(2):117 - 133
http://www.emeraldinsight.com/10.1108/17506120810887916

HSL15043
Demaria AN.
Continuing education, industry, and physicians
J Am Coll 2008;52:1035-1036.

HSL15090
Healy D.
Our Censored Journals
Mens Sana Monographs 2008;6(1):244-256
Link to source with long URL

HSL15107
Jureidini J, Mintzes B, Raven M.
Does direct-to-consumer advertising of antidepressants lead to a net social benefit?
Pharmacoeconomics 2008;26(7):557-66;
http://www.ncbi.nlm.nih.gov/pubmed/18563947

HSL15126
Morrow LE, Kollef MH.
Probiotics in the intensive care unit: why controversies and confusion abound.
Crit Care. 2008;12(3):160
http://ccforum.com/content/12/3/160

HSL15162
Lee PE, Fischer HD, Rochon PA, Gill SS, Herrmann N, Bell CM.
Published randomized controlled trials of drug therapy for dementia
Journal of Clinical Epidemiology 2008;61:1152-1160

HSL15184
Rutter P, Gilbody S.
The European pharmaceuticalindustry: coming to a screen near you?
J R Soc Med 2008;101:485–488.

HSL15207
Pollock A.
Pharmaceutical meaning-making beyond marketing: racialized subjects of generic thiazide.
J Law Med Ethics. 2008 Fal;36(3):530-6
Link to source with long URL

HSL15208
Hudec R, Kriska M, Bozekova L, Foltan V.
Comparison of NSAID consumption in Slovakia, Finland and Norway.
Bratisl Lek Listy. 2008;109(8):370-3
Link to source with long URL

HSL15362
Brezis M.
Big pharma and health care: unsolvable conflict of interests between private enterprise and public health.
Isr J Psychiatry Relat Sc 2008;45(2):83-9;
http://www.ncbi.nlm.nih.gov/pubmed/18982834

HSL15376
Ramsey S, Scoggins J.
Commentary: Practicing on the Tip of an Information Iceberg Evidence of Underpublication of Registered Clinical Trials in Oncology
The Oncologist 2008;13:925–929
http://www.theoncologist.com/cgi/reprint/theoncologist.2008-0133v1.pdf

HSL15402
Glaeske G.
[Why are some drugs so expensive? The price policy of pharmaceutical companies--'digging the grave of our health insurance-system'?]
Z Evid Fortbild Qual Gesundhwes 2008;102(4):269-77
http://www.ncbi.nlm.nih.gov/pubmed/19004366

HSL15460
Parrott R, Volkman J, Ghetian C, Weiner J, Raup-Krieger J, Parrott J.
Memorable messages about genes and health: implications for direct-to-consumer marketing of genetic tests and therapies.
Health Mark Q. 2008;25(1-2):8-32
http://www.ncbi.nlm.nih.gov/pubmed/18935878

HSL15489
Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart A, Choudhry NK, Shrank WH.
Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease: A Systematic Review and Meta-analysis
JAMA 2008;300(21):2514-2526.
Link to source with long URL

HSL15612
Shani S, Yahalom Z.
The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
Food Drug Law J. 2008;63(3):701-11
http://www.ncbi.nlm.nih.gov/pubmed/19031669

HSL15622
Jacobstein JM.
Federal regulatory pre-emption of state tort claims against the manufacturers of medical devices and pharmaceutical drugs.
J Law Med Ethics. 2008 Fal;36(3):594-7
Link to source with long URL

HSL15620
Segman R, Weizman A
Drug industry, psychopharmacology, and mental health care needs: where do we go from here?
Isr J Psychiatry Relat Sci. 2008;45(2):71-9
Link to source with long URL

HSL15625
Hogarth S, Javitt G, Melzer D.
The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.
Annu Rev Genomics Hum Genet 2008;9:161-82
Link to source with long URL

HSL15649
Fugh-Berman A, Dodgson SJ.
Ethical considerations of publication planning in the pharmaceutical industry
Open Medicine 2008;2(4)
http://www.openmedicine.ca/article/view/118/215

HSL15666
Ulaş H, Bınbay T, Alptekın K.
[Financial Conflict of Interest in Clinical Psychiatry Studies: A Review].
Turk Psikiyatri Derg. 2008 Win;19(4):418-426
http://www.turkpsikiyatri.com/ftr.aspx?id=670

HSL15868
Matheson A.
Corporate Science and the Husbandry of Scientific and Medical Knowledge by the Pharmaceutical Industry
BioSocieties 2008;3:355–382
http://www.admatheson.com/AM%20BioSocieties%20paper%20Dec%2008.pdf

HSL15958
Norey E, Simone TM, Mousa SA.
The Impact of Direct-to-Consumer Advertised Drugs on Drug Sales in the US and New Zealand.
Appl Health Econ Health Policy. 2008;6(2-3):93-102
http://www.ncbi.nlm.nih.gov/pubmed/19231903

HSL13202
Holtzman NA.
The strange malady of Alessandro's uncle.
BMJ 2007 Dec 22;335(7633):1306-7
http://www.bmj.com/cgi/content/full/335/7633/1306

HSL13065
Furukawa TA, Watanabe N, Omori IM, Churchill R.
Can pill placebo augment cognitive-behavior therapy for panic disorder?
BMC Psychiatry 2007 Dec 20;7(73)
http://www.biomedcentral.com/1471-244X/7/73

HSL13380
Wadman M.
Regulator under siege.
Nature 2007 Dec 20;450(7173):1143
Link to source with long URL

HSL12949
Twombly R.
So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
J Natl Cancer Inst 2007 Dec 19;99(24):1828-9,
http://jnci.oxfordjournals.org/cgi/content/full/99/24/1828

HSL12986
Main ML, Goldman JH, Grayburn PA.
Thinking outside the 'box' - the ultrasound controversy
J Am Coll Cardiol 2007 Dec 18;50(25):2434-7
http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(07)03575-9

HSL12915
Dyer O.
HPV vaccine campaign struggles: Low Ontario uptake rate "a huge disappointment," says expert
National Review of Medicine 2007 Dec 15;4(20)
Link to source with long URL

HSL12934
FDA off-track on off-label drug promotion.
Lancet. 2007 Dec 15;370(9604):1976
Link to source with long URL

HSL12946
Tanne JH.
FDA may allow drug and device companies to promote "off-label" uses.
BMJ 2007 Dec 15;335(7632):1229
http://www.bmj.com/cgi/content/full/335/7632/1229

HSL12947
Sayburn A.
Drug companies expected to get more leeway in communicating with patients in Europe.
BMJ 2007 Dec 15;335(7632):1228
http://www.bmj.com/cgi/content/full/335/7632/1228-c

HSL12948
Choonara I.
Regulation of drugs for children in Europe.
BMJ 2007 Dec 15;335(7632):1221-2
http://www.bmj.com/cgi/content/full/335/7632/1221

HSL13506
Traynor K.
Trade group says thwarting drug counterfeiters remains challenging.
Am J Health Syst Pharm 2007 Dec 15;64(24):2532,
http://www.ajhp.org/cgi/content/full/64/24/2532

HSL13985
Kripke DF.
Who should sponsor sleep disorders pharmaceutical trials?
J Clin Sleep Med 2007 Dec 15;3(7):671-3
http://www.ncbi.nlm.nih.gov/pubmed/18198797

HSL13246
Galson SK.
The FDA and the IOM report.
N Engl J Med 2007 Dec 13;357(24):2520-1
http://www.ncbi.nlm.nih.gov/pubmed/18077820

HSL12935
Freudenberg N, Bradley SP, Serrano M.
Public Health Campaigns to Change Industry Practices That Damage Health: An Analysis of 12 Case Studies.
Health Educ Behav 2007 Dec 12
Link to source with long URL

HSL12898
Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S.
Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic Epidemiology.
PLoS Med 2007 Dec 11;4(12):e352
Link to source with long URL

HSL12837
Tatsioni A, Bonitsis NG, Ioannidis JPA.
Persistence of Contradicted Claims in the Literature
JAMA 2007 Dec 5;298(21):2517-2526
http://jama.ama-assn.org/cgi/content/abstract/298/21/2517

HSL12900
Tuma RS.
Trend toward noninferiority trials may mean more difficult interpretation of trial results.
J Natl Cancer Inst 2007 Dec 5;99(23):1746-8
http://jnci.oxfordjournals.org/cgi/content/full/99/23/1746

HSL12895
Yach D, Lucio A, Barroso C.
Can food and beverage companies help improve population health? Some insights from PepsiCo.
Med J Aust 2007 Dec 3;187(11-12):656-7
http://www.mja.com.au/public/issues/187_11_031207/yac11168_fm.html

HSL12896
Ernst E.
A beginner's guide to criticism.
Med J Aust 2007 Dec 3;187(11-12):649
http://www.mja.com.au/public/issues/187_11_031207/ern10264_fm.html

HSL13054
Burton B.
Diabetes expert accuses drug company of 'intimidation'
BMJ 2007 Dec 1;335(7630):1113
http://www.bmj.com/cgi/content/full/335/7630/1113-a

HSL13055
O'Dowd A.
Drug companies are ignoring health crisis in poor countries, Oxfam says.
BMJ 2007 Dec 1;335(7630):1111
http://www.bmj.com/cgi/content/full/335/7630/1111

HSL13508
Lal R, Kremzner M.
Introduction to the new prescription drug labeling by the Food and Drug Administration.
Am J Health Syst Pharm 2007 Dec 1;64(23):2488-94
http://www.ajhp.org/cgi/content/full/64/23/2488

HSL13509
Traynor K.
Nonprescription cold remedies unsafe for young children, FDA advisers say.
Am J Health Syst Pharm 2007 Dec 1;64(23):2408-10
http://www.ajhp.org/cgi/content/full/64/23/2408

HSL12786
Dellinger RP, Durbin CG Jr.
Separating practice guidelines from pharmaceutical marketing.
Crit Care Med 2007 Dec;35(12):2878-80
Link to source with long URL

HSL12787
Eichacker PQ, Natanson C, Danner RL.
Separating practice guidelines from pharmaceutical marketing.
Crit Care Med 2007 Dec;35(12):2877-8
Link to source with long URL

HSL12788
Lorence D, Churchill R.
A study of the web as DTC drug marketing agent.
J Med Syst 2007 Dec;31(6):551-6
Link to source with long URL

HSL12804
Carroll AE, Vreeman RC, Buddenbaum J, Inui TS.
To What Extent Do Educational Interventions Impact Medical Trainees' Attitudes and Behaviors Regarding Industry-Trainee and Industry-Physician Relationships?
Pediatrics 2007 Dec;120(6):e1528-e1535
http://pediatrics.aappublications.org/cgi/content/full/120/6/e1528

HSL12821
Jureidini J.
The Black Box Warning: Decreased Prescriptions and Increased Youth Suicide?
Am J Psychiatry 164:1907, December 2007 2007 Dec;164(12):1907
http://ajp.psychiatryonline.org/cgi/content/full/164/12/1907

HSL12854
Schwartz JL, Caplan AL, Faden RR, Sugarman J.
Lessons from the failure of human papillomavirus vaccine state requirements.
Clin Pharmacol Ther 2007 Dec;82(6):760-3
Link to source with long URL

HSL12877
Medicines Australia Code of Conduct: breaches
Australian Prescriber 2007 Dec;30(6)
http://www.australianprescriber.com/upload/pdf/articles/922.pdf

HSL12878
Komesaroff PA.
Relationships between health professionals and industry: maintaining a delicate balance
Australian Prescriber 2007 Dec;30(6):150
http://www.australianprescriber.com/upload/pdf/articles/920.pdf

HSL12885
Breast-cancer awareness: too much of a good thing?
Lancet Oncol 2007 Dec;8(12):1041
Link to source with long URL

HSL12960
Willert PL.
Assessment of the pharmaceutical market in Poland after accession to the European Union.
Eur J Health Econ 2007 Dec;8(4):347-57
http://www.springerlink.com/content/m8025319jm1176w5/

HSL12961
Outreville JF.
Foreign direct investment in the health care sector and most-favoured locations in developing countries.
Eur J Health Econ 2007 Dec;8(4):305-12
http://www.springerlink.com/content/1103802021u62r74/

HSL13056
White PF.
The importance of transparency in industry-sponsored multicenter clinical studies.
2007 Dec;105(6):1861
www.anesthesia-analgesia.org/cgi/content/full/105/6/1861

HSL13080
Haider SI, Johnell K, Thorslund M, Fastbom J.
Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 â 2002.
Int J Clin Pharmacol Ther 2007 Dec;45(12):643-53
Link to source with long URL

HSL13203
Hudson K, Javitt G, Burke W, Byers P; American Society of Human Genetics Social Issues Committee.
ASHG Statement* on direct-to-consumer genetic testing in the United States.
Obstet Gynecol 2007 Dec;110(6):1392-5
http://www.greenjournal.org/cgi/content/full/110/6/1392

HSL13204
Tracy EE.
Are doctors prepared for direct-to-consumer advertising of genetics tests?
Obstet Gynecol 2007 Dec;110(6):1389-91
http://www.greenjournal.org/cgi/content/full/110/6/1389

HSL13208
Fernandez-Llimos F, Vazquez Gomez I.
Information provided by generic and brand-name pharmaceutical manufacturers in response to a request.
Pharm World Sci 2007 Dec;29(6):683-7
http://www.springerlink.com/content/r74x189243174673/

HSL13309
Zeps N.
International Clinical Trials Symposium 2007: improving healthcare in the new millennium.
IDrugs 2007 Dec;10(12):874-6
http://www.ncbi.nlm.nih.gov/pubmed/18041684?dopt=Abstract

HSL13373
Genetic help for a blood-thinner balancing act? There's little evidence yet that a genetic test improves the safety of warfarin?
Harv Heart Lett 2007 Dec;18(4):1-2
http://www.ncbi.nlm.nih.gov/pubmed/18219801

HSL13382
Wohlfarth T, Boer F, van den Brink W.
Withdrawal of attention rather than pharmacological treatment affects suicide rates in depressed children and adolescents.
Am J Psychiatry 2007 Dec;164(12):1908
http://www.ncbi.nlm.nih.gov/pubmed/18056249?dopt=Abstract

HSL13383
Olfson M, Shaffer D.
SSRI prescriptions and the rate of suicide.
Am J Psychiatry 2007 Dec;164(12):1907-8
http://ajp.psychiatryonline.org/cgi/content/full/164/12/1907-a

HSL13384
Leon AC.
The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses.
Am J Psychiatry 2007 Dec;164(12):1786-9
http://ajp.psychiatryonline.org/cgi/content/full/164/12/1786

HSL13385
Baker DD, Chu M, Oza U, Rajgarhia V.
The value of natural products to future pharmaceutical discovery.
Nat Prod Rep 2007 Dec;24(6):1225-44
http://www.rsc.org/publishing/journals/NP/article.asp?doi=b602241n

HSL13420
Mattke S, Seid M, Ma S.
Evidence for the effect of disease management: is $1 billion a year a good investment?
Am J Manag Care 2007 Dec;13(12):670-6
http://www.ajmc.com/article.cfm?ID=6872&CFID=8980495&CFTOKEN=81996035

HSL13505
Onda M, Okuda N, Kosaka N, Takahashi N, Matsuura M, Yamaguchi Y, Yamada R.
[Basic study to establish medication safety culture with patient-commitment style in community pharmacy: An examination from meeting reports].
Yakugaku Zasshi 2007 Dec;127(12):2075-8
http://www.jstage.jst.go.jp/article/yakushi/127/12/127_2075/_article

HSL13507
Alexander-Bridges M, Doan LL; Endocrine Society's Task Force on Increasing Minority Participation in Clinical Research.
Commentary on "increasing minority participation in clinical research": a white paper from the endocrine society.
J Clin Endocrinol Metab 2007 Dec;92(12):4557-9
http://jcem.endojournals.org/cgi/content/full/92/12/4557

HSL13629
Roscam Abbing HD.
Pharmacogenetics: a new challenge for health law.
Med Law 2007 Dec;26(4):781-9
http://www.ncbi.nlm.nih.gov/pubmed/18284117

HSL13631
de la Fuente Cid R, Varela Román A.
[Wich in the role of the angiotensine II receptor blockers (ARBs) for the treatment of heart failure? Do we work in order to evidence/recomendations or to the pharmaceutical industry pression?].
An Med Interna 2007 Dec;24(12):607-9
http://www.ncbi.nlm.nih.gov/pubmed/18279002

HSL13632
Muiño Miguez A, Jiménez Muñoz AB, Pinilla Llorente, Durán García ME, Cabrera Aguilar FJ, Rodríguez Pérez MP.
[Patient safety].
An Med Interna 2007 Dec;24(12):602-6
http://www.ncbi.nlm.nih.gov/pubmed/18279001

HSL13691
Mack GS.
Pfizer dumps Exubera.
Nat Biotechnol. 2007 Dec;25(12):1331-2
http://www.nature.com/doifinder/10.1038/nbt1207-1331

HSL13692
Segraves RT, Balon R.
Patient and provider attitudes toward free drug samples in psychiatric practice.
J Clin Psychopharmacol. 2007 Dec;27(6):732-3
Link to source with long URL

HSL13760
Sinclair RC, Lovsin TK, Moore SE.
Mood state, issue involvement, and argument strength on responses to persuasive appeals.
Psychol Rep 2007 Dec;101(3)
http://www.ncbi.nlm.nih.gov/pubmed/18232427

HSL13763
Fraser H, Mounib EL, Payne S.
Cross-industry collaboration: a critical step to better serve patients.
Healthc Financ Manage 2007 Dec;61(12):90-2
http://www.ncbi.nlm.nih.gov/pubmed/18186211

HSL13764
Sansgiry SS, Chanda S, Shringarpure GS.
Impact of bilingual product information labels on Spanish-speaking adults' ability to comprehend OTC information.
Res Social Adm Pharm 2007 Dec;3(4):410-25
http://www.ncbi.nlm.nih.gov/pubmed/18082876

HSL13766
Briñol P, Petty RE, Valle C, Rucker DD, Becerra A.
The effects of message recipients' power before and after persuasion: a self-validation analysis.
J Pers Soc Psychol 2007 Dec;93(6):1040-53
http://content.apa.org/journals/psp/93/6/1040

HSL13767
Coombs A.
Proposed changes to patent code loom over biotech industry.
Nat Biotechnol 2007 Dec;25(12):1333-4
http://www.nature.com/doifinder/10.1038/nbt1207-1333

HSL13768
Lee DY, Armour C, Krass I.
The development and evaluation of written medicines information for type 2 diabetes.
Health Educ Res 2007 Dec;22(6):918-30
http://her.oxfordjournals.org/cgi/content/full/22/6/918

HSL13891
Hélie F, Hardy JF.
Anesthesiologists and the pharmaceutical industry: awareness is paramount.
Can J Anaesth 2007 Dec;54(12):1026-7
http://www.cja-jca.org/cgi/content/full/54/12/1026?view=long&pmid=18056215

HSL13892
Kopelman CA, Roberts LM, Adab P.
Advertising of food to children: is brand logo recognition related to their food knowledge, eating behaviours and food preferences?
J Public Health (Oxf) 2007 Dec;29(4):358-67
http://jpubhealth.oxfordjournals.org/cgi/content/abstract/29/4/358

HSL13898
Ng DH, Lee MM, Chong N, Eong KG.
Stop-smoking television advertisements: a necessary evil?
Ann Acad Med Singapore 2007 Dec;36(12):1036-7
http://www.annals.edu.sg/pdf/36VolNo12Dec2007/V36N12p1036.pdf

HSL13986
Pine KJ, Wilson P, Nash AS.
The relationship between television advertising, children's viewing and their requests to Father Christmas.
J Dev Behav Pediatr 2007 Dec;28(6):456-61
Link to source with long URL

HSL13988
Bhattacharyya S, Burns A.
Is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive? - No.
Int Psychogeriatr 2007 Dec;19(6):1014-20
Link to source with long URL

HSL13989
Shah AA, Finucane TE.
Yes, industry influence is excessive.
Int Psychogeriatr 2007 Dec;19(6):1004-10
Link to source with long URL

HSL13990
Ames D.
For debate: is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive?
Int Psychogeriatr 2007 Dec;19(6):1003
Link to source with long URL

HSL14181
Friedman LC.
Philip Morris's website and television commercials use new language to mislead the public into believing it has changed its stance on smoking and disease.
Tob Control 2007 Dec;16(6):e9
http://tobaccocontrol.bmj.com/cgi/content/full/16/6/e9

HSL14422
Clarke SH.
Cigarettes, alcohol, and the question of corporate responsibility.
Rev Am Hist 2007 Dec;35(4):636-41
Link to source with long URL

HSL14462
Buchner B.
Industry-sponsored medical education--in the quest for professional integrity and legal certainty.
Eur J Health Law 2007 Dec;14(4):313-9
http://www.ncbi.nlm.nih.gov/pubmed/18431976

HSL14495
de la Fuente Cid R, Varela Román A.
[Which is the role of the angiotensin II receptor blockers (ARBs) for the treatment of heart failure? Do we work based on evidence/recommendations or pharmaceutical industry pressure?].
An Med Interna 2007 Dec;24(12):607-9
http://www.ncbi.nlm.nih.gov/pubmed/18279002

HSL14764
Hüttl P, Heberer J, von Knoch M, Siegert M.
[The advertising rights of medical representatives. 2: Presentation of the legal advertising framework according to the drug advertising law]
Chirurg 2007 Dec;Suppl:421-5
http://www.ncbi.nlm.nih.gov/pubmed/18546571

HSL14878
Pachter WS, Fox RE, Zimbardo P, Antonuccio DO.
Corporate funding and conflicts of interest: a primer for psychologists.
Am Psychol 2007 Dec;62(9):1005-15
http://www.ncbi.nlm.nih.gov/pubmed/18085846

HSL12845
Schultz WB.
Bolstering the FDA's drug-safety authority.
N Engl J Med 2007 Nov 29;357(22):2217-9
http://content.nejm.org/cgi/content/extract/357/22/2217

HSL12952
Reikvam A.
[Fewer new drugs from drug industry].
Tidsskr Nor Laegeforen. 2007 Nov 29;127(23):3106-7
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1622509

HSL13294
Olson MK.
The risk we bear: The effects of review speed and industry user fees on new drug safety.
J Health Econ 2007 Nov 29
Link to source with long URL

HSL13819
Brenner DJ, Hall EJ.
Computed tomography--an increasing source of radiation exposure.
N Engl J Med 2007 Nov 29;357(22):2277-84
www.ncbi.nlm.nih.gov/pubmed/18046031?

HSL12817
Leo J, Lacasse JR.
The Media and the Chemical Imbalance Theory of Depression
Society 2007 Nov 28:epub ahead of print
http://www.springerlink.com/content/u37j12152n826q60/fulltext.html

HSL13304
Berry SR, Hubay S, Soibelman H, Martin DK.
The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
BMC Health Serv Res 2007 Nov 28;7:193
http://www.biomedcentral.com/1472-6963/7/193

HSL12763
Day M.
Threat to break patents saves Brazil $1bn in cost of HIV treatment
BMJ 2007 Nov 24;335(7629):1065
http://www.bmj.com/cgi/content/short/335/7629/1065?etoc

HSL12764
Tanne JH.
US makers of joint replacements are fined for paying surgeons to use their devices
BMJ 2007 Nov 24;335(7629):1065
http://www.bmj.com/cgi/content/short/335/7629/1065-a?etoc

HSL12765
McCartney M.
Mixed messages over breast milk and brainy babies
BMJ 2007 Nov 24;335(7629):1074
http://www.bmj.com/cgi/content/short/335/7629/1074?etoc

HSL12791
Roehr B.
New US charity to foster drug research sparks fears of undue industry influence.
BMJ 2007 Nov 24;335(7629):1069
http://www.bmj.com/cgi/content/extract/335/7629/1069-b

HSL12793
Wibulpolprasert S, Moosa S, Satyanarayana K, Samarage S, Tangcharoensathien V.
WHO's web-based public hearings: hijacked by pharma?
Lancet 2007 Nov 24;370(9601):1754
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(07)61689-4

HSL13306
Jacobson NO.
[Silly box].
Lakartidningen. 2007 Nov 21-27;104(47):3564
http://www.ncbi.nlm.nih.gov/pubmed/18203595

HSL12745
Jones D.
Health authority bans physician shadowing
CMAJ 2007 Nov 20;177(11):1339-40
http://www.cmaj.ca/cgi/reprint/177/11/1339

HSL12753
Giles J.
Drug firms accused of biasing doctors' training The uneasy link between industry and education.
Nature 2007 Nov 20
http://www.nature.com/news/2007/071120/full/450464a.html

HSL13090
Møller N.
Drug industry's 'offers' to health personnel
Ugeskr Laeger 2007 Nov 19;169(47):4081
http://www.ncbi.nlm.nih.gov/pubmed/18087788

HSL12734
Charatan F.
Merck to pay $5bn in rofecoxib claims
BMJ 2007 Nov 17;335(7628):1011
http://www.bmj.com/cgi/content/short/335/7628/1011?etoc

HSL12735
Tuffs A.
Bayer withdraws heart surgery drug
BMJ 2007 Nov 17;335(7628):1015
http://www.bmj.com/cgi/content/short/335/7628/1015?etoc

HSL12736
McClure I.
A deficit of attention to impartiality?
BMJ 2007 Nov 17;335(7628):1047
http://www.bmj.com/cgi/content/short/335/7628/1047?etoc

HSL12746
Yank V.
Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study
BMJ 2007 Nov 16:epub ahead of print
http://www.bmj.com/cgi/content/full/bmj.39376.447211.BEv1

HSL12747
Epstein RA.
Influence of pharmaceutical funding on the conclusions of meta-analyses
BMJ 2007 Nov 16:epub ahead of print
http://www.bmj.com/cgi/content/extract/bmj.39381.655845.BEv1

HSL12782
Steinbrook R.
Closing the Affordability Gap for Drugs in Low-Income Countries
NEJM 2007 Nov 15;357(20):1996-1999
http://content.nejm.org/cgi/content/full/357/20/1996

HSL12848
Storm-Henningsen P.
Glucosamine and conflict of interest.
Tidsskr Nor Laegeforen 2007 Nov 15;127(22):2971
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1616071

HSL12849
Haug C.
[Patients, patents and profits].
Tidsskr Nor Laegeforen. 2007 Nov 15;127(22):2921
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1612095

HSL12850
Frank RG.
The ongoing regulation of generic drugs.
N Engl J Med 2007 Nov 15;357(20):1993-6
http://content.nejm.org/cgi/content/extract/357/20/1993

HSL13464
van Herten J.
[Are you as a veterinarian allowed to advertise for veterinary drugs?]
Tijdschr Diergeneeskd 2007 Nov 15;132(22):884-5
http://www.ncbi.nlm.nih.gov/pubmed/18069529

HSL13247
Psaty BM, Korn D.
Congress responds to the IOM drug safety report--in full.
JAMA 2007 Nov 14;298(18):2185-7
http://jama.ama-assn.org/cgi/content/full/298/18/2185

HSL12999
Epstein JA, Botvin GJ.
Media resistance skills and drug skill refusal techniques: What is their relationship with alcohol use among inner-city adolescents?
Addict Behav 2007 Nov 13
Link to source with long URL

HSL12945
Aagaard E.
[Physicians with Narrower Limits].
Ugeskr Laeger 2007 Nov 12;169(46):3984
http://www.ncbi.nlm.nih.gov/pubmed/18087786

HSL12682
Kamerow D.
Yankee doodling: Paying for promising but unproven technologies
BMJ 2007 Nov 10;335(7627):965
http://www.bmj.com/cgi/content/short/335/7627/965?etoc

HSL12826
Rock EP, Kennedy DL, Furness MH, Pierce WF, Pazdur R, Burke LB.
Patient-reported outcomes supporting anticancer product approvals.
J Clin Oncol 2007 Nov 10;25(32):5094-9
http://jco.ascopubs.org/cgi/content/full/25/32/5094

HSL12827
Sloan JA, Berk L, Roscoe J, Fisch MJ, Shaw EG, Wyatt G, Morrow GR, Dueck AC; National Cancer Institute.
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
J Clin Oncol 2007 Nov 10;25(32):5070-7
http://jco.ascopubs.org/cgi/content/full/25/32/5070

HSL12852
Gondek K, Sagnier PP, Gilchrist K, Woolley JM.
Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.
J Clin Oncol 2007 Nov 10;25(32):5087-93
http://jco.ascopubs.org/cgi/content/full/25/32/5087

HSL12676
Tentler A, Silberman J, Paterniti DA, Kravitz RL, Epstein RM.
Factors Affecting Physicians' Responses to Patients' Requests for Antidepressants: Focus Group Study.
J Gen Intern Med 2007 Nov 7
http://www.springerlink.com/content/jh8844315t767105/

HSL12727
Tuma RS.
Business barriers slowing the pace of cancer immunotherapy research and development.
J Natl Cancer Inst 2007 Nov 7;99(21):1570-3 Epub 2007 Oct 30.
http://jnci.oxfordjournals.org/cgi/content/extract/99/21/1570

HSL12678
Morrato EH, Libby AM, Orton HD, Degruy FV 3rd, Brent DA, Allen R, Valuck RJ.
Frequency of Provider Contact After FDA Advisory on Risk of Pediatric Suicidality With SSRIs.
Am J Psychiatry 2007 Nov 6
Link to source with long URL

HSL13302
Vermeulen M, Bouma J.
[The influence of the pharmaceutical industry in patient organisations].
Ned Tijdschr Geneeskd. 2007 Nov 3;151(44):2432-4
http://www.ncbi.nlm.nih.gov/pubmed/18064861

HSL13303
Smulders YM, Thijs A.
[The influence of the pharmaceutical industry on treatment guidelines].
Ned Tijdschr Geneeskd 2007 Nov 3;151(44):2429-31
http://www.ncbi.nlm.nih.gov/pubmed/18064860

HSL13381
Johnson LJ.
Get informed consent for risky drugs.
Med Econ 2007 Nov 2;84(21):20
http://www.ncbi.nlm.nih.gov/pubmed/18074929?dopt=Abstract

HSL12582
Campbell EG.
Doctors and Drug Companies — Scrutinizing Influential Relationships
NEJM 2007 Nov 1;357(18):1796-1797
http://content.nejm.org/cgi/content/full/357/18/1796

HSL12613
Wasserstein AG, Brennan PJ, Rubenstein AH.
Institutional Leadership and Faculty Response: Fostering Professionalism at the University of Pennsylvania School of Medicine.
Acad Med 2007 Nov;82(11):1049-1056
Link to source with long URL

HSL12626
Stuetz A.
Partnership among dermatology, the Society for Investigative Dermatology, and industry: suggestions for change.
J Invest Dermatol 2007 Nov;127(11):2487-9
http://www.nature.com/jid/journal/v127/n11/full/5701130a.html

HSL12636
Shuster S.
Uninteresting conflicts of interest.
J Invest Dermatol 2007 Nov;127(11):2668
http://www.nature.com/jid/journal/v127/n11/abs/5701108a.html

HSL12677
Wadman M.
New law gives FDA more influence to monitor drug safety.
Nat Med 2007 Nov;13(11):1269
http://www.nature.com/doifinder/10.1038/nm1107-1269

HSL12703
Schoberberger R, Klik K, Korab T, Kunze M.
[The influence of drug packaging on the drug-taking compliance of older patients living on their own].
Wien Med Wochenschr. 2007 Nov;157(11-12):271-8
Link to source with long URL

HSL12789
Vranić E, Uzunović A.
Influence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets.
Bosn J Basic Med Sci 2007 Nov;7(4):328-34
Link to source with long URL

HSL12823
Saviola JF.
Contact Lens Safety and the FDA: 1976 to the Present.
Eye Contact Lens 2007 Nov;33(6)
Link to source with long URL

HSL12825
Jordan MA, Haywood T.
Evaluation of internet websites marketing herbal weight-loss supplements to consumers.
J Altern Complement Med 2007 Nov;13(9):1035-44
http://www.liebertonline.com/doi/pdf/10.1089/acm.2007.7197

HSL12831
Cohen-Kohler JC.
The morally uncomfortable global drug gap.
Clin Pharmacol Ther 2007 Nov;82(5):610-4
http://www.nature.com/clpt/journal/v82/n5/full/6100359a.html

HSL12846
Burnside NL, Bardo JA, Bretz CJ, Busbee LA, Chrymko MM, Tuttle JA.
Effects of including medication indications on prescription labels.
J Am Pharm Assoc (2003) 2007 Nov-Dec;47(6):756-8
Link to source with long URL

HSL12847
Raynor DK, Svarstad B, Knapp P, Aslani P, Rogers MB, Koo M, Krass I, Silcock J.
Consumer medication information in the United States, Europe, and Australia: a comparative evaluation.
J Am Pharm Assoc (2003) 2007 Nov-Dec;47(6):717-24
Link to source with long URL

HSL12858
DiMasi JA, Grabowski HG.
Should the patent system for new medicines be abolished?
Clin Pharmacol Ther 2007 Nov;82(5):488-90
http://www.nature.com/clpt/journal/v82/n5/abs/6100393a.html

HSL12861
Garnerin P, Perneger T, Chopard P, Arès M, Baalbaki R, Bonnabry P, Clergue F.
Drug selection errors in relation to medication labels: a simulation study.
Anaesthesia 2007 Nov;62(11):1090-4
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2044.2007.05198.x

HSL12871
Wolf W, Atkinson DJ, Colletti PM.
Enhancing drug development and drug monitoring: academia, industry and government chart common goals.
Pharm Res 2007 Nov;24(11):2005-7
http://www.springerlink.com/content/3460307826441647/

HSL12872
Arguello B, Fernandez-Llimos F.
Clinical pharmacology information in summaries of product characteristics and package inserts.
Clin Pharmacol Ther 2007 Nov;82(5):566-71
http://www.nature.com/clpt/journal/v82/n5/abs/6100198a.html

HSL12890
Venkataraman S, Stremersch S.
The Debate on Influencing Doctors' Decisions: Are Drug Characteristics the Missing Link?
Management Science 2007 Nov;53(11):1688-1701
http://mansci.journal.informs.org/cgi/content/abstract/53/11/1688

HSL12987
Snyder CF, Watson ME, Jackson JD, Cella D, Halyard MY; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.
Patient-reported outcome instrument selection: designing a measurement strategy.
Value Health 2007 Nov-Dec;10
Link to source with long URL

HSL12988
Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.
Patient-reported outcomes: conceptual issues.
Value Health 2007 Nov-Dec;10
Link to source with long URL

HSL12989
Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL.
Patient-reported outcomes to support medical product labeling claims: FDA perspective.
Value Health 2007 Nov-Dec;10
Link to source with long URL

HSL12990
Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.
Interpreting and reporting results based on patient-reported outcomes.
Value Health 2007 Nov-Dec;10
Link to source with long URL

HSL13058
Sloan JA, Dueck AC, Erickson PA, Guess H, Revicki DA, Santanello NC; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.
Analysis and interpretation of results based on patient-reported outcomes.
Value Health 2007 Nov-Dec;10
http://www.ncbi.nlm.nih.gov/pubmed/17995469

HSL13091
Sim MG, Khong E, Wain TD.
The prescribing dilemma of benzodiazepines.
Aust Fam Physician 2007 Nov;36(11):923-6
http://www.racgp.org.au/afp/200711/21023

HSL13105
Glinick SE.
Recent requirements under the author byline disclosing any financial interests.
Med Health R I 2007 Nov;90(11):369
http://www.ncbi.nlm.nih.gov/pubmed/18092492

HSL13107
Khan MM.
Why physicians should not have any contact with pharmaceutical companies?
J Pak Med Assoc 2007 Nov;57(11):572-3
http://www.ncbi.nlm.nih.gov/pubmed/18062528

HSL13108
Eisman JA, Lorenzo JA.
Challenges in science and academic-industry interactions.
J Bone Miner Res 2007 Nov;22(11):1654-5
http://www.jbmronline.org/doi/abs/10.1359/jbmr.07090a

HSL13205
Abbasi K.
Doctors and the drug industry revisited.
J R Soc Med 2007 Nov;100(11):485
http://www.jrsm.org/cgi/content/full/100/11/485

HSL13310
Fortunak J, Confalone PN, Grosso JA.
Strength and honor through the pharmaceutical industry's embrace of green chemistry?
Curr Opin Drug Discov Devel 2007 Nov;10(6):651-3
http://www.ncbi.nlm.nih.gov/pubmed/17987518?dopt=Abstract

HSL13311
Briñol P, Petty RE, Barden J.
Happiness versus sadness as a determinant of thought confidence in persuasion: a self-validation analysis.
J Pers Soc Psychol 2007 Nov;93(5):711-27
http://content.apa.org/journals/psp/93/5/711

HSL13314
Briñol P, Petty RE, Gallardo I, DeMarree KG.
The effect of self-affirmation in nonthreatening persuasion domains: timing affects the process.
Pers Soc Psychol Bull 2007 Nov;33(11):1533-46
http://psp.sagepub.com/cgi/reprint/33/11/1533

HSL13388
Arnold RJ.
Cost-effectiveness analysis: should it be required for drug registration and beyond?
Drug Discov Today 2007 Nov;12(21-22):960-5
Link to source with long URL

HSL13389
Pitluk Z, Khalil I.
Achieving confidence in mechanism for drug discovery and development.
Drug Discov Today 2007 Nov;12(21-22):924-30
Link to source with long URL

HSL13465
Hanoch Y, Katsikopoulos KV, Gummerum M, Brass EP.
American and German students' knowledge, perceptions, and behaviors with respect to over-the-counter pain relievers.
Health Psychol 2007 Nov;26(6):802-6
http://content.apa.org/journals/hea/26/6/802

HSL13504
Peltier B, Weinstein P, Fredekind R.
Risky business: influencing people to change.
J Calif Dent Assoc 2007 Nov;35(11):794-8
http://www.ncbi.nlm.nih.gov/pubmed/18080485?dopt=Abstract

HSL13511
Light DW.
What's so great about newness?
Health Aff (Millwood) 2007 Nov-Dec;26(6):1793
http://content.healthaffairs.org/cgi/content/full/26/6/1793

HSL13512
Lopert R, Moon M.
Toward a rational, value-based drug benefit for Medicare.
Health Aff (Millwood) 2007 Nov-Dec;26(6):1666-73
http://content.healthaffairs.org/cgi/content/full/26/6/1666

HSL13515
Lemstra AW, Richard E, van Gool WA.
Cholinesterase inhibitors in dementia: yes, no, or maybe?
Age Ageing 2007 Nov;36(6):625-7
http://ageing.oxfordjournals.org/cgi/content/full/36/6/625

HSL13516
Gascón F, de la Fuente D, Puente J, Lozano J.
On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions.
Artif Intell Med 2007 Nov;41(3):223-35
http://linkinghub.elsevier.com/retrieve/pii/S0933-3657(07)00084-X

HSL13565
Contaminated, fake AIDS drugs flood black market in Zimbabwe.
AIDS Read 2007 Nov;17(11):534
http://www.ncbi.nlm.nih.gov/pubmed/18167067?dopt=Abstract

HSL13566
Tillmanns RW, Ringwelski A, Kretschmann J, Spangler LD, Curry RH.
The profession of medicine: a joint US-German collaborative project in medical education.
Med Teach 2007 Nov;29(9):e269-75
http://www.informaworld.com/smpp/content?content=10.1080/01421590701551706

HSL13644
Ranjan D.
Industry support and sepsis guidelines.
Crit Care Med 2007 Nov;35(11):2665
Link to source with long URL

HSL13646
Eberhardie C.
Nutritional supplements and the EU: is anyone happy?
Proc Nutr Soc 2007 Nov;66(4):508-11
Link to source with long URL

HSL13893
Hrywna M, Delnevo CD, Lewis MJ.
Adult recall of tobacco advertising on the Internet.
Nicotine Tob Res 2007 Nov;9(11):1103-7
http://www.informaworld.com/smpp/content?content=10.1080/14622200701488442

HSL14344
[No authors listed].
Pricing. Pharmacies file Norvir suits against Abbott
AIDS Policy Law 2007 Nov;22(21):9
http://www.ncbi.nlm.nih.gov/pubmed/18225373

HSL15455
Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S
Helping Doctors and Patients Make Sense of Health Statistics
Psychological Science in the Public Interest. 2007 Nov;8(2):53-96
http://www3.interscience.wiley.com/journal/121432447/abstract

HSL12565
Khan MM.
Why I declined an invitation to a drug company seminar
BMJ 2007 Oct 27;335(7625):887
http://www.bmj.com/cgi/content/short/335/7625/887?etoc

HSL12856
Wadman M.
Health official speaks out about row over drug critic.
Nature 2007 Oct 25;449(7165):952-3
http://www.nature.com/news/2007/071024/full/449952b.html

HSL12616
Aagaard L, Soendergaard B, Stenver DI, Hansen EH.
Knowledge creation about ADRs - turning the perspective from the rear mirror to the projector?
Br J Clin Pharmacol 2007 Oct 24
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2007.03019.x

HSL12623
Chokshi DA, Rajkumar R.
Leveraging university research to advance global health.
JAMA 2007 Oct 24;298(16):1934-6
http://jama.ama-assn.org/cgi/content/full/298/16/1934

HSL12556
Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R.
Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
Pharmacoepidemiol Drug Saf 2007 Oct 22
Link to source with long URL

HSL12557
Okechukwu I, Mahmud A, Bennett K, Feely J.
Choice of first antihypertensive - are existing guidelines ignored?
Br J Clin Pharmacol 2007 Oct 22
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2007.03005.x

HSL12569
Nieto A, Mazon A, Pamies R, Linana JJ, Lanuza A, Jiménez FO, Medina-hernandez A, Nieto J.
Adverse Effects of Inhaled Corticosteroids in Funded and Nonfunded Studies
Arch Intern Med 2007 Oct 22;167(19):2047-2053
http://archinte.ama-assn.org/cgi/content/abstract/167/19/2047

HSL12726
Lundh A.
[Sponsorship of continuing medical education].
Ugeskr Laeger 2007 Oct 22;169(43):3681
Link to source with long URL

HSL12953
Rhea S.
Under the influence? Study finds medical schools taking industry cash.
Mod Healthc 2007 Oct 22;37(42):14-5
http://www.ncbi.nlm.nih.gov/pubmed/18027477

HSL12504
Burton B.
COX 2 inhibitor rejected in North America but retained in Europe
BMJ 2007 Oct 20;335(7624):791
http://www.bmj.com/cgi/content/short/335/7624/791-a?etoc

HSL12505
Tanne JH.
Financial ties common between US medical schools and drug companies
BMJ 2007 Oct 20;335(7624):793
http://www.bmj.com/cgi/content/short/335/7624/793-b?etoc

HSL12506
Moszynski P.
Government should restrict advertising of baby milk products, say campaigners
BMJ 2007 Oct 20;335(7624):794
http://www.bmj.com/cgi/content/short/335/7624/794-a?etoc

HSL12507
O'Dowd A.
Scientists challenge companies' dubious marketing claims
BMJ 2007 Oct 20;335(7624):795
http://www.bmj.com/cgi/content/short/335/7624/795-b?etoc

HSL12508
Garattini S.
How can we regulate medicines better?
BMJ 2007 Oct 20;335(7624):803
http://www.bmj.com/cgi/content/short/335/7624/803?etoc

HSL12561
Edward C, Himmelmann A, Wallerstedt SM.
Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study.
BMC Clin Pharmacol 2007 Oct 18;7(1):12
http://www.biomedcentral.com/1472-6904/7/12

HSL12622
Food and Drug Administration, HHS.
Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule
Fed Regist. 2007 Oct 18;72(201):58993-9000
Link to source with long URL

HSL12624
Garber AM, McClellan MB.
Satisfaction guaranteed - 'payment by results' for biologic agents.
N Engl J Med 2007 Oct 18;357(16):1575-7
http://content.nejm.org/cgi/content/extract/357/16/1575

HSL12477
Campbell EG, Weissman JS, Ehringhaus S, Rao SR, Moy B, Feibelmann S, Goold SD.
Institutional Academic–Industry Relationships
JAMA 2007 Oct 17;298(15):1779-1786
http://jama.ama-assn.org/cgi/content/short/298/15/1779

HSL12725
Persson U, Ramsberg J.
[Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].
Lakartidningen. 2007 Oct 17;104(42):3046-50
Link to source with long URL

HSL12830
Restuccia R, Rothman DJ, Chimonas S, Hams M.
Physicians are not immune to marketing.
J Am Coll Cardiol 2007 Oct 16;50(16):1615
Link to source with long URL

HSL12466
Kenny LM, Goergen SK, Mandel CJ.
Towards the appropriate use of diagnostic imaging
MJA 2007 Oct 15;187(8):473-474
http://www.mja.com.au/public/issues/187_08_151007/letters_151007_fm-3.html

HSL12467
Frank OR.
Towards the appropriate use of diagnostic imaging
MJA 2007 Oct 15;187(8):473-474
http://www.mja.com.au/public/issues/187_08_151007/letters_151007_fm-3.html

HSL12468
Mendelson RM, Murray CPJ.
Towards the appropriate use of diagnostic imaging
MJA 2007 Oct 15;187(8):473-474
http://www.mja.com.au/public/issues/187_08_151007/letters_151007_fm-3.html

HSL13467
Naik RK, Borrego ME, Gupchup GV, Dodd M, Sather MR.
Pharmacy students' knowledge, attitudes, and evaluation of direct-to-consumer advertising.
Am J Pharm Educ 2007 Oct 15;71(5):86
Link to source with long URL

HSL12414
Poole C.
NICE transparency: Let cost effectiveness models be open to scrutiny
BMJ 2007 Oct 13;335(7623):735
http://www.bmj.com/cgi/content/short/335/7623/735?etoc

HSL12415
Tanne JH.
Bristol-Myers Squibb to pay $0.5bn to settle US lawsuits
BMJ 2007 Oct 13;335(7623):742
http://www.bmj.com/cgi/content/short/335/7623/742-b?etoc

HSL12416
Hitchen L.
Collaboration between regulators and industry on design of drugs could reduce errors
BMJ 2007 Oct 13;335(7623):743
http://www.bmj.com/cgi/content/short/335/7623/743-g?etoc

HSL12417
Cotgrove A.
Head to head: Should young people be given antidepressants? Yes
BMJ 2007 Oct 13;335(7623):750
http://www.bmj.com/cgi/content/short/335/7623/750?etoc

HSL12418
Timimi S.
Head to head: Should young people be given antidepressants? No
BMJ 2007 Oct 13;335(7623):751
http://www.bmj.com/cgi/content/short/335/7623/751?etoc

HSL12419
Iheanacho I.
Drugs, tales, and other stories: Don't mention it
BMJ 2007 Oct 13;335(7623):776
http://www.bmj.com/cgi/content/short/335/7623/776-a?etoc

HSL12420
Shaughnessy AF.
Clinical Epidemiology: A Basic Science for Clinical Medicine
BMJ 2007 Oct 13;335(7623):777
http://www.bmj.com/cgi/content/short/335/7623/777-a?etoc

HSL12442
Declaration of Helsinki: Dead
BMJ 2007 Oct 13;335(7623):736
http://www.bmj.com/cgi/content/extract/335/7623/736

HSL13826
Higgins SP.
Drug representatives: giving you lunch or stealing your soul?
Dermatol Online J 2007 Oct 13;13(4):5
http://dermatology.cdlib.org/134/commentary/drugreps/higgins.html

HSL12491
Kostich MS, Lazorchak JM.
Risks to aquatic organisms posed by human pharmaceutical use.
Sci Total Environ 2007 Oct 12:epub ahead of print
http://linkinghub.elsevier.com/retrieve/pii/S0048-9697(07)00993-X

HSL12492
Allen M, Ferrier S, O'connor N, Fleming I.
Family physicians' perceptions of academic detailing: a quantitative and qualitative study.
BMC Med Educ 2007 Oct 12;7(1):36
http://www.biomedcentral.com/content/pdf/1472-6920-7-36.pdf

HSL12490
Milewa T.
Representation and legitimacy in health policy formulation at a national level: Perspectives from a study of health technology eligibility procedures in the United Kingdom.
Health Policy 2007 Oct 11:epub ahead of print
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(07)00201-1

HSL12860
Leuchter A, Levey GS.
Need to strike balance with industry-academia rules.
Nature 2007 Oct 11;449(7163):658
http://www.nature.com/doifinder/10.1038/449658c

HSL12702
Yeates N.
Health Canada's new standards on conflict of interest.
CMAJ 2007 Oct 9;177(8):900
http://www.cmaj.ca/cgi/content/full/177/8/900

HSL12901
DerGurahian J.
Tempered enthusiasm: Drug-safety law needs more teeth, patient-safety advocates say
Mod Healthc 2007 Oct 8;37(40):16
Link to source with long URL

HSL12351
Editorial .
Medicines for children: safety as an afterthought
The Lancet 2007 Oct 6;370(9594):1190
Link to source with long URL

HSL12353
Howell JV.
The world of the market place
BMJ 2007 Oct 6;335(7622):683
http://www.bmj.com/cgi/content/short/335/7622/683-b?etoc

HSL12354
Toop L, Mangin D.
Industry funded patient information and the slippery slope to New Zealand
BMJ 2007 Oct 6;335(7622):694
http://www.bmj.com/cgi/content/short/335/7622/694?etoc

HSL12355
Godlee F.
Tooth and nail
BMJ 2007 Oct 6;335(7622)
http://www.bmj.com/cgi/content/full/335/7622/0

HSL12422
Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A.
Drug shop regulation and malaria treatment in Tanzania why do shops break the rules, and does it matter?
Health Policy Plan 2007 Oct 4:epub ahead of print
http://heapol.oxfordjournals.org/cgi/content/abstract/czm033v1

HSL12443
Shuchman M.
Commercializing clinical trials--risks and benefits of the CRO boom.
N Engl J Med 2007 Oct 4;357(14):1365-8
http://content.nejm.org/cgi/content/extract/357/14/1365

HSL12387
Maeck L, Haak S, Knoblauch A, Stoppe G.
Primary care physicians' attitudes related to cognition enhancers in early dementia: a representative eight-year follow-up study in Lower Saxony, Germany.
Int J Geriatr Psychiatry 2007 Oct 1
Link to source with long URL

HSL11871
Amran S, Ahmed M, Shaheen SM, Morshed SN, Khandakar J, Rahman M, Rahman M, Hossain A.
Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh.
Pak J Pharm Sci 2007 Oct;20(4):327-32
Link to source with long URL

HSL12130
Ljungberg C, Lindblad AK, Tully MP.
Hospital doctors' views of factors influencing their prescribing.
J Eval Clin Pract 2007 Oct;13(5):765-71
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2006.00751.x

HSL12215
Thornton S.
Drug price reform in the UK: debunking the myths.
Health Econ 2007 Oct;16(10):981-92
Link to source with long URL

HSL12217
Kravitz RL, Bell RA.
Direct-to-Consumer Advertising of Prescription Drugs: Balancing Benefits and Risks, and a Way Forward.
Clin Pharmacol Ther 2007 Oct;82(4):360-2
Link to source with long URL

HSL12218
Calfee JE.
An Assessment of Direct-to-Consumer Advertising of Prescription Drugs.
Clin Pharmacol Ther 2007 Oct;82(4):357-60
http://www.nature.com/clpt/journal/v82/n4/abs/6100353a.html

HSL12284
Holbrook AM, Janjusevic V, Goldsmith CH, Shcherbatykh IY; for the COMPETE Investigators.
A comprehensive appropriateness of prescribing questionnaire was validated by nominal consensus group.
J Clin Epidemiol 2007 Oct;60(10):1022-1028
http://linkinghub.elsevier.com/retrieve/pii/S0895-4356(07)00040-6

HSL12337
Buchan H.
Turning knowledge into action
Aust Prescr 2007 Oct;30:114-5
http://www.australianprescriber.com/magazine/30/5/114/5/

HSL12347
Sernyak M, Rosenheck R.
Experience of VA Psychiatrists With Pharmaceutical Detailing of Antipsychotic Medications
Psychiatr Serv 2007 Oct;58(10):1292-1296
http://ps.psychiatryonline.org/cgi/content/abstract/58/10/1292

HSL12404
Haussler B, Schiffhorst G, Gothe H, Hempel E.
The impact of pharmaceuticals on the decline of cardiovascular mortality in Germany.
Pharmacoepidemiol Drug Saf 2007 Oct;16(10):1167-76
Link to source with long URL

HSL12421
Singh A.
Pharmacogenomics - The potential of genetically guided prescribing.
Aust Fam Physician 2007 Oct;36(10):820-4
Link to source with long URL

HSL12444
Weiss SC, Krochmal L.
Dermatologists in industry.
J Am Acad Dermatol 2007 Oct;57(4):725
http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(07)00410-0

HSL12445
Epstein RJ.
Growth of the Asian health-care market: global implications for the pharmaceutical industry.
Nat Rev Drug Discov 2007 Oct;6(10):785-92
Link to source with long URL

HSL12474
Vitry A, Lexchin J, Mansfield PR.
Is Australia's National Medicines Policy Failing? The Case of Cox-2 Inhibitors
Int J Health Serv 2007 Oct;37(4):735 - 744
Link to source with long URL

HSL12493
Davis J.
The Effect of Qualifying Language on Perceptions of Drug Appeal, Drug Experience, and Estimates of Side-Effect Incidence in DTC Advertising.
J Health Commun 2007 Oct-Nov;12(7):607-22
http://www.informaworld.com/smpp/content?content=10.1080/10810730701615164

HSL12494
Steinman MA, Baron RB.
Is continuing medical education a drug-promotion tool?: YES
Can Fam Physician. 2007 Oct;53(10):1650-3
http://www.cfp.ca/cgi/content/full/53/10/1650

HSL12495
Marlow B.
Is continuing medical education a drug-promotion tool?: NO.
Can Fam Physician 2007 Oct;53(10):1650-2,
http://www.cfp.ca/cgi/content/full/53/10/1650-a

HSL12528
MacLean DS.
Drug Overuse: ‘Get Your Doctors to Fix This’
Caring for the Ages 2007 Oct;8(10):5

HSL12539
Light D.
Misleading Congress about Drug Development
Journal of Health Politics, Policy and Law 2007 Oct;32(5):895-913
http://bioethics.upenn.edu/people/?last=Light&first=Donald

HSL12552
Lohr KN.
Emerging methods in comparative effectiveness and safety: symposium overview and summary.
Med Care 2007 Oct;45(10)
Link to source with long URL

HSL12553
Maclure M, Carleton B, Schneeweiss S.
Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations.
Med Care 2007 Oct;45(10)
Link to source with long URL

HSL12554
Sturmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S.
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.
Med Care 2007 Oct;45(10)
Link to source with long URL

HSL12555
Segal JB, Griswold M, Achy-Brou A, Herbert R, Bass EB, Dy SM, Millman AE, Wu AW, Frangakis CE.
Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication.
Med Care 2007 Oct;45(10)
Link to source with long URL

HSL12558
Ganz PA, Goodwin PJ.
Health-related quality of life measurement in symptom management trials.
J Natl Cancer Inst Monogr 2007 Oct(37):47-52
http://jncimono.oxfordjournals.org/cgi/content/abstract/2007/37/47

HSL12559
Rock EP, Scott JA, Kennedy DL, Sridhara R, Pazdur R, Burke LB.
Challenges to use of health-related quality of life for food and drug administration approval of anticancer products.
J Natl Cancer Inst Monogr 2007 Oct(37):27-30
http://jncimono.oxfordjournals.org/cgi/content/abstract/2007/37/27

HSL12560
Thornton RG.
Preemption, tort reform, and pharmaceutical claims: Part one: Who will become the pharmaceutical industry's insurers (or is it prescribing physicians and we do not know it?)
Proc (Bayl Univ Med Cent). 2007 Oct;20(4):418-22
Link to source with long URL

HSL12563
Ridinger MH.
Nutraceuticals: miracle or meme?
Clin Pharmacol Ther 2007 Oct;82(4):352-6
Link to source with long URL

HSL12566
Biron P, Lévesque P, Plaisance M.
Pharmas-co-dependence exposed: Would it be time to say, 'No thanks'?
Can Fam Physician 2007 Oct;53(10):1635 - 1637
http://www.cfp.ca/cgi/content/full/53/10/1635

HSL12625
Fitz MM, Homan D, Reddy S, Griffith CH 3rd, Baker E, Simpson KP.
The hidden curriculum: medical students' changing opinions toward the pharmaceutical industry.
Acad Med 2007 Oct;82(10)
Link to source with long URL

HSL12637
Fallat ME, Glover J; American Academy of Pediatrics, Committee on Bioethics.
Professionalism in pediatrics.
Pediatrics 2007 Oct;120(4):e1123-33
http://pediatrics.aappublications.org/cgi/content/full/120/4/e1123

HSL12729
Nelson R.
When ads trump evidence: is direct-to-consumer advertising leading practice?
Am J Nurs 2007 Oct;107(10):25-6
Link to source with long URL

HSL12731
Avanzini G, Engel J Jr.
Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
Epilepsia 2007 Oct;48(10):1821-4 Epub 2007 Aug 7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1528-1167.2007.01255.x

HSL12824
Hondeghem LM, De Clerck F, Camm J.
Short patent lives jeopardize drug and patient safety.
J Cardiovasc Pharmacol 2007 Oct;50(4):353-7
Link to source with long URL

HSL12828
Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA.
Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).
Med Care 2007 Oct;45(10)
Link to source with long URL

HSL12829
Crystal S, Akincigil A, Bilder S, Walkup JT.
Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies.
Med Care 2007 Oct;45(10)
Link to source with long URL

HSL12859
Oppenheimer J, Aaronson D.
Impact of recent black box warnings in the allergy world.
Ann Allergy Asthma Immunol 2007 Oct;99(4):364-6
Link to source with long URL

HSL12908
Giraldi A, Kristensen E.
Medical solutions have improved the treatment of sexological problems and created more demand for sexological care.
J Sex Marital Ther 2007 Oct-Dec;33(5):433-7
http://www.informaworld.com/smpp/content?content=10.1080/00926230701477154

HSL12955
Barlow K.
Do we dare use the 'S' word?
Health Care Strateg Manage 2007 Oct;25(10):15-6
http://www.ncbi.nlm.nih.gov/pubmed/17983034

HSL12956
Szczypka G, Wakefield MA, Emery S, Terry-McElrath YM, Flay BR, Chaloupka FJ.
Working to make an image: an analysis of three Philip Morris corporate image media campaigns.
Tob Control 2007 Oct;16(5):344-50
http://tobaccocontrol.bmj.com/cgi/content/full/16/5/344

HSL12991
Naito S, Furuta S, Yoshida T, Kitada M, Fueki O, Unno T, Ohno Y, Onodera H, Kawamura N, Kurokawa M, Sagami F, Shinoda K, Nakazawa T, Yamazaki T.
Current opinion: safety evaluation of drug metabolites in development of pharmaceuticals.
J Toxicol Sci 2007 Oct;32(4):329-41
http://www.jstage.jst.go.jp/article/jts/32/4/32_329/_article

HSL12992
Rankin RC.
The high cost of free lunch.
Obstet Gynecol 2007 Oct;110(4):932
http://www.greenjournal.org/cgi/content/full/110/4/932

HSL12993
Randall DA.
The high cost of free lunch.
Obstet Gynecol 2007 Oct;110(4):932
http://www.greenjournal.org/cgi/content/full/110/4/932-a

HSL12994
Frohlich EP.
The high cost of free lunch.
Obstet Gynecol 2007 Oct;110(4):931
http://www.greenjournal.org/cgi/content/full/110/4/931

HSL12995
Campbell WA.
The high cost of free lunch.
Obstet Gynecol 2007 Oct;110(4):931-2
http://www.greenjournal.org/cgi/content/full/110/4/931-a

HSL13312
Galm U, Shen B.
Natural product drug discovery: the times have never been better.
Chem Biol 2007 Oct;14(10):1098-104
http://linkinghub.elsevier.com/retrieve/pii/S1074-5521(07)00332-8

HSL13390
Grieve AP.
25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel.
Pharm Stat 2007 Oct-Dec;6(4):261-81
Link to source with long URL

HSL13513
Latimer AE, Salovey P, Rothman AJ.
The effectiveness of gain-framed messages for encouraging disease prevention behavior: is all hope lost?
J Health Commun 2007 Oct-Nov;12(7):645-9
http://www.informaworld.com/smpp/content?content=10.1080/10810730701619695

HSL13514
O'Keefe DJ, Jensen JD.
The relative persuasiveness of gain-framed and loss-framed messages for encouraging disease prevention behaviors: a meta-analytic review.
J Health Commun 2007 Oct-Nov;12(7):623-44
http://www.informaworld.com/smpp/content?content=10.1080/10810730701615198

HSL13639
Mills S.
Re: The frequency and impact of restless legs syndrome in primary care.
Ir Med J 2007 Oct;100(9):606
http://www.ncbi.nlm.nih.gov/pubmed/18196890?dopt=Abstract

HSL13894
Anders TF.
The pharmaceutical industry, academic medicine, and the FDA.
J Child Adolesc Psychopharmacol 2007 Oct;17(5):727-30
http://www.liebertonline.com/doi/abs/10.1089/cap.2007.0093

HSL13982
Bonnemain B.
[Pharmaceutical and parapharmaceutical advertising of Annales vertes in 1927].
Rev Hist Pharm (Paris) 2007 Oct;55(355):307-28
http://www.ncbi.nlm.nih.gov/pubmed/18348495

HSL14121
Satyanarayana K, Srivastava S.
Poverty, health & intellectual property rights with special reference to India.
Indian J Med Res 2007 Oct;126(4):390-406
http://www.icmr.nic.in/ijmr/2007/october/1016.pdf

HSL15112
Chaudhry S, Chaudhry S, Chaudhry K.
Point of sale tobacco advertisements in India.
Indian J Cancer 2007 Oct-Dec;44(4):131-6
Link to source with long URL

HSL13109
Larsson DG, de Pedro C, Paxeus N.
Effluent from drug manufactures contains extremely high levels of pharmaceuticals.
J Hazard Mater 2007 Sep 30;148(3):751-5
Link to source with long URL

HSL12294
Briggs AH.
New methods of analysing cost effectiveness
BMJ 2007 Sep 29;335(7621):622
http://www.bmj.com/cgi/content/short/335/7621/622?etoc

HSL12295
Moynihan R.
Healthcare giant advertises to children in classrooms
BMJ 2007 Sep 29;335(7621):637
http://www.bmj.com/cgi/content/short/335/7621/637-b?etoc

HSL12296
Lilford RJ, Brown CA, Nicholl J
Use of process measures to monitor the quality of clinical practice
BMJ 2007 Sep 29;335(7621):648
http://www.bmj.com/cgi/content/short/335/7621/648?etoc

HSL12388
Wittkowsky AK.
Dietary supplements, herbs and oral anticoagulants: the nature of the evidence.
J Thromb Thrombolysis 2007 Sep 29:Epub ahead of print
http://www.springerlink.com/content/137351756p547148/

HSL12389
Price M, Cameron R, Butow P.
Communicating risk information: The influence of graphical display format on quantitative information perception-Accuracy, comprehension and preferences.
Patient Educ Couns 2007 Sep 28
Link to source with long URL

HSL12390
Magrini N, Formoso G, Marata AM, Capelli O, Maestri E, Voci C, Nonino F, Brunetti M, Paltrinieri B, Maltoni S, Magnano L, Bonacini MI, Daya L, Viani N.
Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy.
BMC Health Serv Res 2007 Sep 28;7(1):158
http://www.biomedcentral.com/1472-6963/7/158

HSL12273
Wang PS, Simon GE, Avorn J, Azocar F, Ludman EJ, McCulloch J, Petukhova MZ, Kessler RC.
Telephone Screening, Outreach, and Care Management for Depressed Workers and Impact on Clinical and Work Productivity Outcomes: A Randomized Controlled Trial
JAMA 2007 Sep 26;298(12):1401-1411
http://jama.ama-assn.org/cgi/content/full/298/12/1401

HSL12350
Kukla R.
How Do Patients Know?
Hastings Cent Rep. 2007 Sep 26;37(5):27-35
http://www.medscape.com/viewarticle/563286_1

HSL12391
Lee YC, Huang KH, Huang YT.
Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
Health Policy Plan 2007 Sep 26:epub ahead of print
http://heapol.oxfordjournals.org/cgi/content/abstract/czm035v1

HSL12267
Sismondo S.
Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?
PLoS Medicine 2007 Sep 25;4(9):e286
Link to source with long URL

HSL12268
Allan GM, Lexchin J, Wiebe N.
Physician Awareness of Drug Cost: A Systematic Review
PLoS Med 2007 Sep 25;4(9):e283
Link to source with long URL

HSL12317
Cassels A.
W is for Wilbert’s wee willy (which tends to go off prematurely)
CMAJ 2007 Sep 25;177(7):816
http://www.cmaj.ca/cgi/reprint/177/7/816

HSL14108
Lewis S.
The Power of Pills: Social, Ethical & Legal Issues in Drug Development, Marketing & Pricing - Edited by Jillian C. Cohen, Patricia Illingworth & Udo Schüklenk
Dev World Bioeth. 2007 Sep 25:Epub ahead of print
Link to source with long URL

HSL12203
Burnand A.
Misconceptions about PPRS
BMJ 2007 Sep 22;335(7620):578
http://www.bmj.com/cgi/content/short/335/7620/578?etoc

HSL12204
Iheanacho I.
Drug pricing: Author's reply
BMJ 2007 Sep 22;335(7620):578
http://www.bmj.com/cgi/content/short/335/7620/578-a?etoc

HSL12205
Messori A.
PPRS is not NICE
BMJ 2007 Sep 22;335(7620):578
http://www.bmj.com/cgi/content/short/335/7620/578-b?etoc

HSL12206
Lenzer J.
Advert for breast cancer gene test triggers inquiry
BMJ 2007 Sep 22;335(7620):579
http://www.bmj.com/cgi/content/short/335/7620/579-a?etoc

HSL12207
Spurgeon D.
Number of serious adverse events doubles in seven years in US
BMJ 2007 Sep 22;335(7620):585
http://www.bmj.com/cgi/content/short/335/7620/585-a?etoc

HSL12208
Kmietowicz Z.
NICE should have bigger role in guiding NHS, says report
BMJ 2007 Sep 22;335(7620):585
http://www.bmj.com/cgi/content/short/335/7620/585-b?etoc

HSL12209
Hawkes N.
Have charities been silenced by government gold?
BMJ 2007 Sep 22;335(7620):592
http://www.bmj.com/cgi/content/short/335/7620/592?etoc

HSL12165
Moynihan R.
How to disentangle doctors and drug companies
Open Medicine 2007 Sep 18;1(3):epub
http://www.openmedicine.ca/article/view/145/68

HSL12166
Kassirer JP.
Financial conflicts in the medical profession: an ongoing, unresolved problem
Open Medicine 2007 Sep 18;1(3):epub
http://www.openmedicine.ca/article/view/133/64

HSL12176
Gernburd P, Jadad AR.
Will Spam Overwhelm Our Defenses? Evaluating Offerings for Drugs and Natural Health Products
PLoS Medicine 2007 Sep 18;4(9):e274
Link to source with long URL

HSL12511
Downey JM, Cohen MV.
Bypassing big pharma.
Circulation 2007 Sep 18;116(12):1344-5
http://circ.ahajournals.org/cgi/content/full/116/12/1344

HSL12125
Editorial .
Doctors and medical statistics
The Lancet 2007 Sep 15;370(9591):910
Link to source with long URL

HSL12190
Bosch X.
Dealing with scientific misconduct
BMJ 2007 Sep 15;335(7619):524
http://www.bmj.com/cgi/content/short/335/7619/524?etoc

HSL12191
Magrini N, Font M.
Direct to consumer advertising of drugs in Europe
BMJ 2007 Sep 15;335(7619):526
http://www.bmj.com/cgi/content/short/335/7619/526?etoc

HSL12192
Tanne JH.
Number of bipolar disorder diagnoses leaps among US young people
BMJ 2007 Sep 15;335(7619):535
http://www.bmj.com/cgi/content/short/335/7619/535-a?etoc

HSL12193
Hunt N.
Alzheimer's Society replies to Iain Chalmers
BMJ 2007 Sep 15;335(7619):541
http://www.bmj.com/cgi/content/short/335/7619/541-a?etoc

HSL12194
Guthrie B, Inkster M, Fahey T.
Tackling therapeutic inertia: role of treatment data in quality indicators
BMJ 2007 Sep 15;335(7619):542
http://www.bmj.com/cgi/content/short/335/7619/542?etoc

HSL12212
Gumbs PD, Verschuren WM, Souverein PC, Mantel-Teeuwisse AK, de Wit GA, de Boer A, Klungel OH.
Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.
Br J Clin Pharmacol 2007 Sep 15:epub ahead of print
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2007.02958.x

HSL12270
Stobo J.
Do teachers push docs to overprescribe for ADHD?
National Review of Medicine 2007 Sep 15;4(15):epub
Link to source with long URL

HSL13645
Bonah C.
[The Stalinon scandal and its regulatory consequences, 1954-1959. Drug safety and therapeutic innovation in France fifty years back].
Rev Prat 2007 Sep 15;57(13):1501-5
http://www.ncbi.nlm.nih.gov/pubmed/18018550?dopt=Abstract

HSL12214
Luo X, Doherty J, Cappelleri JC, Frush K.
Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics.
Curr Med Res Opin 2007 Sep 12:epub ahead of print
Link to source with long URL

HSL13152
Carli P, Graffin B, Gisserot O, Landais C, Paris JF.
[Non-diseases: Another field for the specialist of internal medicine.]
Rev Med Interne 2007 Sep 12
Link to source with long URL

HSL12184
Moore TJ, Cohen MR, Furberg CD.
Serious Adverse Drug Events Reported to the Food and Drug Administration, 1998-2005
Arch Intern Med 2007 Sep 10;167(16):1752-1759
http://archinte.ama-assn.org/cgi/content/short/167/16/1752

HSL12119
Pirmohamed M, Atuah KN, Dodoo ANO, Winstanley P.
Pharmacovigilance in developing countries
BMJ 2007 Sep 8;335(7618):462
http://www.bmj.com/cgi/content/full/335/7618/462

HSL12124
Goldacre B.
Journalists: anything to declare?
BMJ 2007 Sep 8;335(7618):480
http://www.bmj.com/cgi/content/extract/335/7618/480

HSL12247
White C.
Cancer expert attacks drug company's funding of research paper.
BMJ 2007 Sep 8;335(7618):469
http://www.bmj.com/cgi/content/extract/335/7618/469-a

HSL12129
Read J.
Schizophrenia, drug companies and the internet.
Soc Sci Med 2007 Sep 7:Epub ahead of print
Link to source with long URL

HSL12302
Miller G.
Living in societies.The art of virtual persuasion
Science. 2007 Sep 7;317(5843):1343
http://www.sciencemag.org/cgi/content/full/317/5843/1343

HSL12094
Smith SW.
Sidelining Safety — The FDA's Inadequate Response to the IOM
NEJM 2007 Sep 6;357(10):960-963
http://content.nejm.org/cgi/content/full/357/10/960

HSL12120
Hébert PC, Stanbrook M.
Indication creep: physician beware
CMAJ 2007 Sep 6:epub ahead of print
http://www.cmaj.ca/cgi/rapidpdf/cmaj.071223

HSL12118
Windish DM, Huot SJ, Green ML.
Medicine Residents' Understanding of the Biostatistics and Results in the Medical Literature
JAMA. 2007 Sep 5;298(9):1010-1022
http://jama.ama-assn.org/cgi/content/abstract/298/9/1010

HSL12401
Boonyasai RT, Windish DM, Chakraborti C, Feldman LS, Rubin HR, Bass EB.
Effectiveness of teaching quality improvement to clinicians: a systematic review.
JAMA 2007 Sep 5;298(9):1023-37
http://jama.ama-assn.org/cgi/content/full/298/9/1023

HSL12195
Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, Meredith LS, Rubenstein LV.
The effect of adherence to practice guidelines on depression outcomes.
Ann Intern Med 2007 Sep 4;147(5):320-9
http://www.annals.org/cgi/content/abstract/147/5/320

HSL12075
Jackson TJ.
Health technology assessment in Australia: challenges ahead
MJA 2007 Sep 3;187(5):262-264
http://www.mja.com.au/public/issues/187_05_030907/jak10484_fm.html

HSL12076
Walley T.
Health technology assessment in England: assessment and appraisal
MJA 2007 Sep 3;187(5):283-285
http://www.mja.com.au/public/issues/187_05_030907/wal10714_fm.html

HSL12077
Hailey DM
Health technology assessment in Canada: diversity and evolution
MJA 2007 Sep 3;187(5):286-288
http://www.mja.com.au/public/issues/187_05_030907/hai10766_fm.html

HSL12078
Petherick ES, Villanueva EV, Dumville J, Bryan EJ, Dharmage S.
An evaluation of methods used in health technology assessments produced for the Medical Services Advisory Committee
MJA 2007 Sep 3;187(5):289-292
http://www.mja.com.au/public/issues/187_05_030907/pet10017_fm.html

HSL12079
Halasz G.
Medical professionalism: it is really under threat?
MJA 2007 Sep 3;187(5):318
http://www.mja.com.au/public/issues/187_05_030907/letters_030907_fm-5.html

HSL12080
Glasziou PP.
Publishing and reporting clinical trials
Med J Aust 2007 Sep 3;187(5):282
http://www.mja.com.au/public/bookroom/2007/glasziou/glasziou.html

HSL12451
Marchetti S, Schellens JH.
The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials.
Br J Cancer 2007 Sep 3;97(5):577-81
http://www.nature.com/bjc/journal/v97/n5/abs/6603925a.html

HSL12600
Vladeck DC.
The Difficult Case of Direct-to-Consumer Drug Advertising
41 Loyola Los Angeles Law Review (forthcoming 2008) 2007 Sep 3
Link to source with long URL

HSL12857
Kucinich D.
Get rid of the for-profits: Healthcare can no longer be a commodity for sale to those who can afford it
Mod Healthc 2007 Sep 3;37(35):40
Link to source with long URL

HSL12041
Butcher J.
The story of fenoterol
The Lancet 2007 Sep 1;370(9589):732
Link to source with long URL

HSL12042
Smith R.
Should we loosen the grip on drug companies?
BMJ 2007 Sep 1;335(7617):454
http://www.bmj.com/cgi/content/short/335/7617/454?etoc

HSL12009
Jones SC, Lynch M.
Non-advertising alcohol promotions in licensed premises: does the Code of Practice ensure responsible promotion of alcohol?
Drug Alcohol Rev 2007 Sep;26(5):477-85
http://www.informaworld.com/smpp/content?content=10.1080/09595230701494390

HSL12087
Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Arch Gen Psychiatry 2007 Sep;64(9):1032-1039
http://archpsyc.ama-assn.org/cgi/content/short/64/9/1032

HSL12105
An S.
Attitude Toward Direct-to-Consumer Advertising and Drug Inquiry Intention: The Moderating Role of Perceived Knowledge.
J Health Commun 2007 Sep;12(6):567-80
http://www.informaworld.com/smpp/content?content=10.1080/10810730701508633

HSL12127
Kallen A, Woloshin S, Shu J, Juhl E, Schwartz L.
Direct-to-consumer advertisements for HIV antiretroviral medications: a progress report.
Health Aff (Millwood) 2007 Sep-Oct;26(5):1392-8
http://content.healthaffairs.org/cgi/content/abstract/26/5/1392

HSL12169
Vitry A, Mintzes B, Lexchin J
Direct-to-consumer advertising policy in Australia: realism in whose interests?
Internal Medicine Journal 2007 Sep;37(9):665–666
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01447.x

HSL12170
Jordens CFC, Kerridge IH, Ankeny RA, MacKenzie FJ, McPhee J.
Reply
Internal Medicine Journal 2007 Sep;37(9):666-667
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01448.x

HSL12211
Seston EM, Ashcroft DM, Griffiths CE.
Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis.
Arch Dermatol 2007 Sep;143(9):1175-9
http://archderm.ama-assn.org/cgi/content/full/143/9/1175

HSL12251
Ozdemir C, Akdis CA.
Discontinued drugs in 2006: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.
Expert Opin Investig Drugs 2007 Sep;16(9):1327-44
http://www.expertopin.com/doi/abs/10.1517/13543784.16.9.1327

HSL12252
Feuerstein GZ, Ruffolo RR.
Discontinued drugs in 2006: cardiovascular drugs translational medicine perspective.
Expert Opin Investig Drugs 2007 Sep;16(9):1315-26
http://www.expertopin.com/doi/abs/10.1517/13543784.16.9.1315

HSL12283
Pena C, Bowsher K, Costello A, De Luca R, Doll S, Li K, Schroeder M, Stevens T.
An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
IEEE Trans Neural Syst Rehabil Eng 2007 Sep;15(3):421-4
Link to source with long URL

HSL12366
[No authors listed].
Take nutrition claims with a grain of salt. Dietary studies sponsored by the food industry are often biased
Sci Am. 2007 Sep;297(3):38, 40
Link to source with long URL

HSL12384
Ross CJ, Carleton B, Warn DG, Stenton SB, Rassekh SR, Hayden MR.
Genotypic Approaches to Therapy in Children: A National Active Surveillance Network (GATC) to Study the Pharmacogenomics of Severe Adverse Drug Reactions in Children.
Ann N Y Acad Sci 2007 Sep;1110:177-92
http://www.annalsnyas.org/cgi/content/abstract/1110/1/177

HSL12385
Korczyn AD.
Drug trials in dementia: challenging ethical dilemmas.
Curr Alzheimer Res 2007 Sep;4(4):468-72
Link to source with long URL

HSL12423
Castano Riera EJ, Oterino de la Fuente D, Rodriguez Rodrigueza RM.
[The advertising message of drugs advertisements in Spanish medical journals.]
Gac Sanit 2007 Sep-Oct;21(5):371-7
Link to source with long URL

HSL12449
Weaver DJ, Sorrells-Jones J.
The business case as a strategic tool for change.
J Nurs Adm 2007 Sep;37(9):414-9
Link to source with long URL

HSL12450
Taylor-Zapata P, Mattison DR.
Making progress for how medicines are used in children.
Arch Pediatr Adolesc Med 2007 Sep;161(9):916
http://archpedi.ama-assn.org/cgi/content/full/161/9/916

HSL12497
Oversteegen L, Rovini H, Belsey MJ.
Respiratory drug market dynamics.
Nat Rev Drug Discov 2007 Sep;6(9):695-6
Link to source with long URL

HSL12517
Mackie P, Sim F.
A question of rhetoric.
Public Health 2007 Sep;121(9):641-2
Link to source with long URL

HSL12614
Cohen-Kohler JC, Esmail LC.
Scientific misconduct, the pharmaceutical industry, and the tragedy of institutions.
Med Law 2007 Sep;26(3):431-46
Link to source with long URL

HSL12639
Schachter AD, Ramoni MF, Baio G, Roberts TG Jr, Finkelstein SN.
Economic evaluation of a Bayesian model to predict late-phase success of new chemical entities.
Value Health 2007 Sep-Oct;10(5):377-85
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4733.2007.00191.x

HSL12643
Capozzi JD.
Physician advertising: evaluation of a sample advertisement.
J Bone Joint Surg Am 2007 Sep;89(9):2089-91
http://www.ejbjs.org/cgi/content/full/89/9/2089

HSL12646
Mrayyan MT, Shishani K, Al-Faouri I.
Rate, causes and reporting of medication errors in Jordan: nurses' perspectives.
J Nurs Manag 2007 Sep;15(6):659-70
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2834.2007.00724.x

HSL12679
Lamarque V, Pletan Y.
[The Pharmaceutical Industry and the adverse effects of the drugs].
Ann Pharm Fr 2007 Sep;65(5):308-14
Link to source with long URL

HSL12680
Imbs JL, Welsch M.
[Clinical assessment of drug safety].
Ann Pharm Fr 2007 Sep;65(5):298-302
Link to source with long URL

HSL12707
Sikora K.
Cost to the NHS of Roche oncology treatments.
J R Soc Med 2007 Sep;100(9):396-7
http://www.jrsm.org/cgi/content/full/100/9/396-b

HSL12708
Miller GM, Stripp R.
A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown.
Leg Med (Tokyo) 2007 Sep;9(5):258-64
http://linkinghub.elsevier.com/retrieve/pii/S1344-6223(07)00057-0

HSL12853
Wilgenbus K, Hill R, Warrander A, Kakkar S, Steiness E, Wessel R.
What pharma wants.
Nat Biotechnol 2007 Sep;25(9):967-9
Link to source with long URL

HSL12855
Lexchin J.
The secret things belong unto the Lord our God: secrecy in the pharmaceutical arena.
Med Law 2007 Sep;26(3):417-30
Link to source with long URL

HSL12864
Brownback S.
Eliminating neglected diseases: impact of published paper.
Health Aff (Millwood) 2007 Sep-Oct;26(5):1509
http://content.healthaffairs.org/cgi/content/full/26/5/1509

HSL12867
Lowe JA 3rd, Jones P.
Biopharmaceuticals and the future of the pharmaceutical industry.
Curr Opin Drug Discov Devel 2007 Sep;10(5):513-4
Link to source with long URL

HSL12868
Landau WM.
Pertinacious prescription of practice paradigms: the ethical burden of coercive clinical guidelines.
Curr Neurol Neurosci Rep 2007 Sep;7(5):355-8
Link to source with long URL

HSL12869
Cohen H.
Protecting patients from harm: reduce the risks of high-alert drugs.
Nursing 2007 Sep;37(9):49-55
Link to source with long URL

HSL12902
Fowler C.
Contentious issue of funding and the pharmaceutical industry--should service user groups take the big pharma shilling, and and what are the costs if they do?
Ment Health Today 2007 Sep;:40
Link to source with long URL

HSL12903
Chen JT, Summers KH.
Pharmaceutical manufacturer prescription assistance programs: are they worth it?
J Manag Care Pharm 2007 Sep;13(7):611-3
http://www.amcp.org/data/jmcp/JMCPMaga_Sept%2007_611-613.pdf

HSL12905
Wick C, Egger M, Trelle S, Jüni P, Fey MF.
The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry.
Ann Oncol 2007 Sep;18(9):1580-2
http://annonc.oxfordjournals.org/cgi/content/full/18/9/1580

HSL12909
Volkers AC, Heerdink ER, van Dijk L.
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Pharmacoepidemiol Drug Saf 2007 Sep;16(9):1054-62
Link to source with long URL

HSL12910
Dean AJ, Hendy A, McGuire T.
Antidepressants in children and adolescents--changes in utilisation after safety warnings.
Pharmacoepidemiol Drug Saf 2007 Sep;16(9):1048-53
http://www3.interscience.wiley.com/cgi-bin/abstract/114210439/ABSTRACT

HSL12957
Klotz U.
The bridging function of clinical pharmacology.
Eur J Clin Pharmacol 2007 Sep;63(9):817-9
http://www.springerlink.com/content/y0h8406051668611/

HSL13083
Kale SA, Barkin RL.
Tactics of the physician-controlled counter--detail and the imminent risk of not changing pharma's detail relationship with physicians.
J Opioid Manag 2007 Sep-Oct;3(5):239-41
http://www.ncbi.nlm.nih.gov/pubmed/18181376

HSL13095
Goldsmith D, Kuhlmann M, Covic A.
Through the looking glass: the protein science of biosimilars.
Clin Exp Nephrol 2007 Sep;11(3):191-5
http://www.ncbi.nlm.nih.gov/pubmed/17891344

HSL13110
Holleman F, Gale EA.
Nice insulins, pity about the evidence.
Diabetologia 2007 Sep;50(9):1783-90
http://www.springerlink.com/content/qt85387u68h1x487/

HSL13111
Halban PA.
The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?
Diabetologia 2007 Sep;50(9):1791-4
http://www.springerlink.com/content/e247801475621302/

HSL13156
Schwartz LM, Woloshin S, Welch HG.
The drug facts box: providing consumers with simple tabular data on drug benefit and harm.
Med Decis Making 2007 Sep-Oct;27(5):655-62
http://mdm.sagepub.com/cgi/reprint/27/5/655

HSL13206
Solomon LM, Sieczkiewicz GJ.
Impact of the US Patent System on the promise of personalized medicine.
Gend Med 2007 Sep;4(3):187-92
Link to source with long URL

HSL13295
Massol J, Puech A, Boissel JP.
How to anticipate the assessment of the public health benefit of new medicines?
Therapie 2007 Sep-Oct;62(5):427-35
Link to source with long URL

HSL13313
Brieger WR, Salami KK, Oshiname FO.
Perceptions of drug color among drug sellers and consumers in rural southwestern Nigeria.
Res Social Adm Pharm 2007 Sep;3(3):303-19
http://www.ncbi.nlm.nih.gov/pubmed/17945160

HSL13378
Wolf MS, Bailey SC.
Improving prescription drug labeling.
N C Med J 2007 Sep-Oct;68(5):340-2
http://www.ncbi.nlm.nih.gov/pubmed/18183755?dopt=Abstract

HSL13466
Van Way CW 3rd.
The new relationship between physicians & industry.
Mo Med 2007 Sep-Oct;104(5):375-7
http://www.ncbi.nlm.nih.gov/pubmed/18018517

HSL13759
Jacob R.
It is time to wash the linen.
Natl Med J India 2007 Sep-Oct;20(5):272
http://www.ncbi.nlm.nih.gov/pubmed/18254532

HSL13765
Sevillano D, Ramos C.
[The birth of the greatest invention of the 20th century].
Rev Esp Quimioter 2007 Sep;20(3):354-8
http://www.ncbi.nlm.nih.gov/pubmed/18080034

HSL14238
Akande TM, Aderibigbe SA.
Influence of drug promotion on prescribing habits of doctors in a teaching hospital.
Afr J Med Med Sci. 2007 Sep;36(3):207-11

HSL15623
Borges de Melo E, Teixeira JJ, Mânica GC.
[Description of attempts to obtain approval for selling medications at ordinary Brazilian establishments after the introduction of the Real Economic Stabilization Plan].
Cien Saude Colet. 2007 Sep-Oct;12(5):1333-9
Link to source with long URL

HSL12026
Nahin RL, Dahlhamer JM, Taylor BL, Barnes , Stussman BJ, Simile CM, Blackman MR, Chesney MA, Jackson M, Miller H, McFann KK.
Health behaviors and risk factors in those who use complementary and alternative medicine
BMC Public Health 2007 Aug 27;7:217
http://www.biomedcentral.com/1471-2458/7/217/abstract

HSL12360
Gornall J.
Hyperactivity in children: the Gillberg affair
BMJ 2007 Aug 25;335(7616):370
http://www.bmj.com/cgi/content/short/335/7616/370?etoc

HSL12361
Burton B.
Australian drugs regulator cancels registration of COX 2 inhibitor
BMJ 2007 Aug 25;335(7616):363
http://www.bmj.com/cgi/content/short/335/7616/363-a?etoc

HSL12362
Chalmers I.
The Alzheimer's Society, drug manufacturers, and public trust
BMJ 2007 Aug 25;335(7616):400
http://www.bmj.com/cgi/content/short/335/7616/400?etoc

HSL12136
Ridley-Smith RM.
A tough market.
N Z Med J 2007 Aug 24;120(1260):U2699
Link to source with long URL

HSL12137
Metcalfe S, Evans J.
PHARMAC responds on Herceptin assumptions and decisions.
N Z Med J 2007 Aug 24;120(1260):U2692
Link to source with long URL

HSL12025
Aven T, Eidesen K.
A predictive Bayesian approach to risk analysis in health care
BMC Medical Research Methodology 2007 Aug 23;7:38
http://www.biomedcentral.com/1471-2288/7/38/abstract

HSL11943
Menkes DB, Jureidini JN, Mansfield PR.
Skepticism about antidepressants for under 18s
BMJ Rapid Response 2007 Aug 22:epub
http://www.bmj.com/cgi/eletters/335/7615/329#175023

HSL12001
Flicker L, Almeida OP.
Commentary.
Int Psychogeriatr 2007 Aug 22;:12-18
Link to source with long URL

HSL12002
Bhattacharyya S, Burns A.
Is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive? - No.
Int Psychogeriatr 2007 Aug 22;:8-12
Link to source with long URL

HSL12003
Shah AA, Finucane TE.
Yes, industry influence is excessive.
Int Psychogeriatr 2007 Aug 22;:2-8
Link to source with long URL

HSL12004
Ames D.
For Debate: Is The Influence Of The Pharmaceutical Industry On Prescribing, Research And Publication In The Field Of Psychogeriatrics Excessive?
Int Psychogeriatr 2007 Aug 22:1 - Epub ahead of print
Link to source with long URL

HSL12005
de Bakker DH, Coffie DS, Heerdink ER, van Dijk L, Groenewegen PP.
Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis.
BMC Health Serv Res 2007 Aug 22;7(1):132
http://www.biomedcentral.com/1472-6963/7/132

HSL12047
Hampton T.
Postmarket 'pharmacovigilance' program on alert for adverse events from drugs.
JAMA 2007 Aug 22;298(8):851-2
http://jama.ama-assn.org/cgi/content/extract/298/8/851

HSL12363
Forslund L.
[Variable products information is a problem].
Lakartidningen 2007 Aug 22-28;104(34):2360
Link to source with long URL

HSL12007
Layton MR, Sritanyarat W, Chadbunchachai S, Wertheimer AI.
Sources of information for new drugs among physicians in Thailand.
Pharm World Sci 2007 Aug 21:epub ahead of print
http://www.springerlink.com/content/p224j6xmg11w64x2/

HSL12138
Katz D.
Literacy and misunderstanding prescription drug labels.
Ann Intern Med 2007 Aug 21;147(4):281
http://www.annals.org/cgi/content/full/147/4/281

HSL12139
Jawaid A.
Literacy and misunderstanding prescription drug labels.
Ann Intern Med 2007 Aug 21;147(4):280
http://www.annals.org/cgi/content/full/147/4/280

HSL12140
Wheby MS.
Literacy and misunderstanding prescription drug labels.
Ann Intern Med 2007 Aug 21;147(4):280
http://www.annals.org/cgi/content/full/147/4/280-a

HSL12141
Parker CT.
Literacy and misunderstanding prescription drug labels.
Ann Intern Med 2007 Aug 21;147(4):280-1
http://www.annals.org/cgi/content/full/147/4/280-b

HSL11960
Hampson LA, Joffe S, Fowler R, Verter J, Emanuel EJ.
Frequency, Type, and Monetary Value of Financial Conflicts of Interest in Cancer Clinical Research
Journal of Clinical Oncology 2007 Aug 20;25(24):3609-3614
http://jco.ascopubs.org/cgi/content/full/25/24/3609

HSL12021
Pearson S-A, Ringland CL, Ward RL.
Trastuzumab and Metastatic Breast Cancer: Trastuzumab Use in Australia—Monitoring the Effect of an Expensive Medicine Access Program
Journal of Clinical Oncology 2007 Aug 20;25(24):3688-3693
http://jco.ascopubs.org/cgi/content/abstract/25/24/3688

HSL11931
Avery AJ, James V.
Developing nurse prescribing in the UK
BMJ 2007 Aug 18;335(7615):316
http://www.bmj.com/cgi/content/full/335/7615/316

HSL11947
Dyer O.
High Court upholds NICE decision to limit treatments for Alzheimer's disease
BMJ 2007 Aug 18;335(7615):319
http://www.bmj.com/cgi/content/full/335/7615/319

HSL11948
White C.
NICE delays decision on drugs for macular degeneration
BMJ 2007 Aug 18;335(7615):319
http://www.bmj.com/cgi/content/full/335/7615/319-a

HSL11949
Tanne JH.
FDA needs more funding, NEJM says, amid questions about antidiabetes drug
BMJ 2007 Aug 18;335(7615):322
http://www.bmj.com/cgi/content/full/335/7615/322

HSL11950
Parker G.
Head to head: Is depression overdiagnosed? Yes
BMJ 2007 Aug 18;335(7615):328
http://www.bmj.com/cgi/content/full/335/7615/328

HSL11951
Hickie I.
Head to head: Is depression overdiagnosed? No
BMJ 2007 Aug 18;335(7615):329
http://www.bmj.com/cgi/content/full/335/7615/329

HSL11952
Todres M, Stephenson A, Jones R.
Medical education research remains the poor relation
BMJ 2007 Aug 18;335(7615):333
http://www.bmj.com/cgi/content/full/335/7615/333

HSL11903
Donohue JM, Cevasco M, Rosenthal MB.
A Decade of Direct-to-Consumer Advertising of Prescription Drugs
NEJM 2007 Aug 16;357(7):673-681
http://content.nejm.org/cgi/content/full/357/7/673?query=TOC

HSL11911
Avorn J.
Keeping Science on Top in Drug Evaluation
NEJM 2007 Aug 16;357(7):633-635
http://content.nejm.org/cgi/content/full/357/7/633

HSL11993
Check E.
Transparency urged over research payments
Nature 2007 Aug 16;448(7155):738
http://www.nature.com/nature/journal/v448/n7155/index.html

HSL12513
Evans O.
Victory for NICE as High Court rejects drugs firm complaints.
Health Serv J 2007 Aug 16;117(6069):5
Link to source with long URL

HSL11918
Ashker S, Burkiewicz JS.
Pharmacy residents' attitudes toward pharmaceutical industry promotion.
Am J Health Syst Pharm 2007 Aug 15;64(16):1724-31
http://www.ajhp.org/cgi/content/full/64/16/1724

HSL12564
Piascik P, Bernard D, Madhavan S, Sorensen TD, Stoner SC, TenHoeve T.
Gifts and corporate influence in doctor of pharmacy education.
Am J Pharm Educ 2007 Aug 15;71(4):68
Link to source with long URL

HSL16609
Rodwin MA.
Medical Commerce, Physician Entrepreneurialism, and Conflicts of Interest
Cambridge Quarterly of Healthcare Ethics 2007 Aug 15;16:387-397
Link to source with long URL

HSL12010
Montgomery AT, Kalvemark-Sporrong S, Henning M, Tully MP, Kettis-Lindblad A.
Implementation of a pharmaceutical care service: prescriptionists', pharmacists' and doctors' views.
Pharm World Sci 2007 Aug 14:epub ahead of print
http://www.springerlink.com/content/t799k745372221h5/

HSL12142
Ogbogu U.
Canada's approach to conflict- of-interest oversight.
CMAJ 2007 Aug 14;177(4):375-6
http://www.cmaj.ca/cgi/content/full/177/4/375-b

HSL11843
Timmins N.
Government pushes ahead with plan for cheaper drugs deal for NHS
BMJ 2007 Aug 11;335(7614):273
http://www.bmj.com/cgi/content/full/335/7614/273

HSL11844
Mudur G.
Court dismisses Novartis challenge to Indian patent law
BMJ 2007 Aug 11;335(7614):273
http://www.bmj.com/cgi/content/full/335/7614/273-a

HSL11845
Mangin D, Sweeney K, Heath I.
Preventive health care in elderly people needs rethinking
BMJ 2007 Aug 11;335(7614):285
http://www.bmj.com/cgi/content/full/335/7614/285

HSL11917
Gray SW, Hlubocky FJ, Ratain MJ, Daugherty CK.
Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
J Clin Oncol 2007 Aug 10;25(23):3488-94
http://jco.ascopubs.org/cgi/content/full/25/23/3488

HSL12059
Ratain MJ, Cohen EE.
The value meal: how to save $1,700 per month or more on lapatinib.
J Clin Oncol 2007 Aug 10;25(23):3397-8
http://jco.ascopubs.org/cgi/content/full/25/23/3397

HSL12012
Lyra DP Jr, Rocha CE, Abriata JP, Gimenes FR, Gonzalez MM, Pela IR.
Influence of Pharmaceutical Care intervention and communication skills on the improvement of pharmacotherapeutic outcomes with elderly Brazilian outpatients.
Patient Educ Couns 2007 Aug 8:epub ahead of print
Link to source with long URL

HSL12031
Rosen CJ.
The Rosiglitazone Story -- Lessons from an FDA Advisory Committee Meeting.
N Engl J Med 2007 Aug 8
http://content.nejm.org/cgi/content/full/357/9/844?query=TOC

HSL11804
McAlister FA, van Diepen S, Padwal RS, Johnson JA, Majumdar SR.
How Evidence-Based Are the Recommendations in Evidence-Based Guidelines?
PLoS Medicine 2007 Aug 7;4(8):e250
Link to source with long URL

HSL11805
Montori VM, Breslin M, Maleska M, Weymiller AJ.
Creating a Conversation: Insights from the Development of a Decision Aid
PLoS Medicine 2007 Aug 7;4(8):e233
Link to source with long URL

HSL11762
Mikhail SS, Zwar NA, Vagholkar S, Dennis SM, Day RO.
Non-steroidal anti-inflammatory drugs in general practice: a decision-making dilemma
MJA 2007 Aug 6;187(3):160-163
http://www.mja.com.au/public/issues/187_03_060807/mik11253_fm.html

HSL11763
McLean R, Richards BH, Wardman JI.
The effect of Web 2.0 on the future of medical practice and education: Darwikinian evolution or folksonomic revolution?
MJA 2007 Aug 6;187(3): 174-177
http://www.mja.com.au/public/issues/187_03_060807/mcl10181_fm.html

HSL11756
Goodyer IM.
Depression in adolescents: Author's reply
BMJ 2007 Aug 4;335(7613):221
http://www.bmj.com/cgi/content/full/335/7613/221-a

HSL11831
Winther FO, Hole OP, Nitter-Hauge S.
An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
Eur J Clin Pharmacol 2007 Aug 3
http://www.springerlink.com/content/5525671542064288/

HSL12424
Glover GJ.
The influence of market exclusivity on drug availability and medical innovations.
AAPS J 2007 Aug 3;9(3):E312-6
Link to source with long URL

HSL12728
Kesselheim AS.
Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system.
AAPS J 2007 Aug 3;9(3):E306-11
http://www.aapsj.org/view.asp?art=aapsj0903033

HSL16083
Eccles MP, Grimshaw JM, Johnston M, Steen N, Pitts NB, Thomas R, Glidewell E, Maclennan G, Bonetti D, Walker A.
Applying psychological theories to evidence-based clinical practice: Identifying factors predictive of managing upper respiratory tract infections without antibiotics.
Implement Sci 2007 Aug 3;2:26
http://www.implementationscience.com/content/2/1/26

HSL11832
Stover EL, Brady L, Marder SR.
New Paradigms for Treatment Development.
Schizophr Bull 2007 Aug 2
http://schizophreniabulletin.oxfordjournals.org/cgi/content/full/sbm085v1

HSL11864
Grande D.
A national survey of physician-industry relationships.
N Engl J Med 2007 Aug 2;357(5):507-8
Link to source with long URL

HSL11865
Gorske AL.
A national survey of physician-industry relationships.
N Engl J Med 2007 Aug 2;357(5):508
Link to source with long URL

HSL11866
Sade RM.
A national survey of physician-industry relationships.
N Engl J Med 2007 Aug 2;357(5):507
Link to source with long URL

HSL11742
Lippman A, Melnychuk R, Shimmin C, Boscoe M.
Human papillomavirus, vaccines and women's health: questions and cautions
CMAJ 2007 Aug 1:epub ahead of print
http://www.cmaj.ca/cgi/rapidpdf/cmaj.070944v1

HSL11966
Miller JD.
Study affirms PhRMA's influence on physicians.
J Natl Cancer Inst 2007 Aug 1;99(15):1148-50
http://jnci.oxfordjournals.org/cgi/content/extract/99/15/1148

HSL7614
Ashmore R, Carver N, Banks D.
Mental health nursing students' relationships with the pharmaceutical industry.
Nurse Educ Today 2006 Aug;27(6):551-60. Epub 2006 Nov 20
http://linkinghub.elsevier.com/retrieve/pii/S0260-6917(06)00146-8

HSL11216
Schneeweiss S.
Developments in Post-marketing Comparative Effectiveness Research.
Clin Pharmacol Ther 2007 Aug;82(2):143-56
Link to source with long URL

HSL11656
Mathis LL, Iyasu S.
Safety Monitoring of Drugs Granted Exclusivity Under the Best Pharmaceuticals for Children Act: What the FDA has Learned.
Clin Pharmacol Ther 2007 Aug;82(2):133-4
Link to source with long URL

HSL11753
Dowden JS.
A century of concern about complementary medicines
Aust Prescr 2007 Aug;30(4):91
http://www.australianprescriber.com/magazine/30/4/artid/896/

HSL11774
Kahn J.
Race in a Bottle
Scientific American 2007 Aug
Link to source with long URL

HSL11779
[No authors listed].
Celebrex: new ad, with questionable claims.
Consum Rep 2007 Aug;72(8):52-3
Link to source with long URL

HSL11790
Williams HC.
Full disclosure--nothing less will do.
J Invest Dermatol 2007 Aug;127(8):1831-3
Link to source with long URL

HSL11826
van Driel ML, Vander Stichele R, De Maeseneer J, De Sutter A, Christiaens T.
Medical evidence and health policy: a marriage of convenience? The case of proton pump inhibitors.
J Eval Clin Pract. 2007 Aug;13(4):674-80
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2007.00829.x

HSL11827
Shuval K, Berkovits E, Netzer D, Hekselman I, Linn S, Brezis M, Reis S.
Evaluating the impact of an evidence-based medicine educational intervention on primary care doctors' attitudes, knowledge and clinical behaviour: a controlled trial and before and after study.
J Eval Clin Pract 2007 Aug;13(4):581-98
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2007.00859.x

HSL11932
Spurling G, Mansfield P.
General practitioners and pharmaceutical sales representatives: quality improvement research.
Qual Saf Health Care 2007 Aug;16(4):266-70
http://qshc.bmj.com/cgi/content/full/16/4/266

HSL11937
McGee G.
How Much Should Gardasil Cost?
The Scientist 2007 Aug;21(8):26
http://www.the-scientist.com/article/home/53410/

HSL11963
[No authors listed].
Putting 'sleepdriving' and new safety warning in perspective.
Johns Hopkins Med Lett Health After 50. 2007 Aug;19(6):1-2
Link to source with long URL

HSL11975
Gilpin EA, White MM, Messer K, Pierce JP.
Receptivity to tobacco advertising and promotions among young adolescents as a predictor of established smoking in young adulthood.
Am J Public Health 2007 Aug;97(8):1489-95
http://www.ajph.org/cgi/content/abstract/97/8/1489

HSL11976
Ling PM, Neilands TB, Glantz SA.
The effect of support for action against the tobacco industry on smoking among young adults.
Am J Public Health 2007 Aug;97(8):1449-56
http://www.ajph.org/cgi/content/abstract/97/8/1449

HSL12011
Tonelli MR.
Conflict of interest in clinical practice.
Chest 2007 Aug;132(2):664-70
http://www.chestjournal.org/cgi/content/abstract/132/2/664

HSL12051
Morrow DG, Weiner M, Steinley D, Young J, Murray MD.
Patients' health literacy and experience with instructions: influence preferences for heart failure medication instructions.
J Aging Health 2007 Aug;19(4):575-93
http://jah.sagepub.com/cgi/content/abstract/19/4/575

HSL12052
Dore DD, Zierler S.
Over-reliance on patient information sheets.
Am J Med 2007 Aug;120(8):e3
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(06)00910-7

HSL12062
Brinol P, Horcajo J, Diaz D, Valle C, Becerra A, de Miguel J.
[The impact of training on interpersonal influence].
Psicothema 2007 Aug;19(3):401-5
Link to source with long URL

HSL12107
Morrow DG, Weiner M, Steinley D, Young J, Murray MD.
Patients' health literacy and experience with instructions: influence preferences for heart failure medication instructions.
J Aging Health 2007 Aug;19(4):575-93
http://jah.sagepub.com/cgi/content/abstract/19/4/575

HSL12132
Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N.
Novel statistical tools for monitoring the safety of marketed drugs.
Clin Pharmacol Ther 2007 Aug;82(2):157-66
Link to source with long URL

HSL12133
Lehman HP, Chen J, Gould AL, Kassekert R, Beninger PR, Carney R, Goldberg M, Goss MA, Kidos K, Sharrar RG, Shields K, Sweet A, Wiholm BE, Honig PK.
An evaluation of computer-aided disproportionality analysis for post-marketing signal detection.
Clin Pharmacol Ther 2007 Aug;82(2):173-80
http://www.nature.com/clpt/journal/v82/n2/abs/6100233a.html

HSL12144
Romano TJ.
Divergent views on managing clinical conflicts of interest.
Mayo Clin Proc 2007 Aug;82(8):1014
http://www.mayoclinicproceedings.com/inside.asp?AID=4452

HSL12145
Epstein RA.
The pharmaceutical industry at risk: how excessive government regulation stifles innovation.
Clin Pharmacol Ther 2007 Aug;82(2):131-2
http://www.nature.com/clpt/journal/v82/n2/abs/6100257a.html

HSL12219
Finch R.
Innovation - drugs and diagnostics.
J Antimicrob Chemother 2007 Aug;60
http://jac.oxfordjournals.org/cgi/content/full/60/suppl_1/i79

HSL12235
Abraham J.
Building on Sociological Understandings of the Pharmaceutical Industry or Reinventing the Wheel? Response to Joan Busfield's `Pills, Power, People'
Sociology 2007 Aug;41(4):727 - 736
http://soc.sagepub.com/cgi/reprint/41/4/727

HSL12288
Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ.
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
Am J Psychiatry 2007 Aug;164(8):1198-205
http://ajp.psychiatryonline.org/cgi/content/full/164/8/1198

HSL12301
Rollin BE.
An ethicist's commentary on avoiding impropriety in corporate sponsorship of conferences and journals.
Can Vet J 2007 Aug;48(8):792
Link to source with long URL

HSL12303
Hughes B.
Transatlantic regulatory cooperation expanded.
Nat Rev Drug Discov 2007 Aug;6(8):589-90
Link to source with long URL

HSL12305
Klugman CM.
Buying the fourth estate.
Am J Bioeth 2007 Aug;7(8):16-8
http://www.informaworld.com/smpp/content?content=10.1080/15265160701462269

HSL12313
Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, Quaranta R, Dell'Erba AS.
Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
Pharm World Sci 2007 Aug;29(4):361-7
http://www.springerlink.com/content/3p67961682r882w3/

HSL12367
Kelly B, King L, Bauman A, Smith BJ, Flood V.
The effects of different regulation systems on television food advertising to children.
Aust N Z J Public Health 2007 Aug;31(4):340-3
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1753-6405.2007.00083.x

HSL12370
Tormala ZL, Falces C, Brinol P, Petty RE.
Ease of retrieval effects in social judgment: the role of unrequested cognitions.
J Pers Soc Psychol 2007 Aug;93(2):143-57
http://content.apa.org/journals/psp/93/2/143

HSL12393
Kalisch LM, Roughead EE, Gilbert AL.
Pharmaceutical brand substitution in Australia--are there multiple switches per prescription?
Aust N Z J Public Health 2007 Aug;31(4):348-52
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1753-6405.2007.00085.x

HSL12405
Grimmsmann T, Schwabe U, Himmel W.
The influence of hospitalisation on drug prescription in primary care - a large-scale follow-up study.
Eur J Clin Pharmacol 2007 Aug;63(8):783-90
http://www.springerlink.com/content/t68066m613576461/

HSL12407
Collins JJ, Bukowski JA, Weed DL, Brent RL, Klein P, Boerstoel-Streefland M, Sprafka JM, Williams AL, Holsapple MP.
Evaluating emerging issues in epidemiology.
Regul Toxicol Pharmacol 2007 Aug;48(3):296-307
Link to source with long URL

HSL12452
Newland J.
Direct-to-consumer ads impact practice.
Nurse Pract 2007 Aug;32(8):5
Link to source with long URL

HSL12457
Forman SF, Woods ER.
Human papilloma virus vaccine: a new frontier or political controversy?
Curr Opin Pediatr 2007 Aug;19(4):387-8
Link to source with long URL

HSL12463
Chung EP, Hwang HJ, Kim MK.
Evaluation of non-English dietary supplement advertisements in an ethnic minority community in America.
Public Health Nutr 2007 Aug;10(8):834-7
Link to source with long URL

HSL12499
Sun SX, Lee KY, Bertram CT, Goldstein JL.
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization.
Curr Med Res Opin 2007 Aug;23(8):1859-66
Link to source with long URL

HSL12514
Cyranoski D.
Executed Chinese drug czar corrupted by system, observers say.
Nat Med 2007 Aug;13(8):889
Link to source with long URL

HSL12515
Hopkinson JM.
Response to 'Is breast really best? Risk and total motherhood in the National Breastfeeding Awareness Campaign'.
J Health Polit Policy Law. 2007 Aug;32(4):637-48
http://jhppl.dukejournals.org/cgi/reprint/32/4/637?view=long&pmid=17639014

HSL12516
Wolf JB.
Is breast really best? Risk and total motherhood in the National Breastfeeding Awareness Campaign
J Health Polit Policy Law. 2007 Aug;32(4):595-636
http://jhppl.dukejournals.org/cgi/reprint/32/4/595?view=long&pmid=17639013

HSL12617
Messerly W, Ruoff K.
Put your office in the driver's seat. Eight steps to streamline sales rep support
MGMA Connex. 2007 Aug;7(7):27-8
Link to source with long URL

HSL12640
[No authors listed].
Compensation monitor. Psychiatrists paid well by drugmakers
Manag Care. 2007 Aug;16(8):17
Link to source with long URL

HSL12642
Jaffre Y.
[When health makes the headlines. Press, elite complicities and health globalisation in Bamako, Mali]
Bull Soc Pathol Exot 2007 Aug;100(3):207-15
Link to source with long URL

HSL12701
Parker A, Dagnall N.
Effects of retrieval practice on consumer memory for brand attributes.
Psychol Rep 2007 Aug;101(1):311-8
Link to source with long URL

HSL12730
Kessel M, Frank F.
A better prescription for drug-development financing.
Nat Biotechnol 2007 Aug;25(8):859-66
Link to source with long URL

HSL12904
Barkin J.
Clinical trials: benefit or danger to the patient?
Can J Urol 2007 Aug;14(4):3660-1
Link to source with long URL

HSL12907
Campbell JM, Edwards MS, Horswill MS, Helman S.
Effects of contextual cues in recall and recognition memory: the misinformation effect reconsidered.
Br J Psychol 2007 Aug;98(Pt)
Link to source with long URL

HSL12911
Dear JW, Webb DJ.
Disease mongering -- a challenge for everyone involved in healthcare.
Br J Clin Pharmacol 2007 Aug;64(2):122-4
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2006.02830.x

HSL12975
Mao AR, Findling RL.
Growing evidence to support early intervention in early onset bipolar disorder.
Aust N Z J Psychiatry 2007 Aug;41(8):633-6
http://www.informaworld.com/smpp/content?content=10.1080/00048670701451985

HSL12997
Durrieu G, Hurault C, Bongard V, Damase-Michel C, Montastruc JL.
Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course.
Br J Clin Pharmacol 2007 Aug;64(2):233-6
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2007.02882.x

HSL13096
Borer JS, Pouleur H, Abadie E, Follath F, Wittes J, Pfeffer MA, Pitt B, Zannad F.
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
Eur Heart J 2007 Aug;28(15):1904-9
http://www.ncbi.nlm.nih.gov/pubmed/17615083

HSL13207
Tweed S.
Five levels of persuasion.
Caring 2007 Aug;26(8):62
http://www.ncbi.nlm.nih.gov/pubmed/17966311

HSL13444
Pearce N.
Commentary: The rise and rise of corporate epidemiology and the narrowing of epidemiology's vision.
Int J Epidemiol 2007 Aug;36(4):713-7
http://ije.oxfordjournals.org/cgi/content/full/36/4/713

HSL13470
Lim RR.
Model competencies in regulatory therapeutic product assessment: Health Canada's good review guiding principles as a reviewing community's code of intellectual conduct.
Pharmacoepidemiol Drug Saf 2007 Aug;16(8):933-41
Link to source with long URL

HSL13651
Ashmore R, Carver N, Banks D.
Mental health nursing students’ relationships with the pharmaceutical industry
Nurse Education Today 2007 Aug;27(6):551–560
Link to source with long URL

HSL14618
Outterson K, Samora JB, Keller-Cuda K.
Will longer antimicrobial patents improve global public health?
Lancet Infect Dis 2007 Aug;7(8):559-66
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(07)70188-3

HSL11776
Esmail LC.
Reforming Canada's Access to Medicines Regime.
CMAJ 2007 Jul 31;177(3):270
Link to source with long URL

HSL11777
Elliott R.
Reforming Canada's Access to Medicines Regime.
CMAJ 2007 Jul 31;177(3):270-1
Link to source with long URL

HSL11672
Biles D, Howlett P, Hughes R.
Journals and drug advertising: Medical schools, take the lead
BMJ 2007 Jul 28;335(7612):172
http://www.bmj.com/cgi/content/full/335/7612/172-a

HSL11673
Vlassov V
Journals and drug advertising: Beware advertising packages
BMJ 2007 Jul 28;335(7612):172
http://www.bmj.com/cgi/content/short/335/7612/172-b?etoc

HSL11746
Light DW.
Is G8 putting profits before the world's poorest children?
The Lancet 2007 Jul 28;370(9584):297-298
Link to source with long URL

HSL11867
Van Duppen D, Avonts M.
The cost of the newest cancer drugs.
Lancet 2007 Jul 28;370(9584):317-8
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(07)61158-1

HSL11964
Kaiser J.
Conflict of interest. Stung by controversy, biomedical groups urge consistent guidelines
Science 2007 July 27;317(5837):441
http://www.sciencemag.org/cgi/content/summary/317/5837/441a

HSL12253
Rozet E, Ceccato A, Hubert C, Ziemons E, Oprean R, Rudaz S, Boulanger B, Hubert P.
Analysis of recent pharmaceutical regulatory documents on analytical method validation.
J Chromatogr A 2007 Jul 27;1158(1-2):111-25
Link to source with long URL

HSL12053
Check E.
California campuses resist industry restrictions.
Nature 2007 Jul 26;448(7152):394-5
http://www.nature.com/doifinder/10.1038/448394b

HSL12054
[No authors listed] .
California dreaming.
Nature. 2007 July 26;448(7152):388
http://www.nature.com/doifinder/10.1038/448388a

HSL11709
Shrank WH, Stedman M, Ettner SL, Delapp D, Dirstine J, Brookhart MA, Fischer MA, Avorn J, Asch SM.
Patient, Physician, Pharmacy, and Pharmacy Benefit Design Factors Related to Generic Medication Use.
J Gen Intern Med 2007 Jul 24
Link to source with long URL

HSL12056
Rahman SZ, Khan RA, Gupta V, Uddin M.
Pharmacoenvironmentology--a component of pharmacovigilance.
Environ Health 2007 Jul 24;6:20
http://www.ehjournal.net/content/6/1/20

HSL11676
Editorial .
Macular degeneration, patients' groups, and pharma
The Lancet 2007 Jul 21;370(9583):194
Link to source with long URL

HSL11696
Jack A.
Drug pricing: No cure, no cost.
BMJ 2007 Jul 21;335(7611):122-3
http://www.bmj.com/cgi/content/full/335/7611/122

HSL11697
Dyer C.
Doctor ordered to pay 300,000 pounds sterling in libel damages.
BMJ 2007 Jul 21;335(7611):119
http://www.bmj.com/cgi/content/full/335/7611/119

HSL11798
Iheanacho I.
Drugs, tales, and other stories: Dunno, mate
BMJ 2007 Jul 21;335(7611):160
http://www.bmj.com/cgi/content/full/335/7611/160-a

HSL11477
Epstein H.
Getting away with murder.
New York Rev Books 2007 Jul 19;54(12):38-40
http://www.nybooks.com/articles/article-preview?article_id=20396

HSL11970
Finkelstein J.
FDA user fee law poised for passage in Congress but not without stirring up controversy.
J Natl Cancer Inst 2007 Jul 18;99(14):1072-3
http://jnci.oxfordjournals.org/cgi/content/extract/99/14/1072

HSL12014
Kavanaugh CJ, Trumbo PR, Ellwood KC.
The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer.
J Natl Cancer Inst. 2007 July 18;99(14):1074-85
http://jnci.oxfordjournals.org/cgi/content/abstract/99/14/1074

HSL12216
Riska E, Heikell T.
Gender and images of heart disease in Scandinavian drug advertising.
Scand J Public Health 2007 Jul 16;:1-6:epub ahead of print
http://www.informaworld.com/smpp/content?content=10.1080/14034940701349233

HSL12365
Conn J.
Not worth the risk? Privacy advocates slam FDA's web-based safety program for high-risk drugs
Mod Healthc. 2007 July 16;37(28):36-7
Link to source with long URL

HSL11568
Feliu AL, Rupnow MF, Blount A, Boccuzzi SJ, Vermilyea J.
Resource use associated with topiramate in migraine prophylaxis.
Am J Health Syst Pharm 2007 Jul 15;64(14):1483-91
http://www.ajhp.org/cgi/content/full/64/14/1483

HSL11869
Young D.
Medication guides scrutinized.
Am J Health Syst Pharm 2007 Jul 15;64(14):1464-6
http://www.ajhp.org/cgi/content/full/64/14/1464

HSL11539
Smith R.
Head to head: Should medical journals carry drug advertising? Yes
BMJ 2007 Jul 14;335(7610):74
http://www.bmj.com/cgi/content/full/335/7610/74

HSL11540
Kamerow D.
Do adverts subvert? Are bacteria good for us?
BMJ 2007 Jul 14;335(7610)
http://www.bmj.com/cgi/content/full/335/7610/0-a

HSL11541
Williams G.
Head to head: Should medical journals carry drug advertising? No
BMJ 2007 Jul 14;335(7610):75
http://www.bmj.com/cgi/content/full/335/7610/75

HSL11542
Dyer C.
Drug industry challenges government's action on generic statins
BMJ 2007 Jul 14;335(7610):63
http://www.bmj.com/cgi/content/full/335/7610/63

HSL11699
Dyer C.
UK drug industry challenges government's action.
BMJ 2007 Jul 14;335(7610):63
http://www.bmj.com/cgi/content/full/335/7610/63

HSL11543
Vlassov V.
Drug and poison
BMJ 2007 Jul 13;335(7610):epub
http://www.bmj.com/cgi/eletters/335/7610/74

HSL11659
Segovis CM, Mueller PS, Rethlefsen ML, Larusso NF, Litin SC, Tefferi A, Habermann TM.
If you feed them, they will come: A prospective study of the effects of complimentary food on attendance and physician attitudes at medical grand rounds at an academic medical center.
BMC Med Educ 2007 Jul 12;7(1):22
http://www.biomedcentral.com/1472-6920/7/22

HSL11965
Johannesson M, Berglund EG.
[The Medical Products Agency's preparations prior to the new EU regulation on children and drugs].
Lakartidningen 2007 Jul 11-24;104(28-29):2099
Link to source with long URL

HSL11615
Fretheim A, Håvelsrud K, MacLennan G, Kristoffersen DT, Oxman AD.
Effects of Mandatory Prescribing of Thiazides for Newly Treated, Uncomplicated Hypertension: Interrupted Time-Series Analysis
PLoS Med 2007 Jul 10;4(7):e232
Link to source with long URL

HSL11507
Holtedahl KA, Meland E.
Drug trials in general practice
BMJ 2007 Jul 7;335(7609):7
http://www.bmj.com/cgi/content/full/335/7609/7-a

HSL11513
Burton B.
Drug industry loses bid to block disclosure of doctors' gifts
BMJ 2007 Jul 7;335(7609):12
http://www.bmj.com/cgi/content/full/335/7609/12-b

HSL11514
Kmietowicz Z.
Doctors reject call for a ban on advertisements of reformulated drugs
BMJ 2007 Jul 7;335(7609):14
http://www.bmj.com/cgi/content/full/335/7609/14

HSL11711
Dyer C.
Lawyers claim 'concession' over drug prescribing for Alzheimer's disease.
BMJ 2007 Jul 7;335(7609):11
http://www.bmj.com/cgi/content/full/335/7609/11

HSL11957
Baillie DWH, Salter M
Before and after pictures: A time honoured way of oversimplifying complex problems
BMJ 2007 Jul 7;335(7609):8
http://www.bmj.com/cgi/content/full/335/7609/8

HSL11958
O'Dowd A.
Economist says NICE should approve fewer costly drugs
BMJ 2007 Jul 7;335(7609):11
http://www.bmj.com/cgi/content/full/335/7609/11-a

HSL11580
Psaty BM, Furberg CD.
The record on rosiglitazone and the risk of myocardial infarction.
N Engl J Med 2007 Jul 5;357(1):67-9
http://content.nejm.org/cgi/content/extract/357/1/67

HSL11522
Goldman DP, Joyce GF, Zheng Y.
Prescription drug cost sharing: associations with medication and medical utilization and spending and health.
JAMA 2007 Jul 4;298(1):61-9
http://jama.ama-assn.org/cgi/content/full/298/1/61

HSL11575
Twombly R.
Small study on industry trial sponsorship leads to big questions about quality and bias.
J Natl Cancer Inst 2007 Jul 4;99(13):988-90
http://jnci.oxfordjournals.org/cgi/content/full/99/13/988

HSL12465
Mendelson RM, Murray CPJ.
Towards the appropriate use of diagnostic imaging
MJA 2007 Jul 2;187(1):5-6
http://www.mja.com.au/public/issues/187_01_020707/men10331_fm.html

HSL11460
Wall LL, Brown D.
The High Cost of Free Lunch
Obstet Gynecol 2007 Jul 1;110(1):169-173
http://www.greenjournal.org/cgi/content/full/110/1/169

HSL11635
Fiorino T.
Industry, clinical trials, and the cost of cancer drugs: an investor's perspective.
J Clin Oncol 2007 Jul 1;25(19):e21-3
http://jco.ascopubs.org/

HSL11702
Treadway AK, Craddock D, Leff R.
Practices of pharmacies that compound extemporaneous formulations.
Am J Health Syst Pharm 2007 Jul 1;64(13):1403-9
http://www.ajhp.org/cgi/content/full/64/13/1403

HSL11977
Maron BJ, Hauser RG.
Perspectives on the failure of pharmaceutical and medical device industries to fully protect public health interests.
Am J Cardiol 2007 Jul 1;100(1):147-51
http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(07)00628-5

HSL10482
Lo Re V 3rd, Strom BL.
The role of academia and the research community in assisting the food and drug administration to ensure U.S. drug safety.
Pharmacoepidemiol Drug Saf. 2007 July;16(7):818-25
Link to source with long URL

HSL10717
Roughead E, Pratt N, Peck R, Gilbert A.
Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.
Pharmacoepidemiol Drug Saf 2007 July;16(7):797-803
Link to source with long URL

HSL11104
Fuchs J, Hippius , M .
Inappropriate dosage instructions in package inserts
Patient Educ Couns 2007 July;67((1-2)):157-168

HSL11396
Olijhoek JK, van der Graaf Y, Haffner SM, Visseren FL; for the SMART Study Group.
Defining the metabolic syndrome: Resolving unresolved issues?
Eur J Intern Med 2007 Jul;18(4):309-13
http://linkinghub.elsevier.com/retrieve/pii/S0953-6205(07)00082-9

HSL11442
Fugh-Berman A, Bythrow J.
Bioidentical hormones for menopausal hormone therapy: variation on a theme.
J Gen Intern Med 2007 Jul;22(7):1030-4
http://www.springerlink.com/content/q4772464371784g2/

HSL11479
Shroot B.
Great expectations--SID and industry relationship: a 20-year perspective.
J Invest Dermatol 2007 Jul;127(7):1561-2
Link to source with long URL

HSL11556
Lelorier J, Rawson NS.
Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand.
Can J Cardiol 2007 Jul;23(9):711-8
Link to source with long URL

HSL11564
Doshi JA, Polsky D.
Drug benefit generosity and essential medication use among Medicare-eligible retirees.
Am J Manag Care 2007 Jul;13(7):425-31
http://www.ajmc.com/Article.cfm?ID=3341&CFID=8980495&CFTOKEN=81996035

HSL11634
Soller RW, Lightwood JM.
Comparison of the packaging and labeling of Target ClearRx with conventional prescription drug packaging and labeling.
J Am Pharm Assoc (2003) 2007 Jul-Aug;47(4):484-90
Link to source with long URL

HSL11698
Turpin DL.
Commercialism on the rise, again.
Am J Orthod Dentofacial Orthop 2007 Jul;132(1):1-2
http://linkinghub.elsevier.com/retrieve/pii/S0889-5406(07)00571-9

HSL11700
Barbui C, Cipriani A.
Publication bias in systematic reviews.
Arch Gen Psychiatry 2007 Jul;64(7):868
http://archpsyc.ama-assn.org/cgi/content/full/64/7/868-a

HSL11708
Krege S, Rohde D.
[Off-label use: update and relevance for urology].
Aktuelle Urol 2007 Jul;38(4):301-4
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-980077

HSL11784
[No authors listed].
Beware of drug soundalikes.
Consum Rep. 2007 07;72(7):53
Link to source with long URL

HSL11830
Obias-Manno D, Scott PE, Kaczmarczyk J, Miller M, Pinnow E, Lee-Bishop L, Jones-London M, Chapman K, Kallgren D, Uhl K.
The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy.
J Womens Health (Larchmt) 2007 Jul;16(6):807-17
http://www.liebertonline.com/doi/abs/10.1089/jwh.2006.0135

HSL11833
Clay P, Vaught E, Glaros A, Mangum S, Hansen D, Lindsey C.
Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.
J Manag Care Pharm 2007 Jul-Aug;13(6):506-14
http://www.amcp.org/data/jmcp/pages%20506-514.pdf

HSL11834
Dodge T, Kaufman A.
What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval
Health Psychol. 2007 July;26(4):513-7
http://content.apa.org/journals/hea/26/4/513

HSL11872
Towse A.
If it ain't broke, don't price fix it: the OFT and the PPRS.
Health Econ 2007 Jul;16(7):653-65
Link to source with long URL

HSL11877
Chadwick D, Marson T.
Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients.
Epilepsia 2007 Jul;48(7):1259-63
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1528-1167.2007.01086.x

HSL11923
Shepherd M.
Drug importation and safety of drugs obtained from Canada.
Ann Pharmacother 2007 Jul;41(7):1288-91
http://www.theannals.com/cgi/content/full/41/7/1288

HSL11972
Colmenero F, Sullivan SD, Palmer JA, Brauer CA, Bungay K, Watkins J, Neumann PJ.
Quality of clinical and economic evidence in dossier formulary submissions.
Am J Manag Care 2007 Jul;13(7):401-7
http://www.ajmc.com/Article.cfm?ID=3338&CFID=10776678&CFTOKEN=50788056

HSL11982
Powell JR, Gobburu JV.
Pharmacometrics at FDA: evolution and impact on decisions.
Clin Pharmacol Ther 2007 Jul;82(1):97-102
Link to source with long URL

HSL11986
McInnes RJ, Wright C, Haq S, McGranachan M.
Who's keeping the code? Compliance with the international code for the marketing of breast-milk substitutes in Greater Glasgow.
Public Health Nutr 2007 Jul;10(7):719-25
Link to source with long URL

HSL11987
Halford JC, Boyland EJ, Hughes G, Oliveira LP, Dovey TM.
Beyond-brand effect of television (TV) food advertisements/commercials on caloric intake and food choice of 5-7-year-old children.
Appetite 2007 Jul;49(1):263-7
Link to source with long URL

HSL12015
Heng BC.
Reluctance of medical professionals in adopting natural-cycle and minimal ovarian stimulation protocols in human clinical assisted reproduction.
Reprod Biomed Online 2007 Jul;15(1):9-11
Link to source with long URL

HSL12050
Hammond DC.
Hypnosis, placebos, and systematic research bias in biological psychiatry.
Am J Clin Hypn 2007 Jul;50(1):37-47
Link to source with long URL

HSL12063
Ahlen K, Buckley C, Pulsford AH.
AstraZeneca's response to the review by Wysowski and Pollock regarding deaths reported in association with propofol use.
Anesthesiology 2007 Jul;107(1):175
Link to source with long URL

HSL12106
Schulke DG, Krantzberg E, Grant J.
Introduction: Medicare quality improvement organizations--activities and partnerships.
J Manag Care Pharm 2007 Jul;13(6)
Link to source with long URL

HSL12111
Miller HI, Henderson DR.
Governmental influences on drug development: striking a better balance.
Nat Rev Drug Discov 2007 Jul;6(7):532-9
Link to source with long URL

HSL12151
Humphries RF.
Industry gifting should end.
Am J Crit Care 2007 Jul;16(4):332
http://ajcc.aacnjournals.org/cgi/content/full/16/4/332

HSL12285
Mansley EC, Elbasha EH, Teutsch SM, Berger ML.
The decision to conduct a head-to-head comparative trial: a game-theoretic analysis.
Med Decis Making 2007 Jul-Aug;27(4):364-79
http://mdm.sagepub.com/cgi/reprint/27/4/364

HSL12290
Shankar PR, Mishra P, Subish P, Upadhyay DK.
Can drug utilization help in promoting the more rational use of medicine? Experiences from Western Nepal
Pak J Pharm Sci. 2007 July;20(3):243-48
Link to source with long URL

HSL12307
DiSilvestro R.
What's wrong with deliberately proselytizing patients?
Am J Bioeth 2007 Jul;7(7):22-4
http://www.informaworld.com/smpp/content?content=10.1080/15265160701399610

HSL12308
McGee G, Johnson S.
Has the spread of HPV vaccine marketing conveyed immunity to common sense?
Am J Bioeth 2007 Jul;7(7):1-2
http://www.informaworld.com/smpp/content?content=10.1080/15265160701511461

HSL12309
Ludwig WD.
[Editorial comment on Krege S.et al: off-label use: an unsolved problem]
Aktuelle Urol 2007 Jul;38(4):299-300
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-980091

HSL12312
Waller DG.
Off-label and unlicensed prescribing for children: have we made any progress?
Br J Clin Pharmacol 2007 Jul;64(1):1-2
http://www.blackwell-synergy.com/doi/full/10.1111/j.1365-2125.2007.02987.x

HSL12314
Stewart D, Rouf A, Snaith A, Elliott K, Helms PJ, McLay JS.
Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.
Br J Clin Pharmacol 2007 Jul;64(1):90-5
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2007.02865.x

HSL12368
Boutros A.
How to make innovation happen--part 3.
Physician Exec 2007 Jul-Aug;33(4):56-9,
Link to source with long URL

HSL12386
Mullner M, Vamvakas S, Rietschel M, van Zwieten-Boot BJ.
Are women appropriately represented and assessed in clinical trials submitted for marketing authorization? A review of the database of the European Medicines Agency
Int J Clin Pharmacol Ther. 2007 Sep;45(9):. 2007 Sep;45(9):477-84
Link to source with long URL

HSL12394
Fajt VR.
Regulation of drugs used in feedlot diets.
Vet Clin North Am Food Anim Pract 2007 Jul;23(2):299-307,
http://linkinghub.elsevier.com/retrieve/pii/S0749-0720(07)00018-7

HSL12426
Somberg J.
Mandatory post marketing studies.
Am J Ther 2007 Jul-Aug;14(4):321
Lin